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Cytotoxic compounds from the genus Centaurea 
MOHAMMAD SHOEB 
A thesis submitted in partial fulfilment of the requirements of The Robert Gordon 
University for the degree of Doctor of Philosophy 
Abstract 
This thesis, which is divided into four chapters, represents an account on the 
isolation, identification and the assessment of bioactivity of cytotoxic compounds 
from the genus Centaurea (Family: Asteraceae alto Compositae), a large genus of 
about 500 species. The first three chapters deal with an introduction of natural 
products and Centaurea species, followed by the isolation and characterisation of 
compounds from twelve Centaurea species. The last chapter describes the 
bioactivities of extracts and isolated compounds from these species. A total of 45 
compounds were isolated from twelve Centaurea species, and only C. americana, C. 
cyanus, C. dealbata and C. macrocephala had previously been studied. Four of these 
are novel compounds. 
Four lignans arctiin, matairesinoside, matairesinol and lappaol A were isolated from 
the methanol extract of C. macrocephala seeds. Arctiin and matairesinoside were 
also isolated from the methanol extract of C. americana, C. bornmuel/eri, C. 
dealbata, C. huber-morathii, C. mucronifera, C. pamphylica, C. schischkinii and C. 
urvillei. The methanol extract of C. americana also afforded 20-hydroxyecdysone, 
24-hydroxyecdysone, lappaol A, arctigenin and a novel compound, 3" -O-caffeoyl-
(9"' ..... 3' ')-arctiin. The methanol extract of C. cyanus produced lariciresinol 4-0-~-o-
glucoside, berchemol, moschamine and cis-moschamine. Arctigenin, astragalin, 
afzelin, matairesinol and a novel indole alkaloids, schischkiniin, were isolated from 
the methanol extract of C. schischkinii. Extract from C. bornmuelleri afforded 
arctigenin, astragalin, afzelin and matairesinol. The methanol extract of C. mon/ana 
yielded berchemol, berchemol 4' -O-P-D-glucoside, p-coumaroylquinic acid, cis-p-
coumaroylquinic acid, pinoresinol, pinoresinol mono methyl ether, pinoresinol 
dimethyl ether, pinoresinol 4-0-p-o-glucoside, pinoresinol 4,4'di-0-p-o-glucoside, 
pinoresinol 4-0-apiose-( 1 ~2)-P-o-glucoside, centcyamine, cis-centcyamine, 
N-( 4-hydroxycinnamoyl)-5-hydroxytryptamine, cis-N-( 4-hydroxycinnamoyl)-5-
hydroxytryptamine, moschamine, cis-moschamine, tryptamine and two novel 
compounds, flavanone-apiose-glucuronic acid and montamine. C. gigantea afforded 
arctiopicrin, 8-0-( 4-hydroxy-3-methylbutanoyl)-salonitenolide, chlorogenic acid, 
cirsiliol, isoquercetrin, orientin, isoorientin and 4" -hydroxybenzoyl-isoorientin. 
General toxicity, cytotoxicity and antioxidant activity of the extracts and isolated 
compounds were evaluated, respectively, by the brine shrimp lethality assay, MTT 
assay on human colon cancer cell line (CaCo-2) and DPPH assay. Among all the 
species, the methanol extract of C. bornmuelleri, C. gigantea, C. huber-morathii and 
C. montana were the most toxic extracts in brine shrimp lethality and MTT assay. 
Arctigenin (IC50=7.0 J.1M), matairesinol, montamine (IC50=43.9 IlM) and lappol A, 
schischkiniin, arctiopicrin (IC50=8.5 J.1M) and 8-0-( 4-hydroxy-3-methylbutanoyl)-
salonitenolide (IC50=26.4 J.1M) showed higher cytotoxicity against MTT assay. 
Matairesinoside (ICso=2.2 x 10-3 mg/mL), matairesinol (lCso=2.0 x 10-3 mg/mL) and 
schischkiniin (lC50=3.8 x 10-3 mg/mL) exhibited significant free radical scavenging 
activities towards DPPH assay. 
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CHAPTER ONE 
Introduction 
1 Introduction 
1.1 Background 
Natural Products, especially plants, have been used for the treatment of various 
diseases for thousands of years. Terrestrial plants have been used as medicines in 
Egypt, China, India and Greece from ancient time and an impressive number of 
modem drugs have been developed from them. The first written records on the 
medicinal uses of plants appeared in about 2600 BC from the Sumerians and 
Akkaidians. 1 The "Ebers Papyrus", the best known Egyptian pharmaceutical record, 
which documented over 700 drugs, represents the history of Egyptian medicine 
dated from 1500 BC. The Chinese Materia Medica, which describes more than 600 
medicinal plants, has been well documented with the first record dating from about 
1100 BC? Documentation of the Ayurvedic system recorded in Susruta and Charaka 
dates from about 1000 BC.3 The Greeks also contributed substantially to the rational 
development of the herbal drugs. Dioscorides, the Greek physician (lOO A.D.), 
described in his work "De Materia Medica" more than 600 medicinal plants.) The 
World Health Organization estimates that approximately 80% of the world's 
inhabitants rely on traditional medicine for their primary health care.4 Thirty-nine 
percent of the 520 new drugs approved between 1983 and 1994 were natural 
products and the proportion of antibacterials and anticancer drugs derived from 
natural products, was more than 60%? Analysis of data on prescriptions dispensed 
from community pharmacies in the United States from 1959 to 1980 indicates that 
about 25% of them contained plant extracts or active principles derived from higher 
plants, and at least 119 chemical substances, derived from 90 plant species, can be 
considered important drugs currently in use in one or more countries. S Various types 
of new diseases have emerged recently, and microbes are becoming resistant to 
2 
current drugs. Plants can serve to combat diseases by providing new drugs in three 
different ways: firstly, by acting as new drugs which can be used in an unmodified 
state (e.g. vincristine from Catharanthus roseus), secondly, by providing chemical 
building blocks used to synthesise more complex molecules (e.g. diosgenin from 
Dioscorea floribunda for the synthesis of oral contraceptives) and thirdly, by 
indicating new modes of pharmacological action that allow complete synthesis of 
novel analogues (e.g. most of these semisynthetic analogues of penicillin from 
Penicillium notatum).6 
The discovery and development of new drugs from natural products requires close 
collaboration between chemists, pharmacologists, biochemists, taxonomists, 
zoologists and others. The National Cancer Institute (NCI), USA has established 
collaborations between organisations worldwide including Bangladesh, Brazil, 
China, Costa Rica, Iceland, Malaysia, Panama, Russia, South Africa and Zimbabwe 
for collection, extraction and isolation of natural products for their drug discovery 
program.? 
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The isolation of morphine (1) from opium poppy (Papaver somnijerum)8 in 1816 by 
the German pharmacist Serturner inspired scientists to isolate active compounds 
3 
from plants for drug discovery. The French pharmacists Caventou and Pelletier 
reported the isolation of antimalarial drug quinine (2) from the bark of Cinchona 
officinalis in 1820.9,10 The discovery of penicillin (3) from Penicillium notatum ll by 
Fleming, Florey and Chain directed scientists to other natural sources in the hunt for 
novel bioactive compounds. The isolation of the vinca alkaloids, vinblastine (4) and 
vincristine (5) from Catharanthus rose us (formerly Vinca rosea Linn) introduced a 
new era of the use of plant material as anticancer agents. They were approved for the 
treatment of malignant diseases in 1974.1 The discovery of Taxol® (6) from the 
bark of the Pacific yew, Taxus brevi/olia, is another evidence of the success in 
natural product drug discovery. The structure of Taxol® was elucidated in 1971, yet 
was not approved for use until mid 1990'S.12 Taxol® is significantly active against 
ovarian cancer, advanced breast cancer, small and non-small cell lung cancer. 13 
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1.2 Plant Derived Anticancer Agents 
Plants have long been used in the treatment of cancer. 14 The National Cancer 
Institute collected about 35,000 plant samples from 20 countries and has screened 
around 114,000 extracts for anticancer activity. Of the 92 anticancer drugs 
commercially available prior to 1983 in the US and approved world wide between 
1983 and 1994, 60% are of natural origin? In this instance, natural origin is defined 
as natural products, derivatives of natural products or synthetic pharmaceuticals 
based on natural product models. IS 
7 
5 
HO 
Me __ ",·· 
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Camptothecin (7), isolated from the Chinese ornamental tree Camptotheca 
acuminate, was advanced to clinical trials by NCI in the 1970s but was dropped 
because of severe bladder toxicity.16 Topotecan (8) and irinotecan (9) are semi-
synthetic derivatives of 7 and have shown significant antitumour activity against 
ovarian and colorectal cancer, respectively. 17.18 Epipodophyllotoxin is an isomer of 
podophyllotoxin (10) which was isolated as the active antitumour agent from the 
roots of Podophyllum peltatum and Podophyllum emodi. 19 Etoposide (11) and 
teniposide (12) are two semi-synthetic derivatives of epipodophyllotoxin and have 
shown significant activity against small-cell lung carcinoma.2o 
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Flavopiridol (13) is a synthetic flavone, derived from the plant alkaloid rohitukine, 
which was isolated from Dysoxylum binectariJerum.21 It is currently in phase 11 
clinical trials against a broad range of tumours.22 Homoharringtonine (14), isolated 
from the Chinese tree Cephalotaxus harringtonia var. drupacea, has shown efficacy 
against various leukemias.23•24 Elliptinium (15), a derivative of ellipticine, isolated 
from a Fijian medicinal plant Bleekeria vitensis, is marketed in France for the 
f 25 treatment 0 breast cancer. 
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1.3 The Genus Centaurea 
The genus Centaurea belongs to the family Asteraceae alto Compositae and 
comprises about 500 species which are distributed mainly in Turkey, Iran, Greece, 
Algeria, North America and some parts of Asia.26 Centaurea, which is the third 
largest genus of Asteraceae family in Turkey, is represented by 177 species, 
distributed mainly in the south-western, central, and eastern parts of the country and 
about 109 species are endemic (endemism ratio: 61.6%).27 A higher endemism ratio 
implies that Turkey is one of the gene centres of this genus. Many species of this 
genus have traditionally been used to cure various ailments, e.g. diabetes, diarrhoea, 
rheumatism, malaria, hypertension etc.28 In Turkey, C. cyanus and C. scabiosa are 
used against coughs and as liver-strengthening, itch eliminating, and ophthalmic 
8 
remedies?9,30 C. calcitrapa, C. solstitialis and C. melitensis were found to have 
hypoglycemic effects and C. calcitrapa, C. iberica and C. jacea to possess an 
antipyretic effect.31 ,32 C. seridis L. var. maritime showed antidiabetic activity in 
streptozotocin-induced diabetic rats and p-sitosterol 3-P D-glucoside was found 
responsible for the activity of this plant.33 Aqueous extracts of C. aspera L. showed 
hypoglycemic activity in normal and alloxan-diabetic rats.34 The roots of C. ornate 
has been used as traditional medicine in Spain as depuratives and cholagogues.35 
Ingestion of C. repens by horses was reported to cause movement disorder and 
neurodegenerative disorder, which is comparable to Parkinson's disease with respect 
to symptoms and pathology.36 Several plant secondary metabolites including 
sesquiterpene lactones, lignan, alkaloids, flavonoids, etc., have been reported from 
various species of Centaurea, and many of those compounds have also been found to 
have different kinds of potential pharmacological properties.28 
1.4 Phytochemistry of the Genus Cenlaurea 
Centaurea is a big genus, but only a small portion has been investigated for 
secondary metabolites to date. An extensive summary of secondary metabolites 
isolated from Centaurea species is presented in Table 1. Sesquiterpene lactones are 
the most investigated secondary metabolites from this genus and the alkaloids are the 
least. Sesquiterpene lactones, chlorohyssopifolin A (68), cynaropicrin (47) and 
deacylcynaropicrin (46), from this genus exhibit cytotoxic and cytostatic activities.37-
39 Sesquiterpene lactones isolated from the aerial parts of C. zuccariniana, C. achaia 
and C. thessala were found to have cytotoxic effect in five human celllines.4o 
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1.4.1 Sesquiterpenoids 
The terpenoids are formed by head-to-tail condensation of 5-carbon isoprene 
precursors, dimethylallyl diphosphate (DMAP) and isopentenyl diphosphate (lpp).41 
Two such units form monoterpenoids (Scheme 1) and three such units form 
sesquiterpenoids. Thus, terpenoids are classified according to the number of isoprene 
units from which they are biogenetically derived. In monoterpenoid biosynthesis, the 
first 10-carbon intermediate, formed from the union of DMAP and IPP, is geranyl 
diphosphate which may undergo further enzymatic modification to yield acyclic 
monoterpenes. However, monocyclic and bicyclic monoterpenoids require a 
cyclising enzyme to complete their biosynthesis. Lower terpenoids are volatile 
compounds and approximately 20000 different terpenes and terpenoids have been 
characterised from plant kingdom so far.42 
Sesquiterpenoids are 15 carbon compounds formed by the assembly of three 
isoprenoid units and are founds in many living systems but particularly in higher 
plants. The biosynthesis of sesquiterpenoids initiates with the formation of famesyl 
diphosphate from the condensation of geranyl diphosphate and IPP. This then 
undergoes a variety of enzymatic modifications to produce different sesquiterpenoids 
found in nature.43 Sesquiterepenoids co-occur with monoterpenoids in plant essential 
oils and can usually be distinguished by their higher boiling points. The genus 
Centaurea produces a variety of compounds, the majority of them are sesquiterpene 
lactones. Biosynthesis of carvone, a monoterpenoid from Mentha spicata is shown in 
Scheme 1.41 
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Table 1. Plant secondary metabolites from Centaurea species 
Name of species Plant Compounds Type References 
Earts 
C. adjarica Alb. Aerial Centaurepensin (68) Sesquiterpene 44 
Syn. C. koenigii Chlorojanerin (61) lactones 
Sosn. Janerin (78) 
Repin (77) 
C. aegialophila Aerial Cnicin (17) Sesquiterpene 45 
Wagenitz Dehydromelitensin (87) lactones 
Elemanolide (88) 
C. aegyptica L. Aerial Stigmasterol (156) Steroids 46 
~-sitosterol (155) 
Taraxasterol 
Chlorojanerin (61) Sesquiterpene 
lactones 
C. affinis Friv. Aerial Cnicin (17) Sesquiterpene 47 
Salonitenolide (16) lactones 
Apigenin (108) Flavonoids 
Eupatorin 
Salvigenin (115) 
Arctigenin (139) Lignans 
Matairesinol (140) 
C. alba L. Aerial Cnicin (17) Sesquiterepen 48 
Cnicin 4' -a-acetate (18) lactones 
Salonitenolide (16) 
Dihyrdosalonitenolide 
(32) 
Salonitenolide 8-0-(4'-
acetoxy-5' -hydroxy)-
angelate (24) 
C. alexandrina Apigenin (108) Flavonoids 49 
Del. Luteolin (112) 
Quercetin (125) 
Rutin 
12 
C. achaia Boiss. Aerial 8a.-O-(3-Hydroxy-2- Sesquiterpene 40 
& Heldr. methylenepropanoyl- lactones 
dehydromelitensin (90) 
C. americana Seed Cynaropicrin (47) Sesquiterpene 50-52 
Nutt. lactones 
Arctiin (137) Lignans 
Matairesinoside (138) 
20-Hydroxyecdysone Phytoecdysteroid 
(169) 
3,4-Dihydroxycinnamic Phenylpropane 
acid derivatives 
~-Sitosterol (155) Steroids 
C. aspera L. var. Aerial Benzoic acid Aromatic 53-54 
subinermis DC. p-Hydroxy benzoic acid compounds 
p-Coumaric acid Phenyl propane 
derivatives 
Scopoletin (154) Coumarins 
Eupafolin (113) Flavonoids 
Hispidulin (117) 
Jaceosidin (118) 
Pectolinarigenin (116) 
Eudesmanolide A (103) Sesquiterpene 
Eudesmanolide B (104) lactones 
Dehydromelitensin (87) 
Isomelitensin (86) 
Melitensin (82) 
StenophyUolide (28) 
Dihydrostenophyllolide 
(29) 
C. aspera L. var Flower Benzoic acid Aromatic 55 
stenophylla p-Hydroxybenzoic acid compounds 
Apigenin (108) Flavonoids 
Eupafolin (113) 
EthyI7-0-apigenin-
glucuronate 
~-Sitosterol (155) Steroids 
Stigmasterol glucoside 
13 
C. aspera L. var Flower Melitensin (S2) Sesquiterpene 55 
stenophylla Dehydromelitensin (S7) lactones 
Stenophyllolide (2S) 
C. aspera L. Aerial Cnicin (17) Sesquiterpene 56 
subsp. aspera and Cnicin 4'-0-acetate (IS) lactones 
C. aspera L. Elemacarmanin (92) 
subsp. Gennacranolide 25 
stenophylla Gennacranolide 32 
(Dufour) Nyman Gennacranolide 36 
(syn. C. Onopordopicrin (26) 
stenophylla Salonitenolide (16) 
Dufour) 
I-Hydroxy-3-methyl-2-
butenoic acid ester of 
salonitenolide (22) 
Salonitenolide 8-0-(4'-
acetoxy-5' -hydroxy)-
angelate (24) 
Stenophyllolide (2S) 
Dihydrostenophyllolide 
(29) 
C. attica ssp. Aerial Atticin (97) Sesquiterpene 57-58 
attica Cnicin (17) lactones 
Cnicin 4' -a-acetate (IS) 
80.-[ 4-acetoxy-5 -hydroxy-
angelate ]-salonitenolide 
(24) 
8a.-(3,4-dihydroxy-2-
methylene-butanoyloxy)-
dehydromelitensin (SS) 
Methyl 80.-(3,4-
dihydroxy-2-methylene-
butanoyloxy)-6a.,15-
dihydroxyelema-l,3,11 
(13)-trien-12-oate (91) 
Malacitanolide (95) 
4' -acetoxy-malacitanolide 
(90) 
8a.-(hydroxy-4-epi-
Sonchucarpolide (94) 
C. bella. Trautv. Aerial Cebellin J Sesquiterpene 44 
lactones 
14 
C. bella Trautv. Aerial Cebellin N (54) Sesquiterpene 59 
Cebellin 0 (SS) lactones 
Cynaropicrin (47) 
19-Desoxychloroj anerin 
(62) 
8-Deacyloxy-8a-[2-
methylacryloxy]-
Subluteolide (78) 
C. behen L. Leaves Aguerin B (SO) Sesquiterpene 60 
Cynaropicrin (47) lactones 
Desacylcynaropicrin (46) 
Grosshemin (58) 
Mono acetyl solstitalin A 
(59) 
Circimaritin (110) Flavonoids 
C. bombycina Aerial Cnicin (17) Sesquiterpene 61 
Salonitenolide (16) lactones 
Salonitenolide 8-0- (4'-
acetoxy-5'-
hydroxyangelate (24) 
C. bracteata Aerial Axillarin (126) Flavonoids 62,63 
Scop. Axillarin 7-glucoside 
Bracteoside (135) 
Centabractein (134) 
Centradixin (133) 
Hispidulin-7-sulphate 
Jaceidin (120) 
Jacein (119) 
Luteolin (112) 
Nepetin 7-sulphate 
Patuletin 7 -sulphate 
Nepetin (113) 
Centaureidin 
Hispidulin (117) 
Apigenin 7-glucuronide 
3,4 Dicaffeoylquinic acid Quinic acid 
3-Caffeoylquinic acid derivatives 
methyl ester 
Caffeic acid Phenylpropane 
Protocatechuic derivatives 
P-Sitosterol-3-glucoside 
5- Caffeoylquinic acid 
15 
C. ca/citrapa L. Aerial Cnicin (17) Sesquiterpene 49,64,65 
Cnicin 4'-O-acetate (18) lactones 
Melitensin (82) 
Salonitenolide (16) 
11~, 13-a 
Dihydroxygermacra-
1 (1 O)E,4E-diene-
6~, 11 ~H-12,6-olide-
dihydro-salonitenolide 
(31) 
lla, 13~-
Dihydroxygermacra-
1 (1 O)E,4E-diene-
6~, 11 ~H-12,6-olide-
dihydro-salonitenolide 
(32) 
Arctigenin (139) 
Lignans Matairesinol (140) 
Pinoresinol (144) 
7' (S)-hydroxyarctigenin 
(142) 
Astragalin (123) 
Flavonoids Luteolin (112) 
Quercetin (125) 
Kaempferol (122) 
Apigenin (108) 
Naringenin 
p-Hydroxyacetophenone 
Chalcone (167) 
eis-isomer of 167 (168) 
C. canariensis Aguerin A (51) Sesquiterpene 66 
Aguerin B (50) lactones 
Cynaropicrin (47) 
Deacylcynaropicrin (46) 
C. caslel/ana Aerial Artemissifolin Sesquiterpene 67 
Boiss Dehydromelitensin (87) lactones 
11~,15-
Dehydroxysaussurea (85) 
Centaurea Aerial Cnicin (17) Sesquiterpene 68 
eineraria L. ssp. Cnicin 4' -O-acetate (18) lactones 
busambarensis Dehydromelitensin (87) 
16 
C. cineraria ssp. Aerial Cnicin (17) Sesquiterpene 69 
umbrosa Cnicin 4'-O-acetate (18) lactones 
Elemandienolide 88 
Salvigenin (115) Flavonoids 
Eupatilin (121) 
Jaceosidin (118) 
C. conifera L. Aerial Chlorojanerin (61) Sesquiterpene 48,68 
Chlorohyssopifolin A lactones 
(68) 
Centaurepensin 17' 
epimer (69) 
Janerin (78) 
Repin (77) 
Subluteolide (76) 
C. collina L. Aerial 3J3-Hydroxy-8a- Sesquiterpene 70 
epoxymethylacriloiloxy-4 lactones 
(15)10 (14),1 I (13)-trien-
(I aH),( 5 aH)-guaian-
6,12-olide (43) 
IIJ3,13-Dihydro 
derivative of guaianolide 
43 (44) 
C. cyanus Centcyamine (146) Alkaloids 71-73 
L. cis-Centcyamine (147) 
Moschamine (148) 
cis-Moschamine (149) 
Scopoletin (154) Coumarins 
Umbelliferone (153) 
Apigenin (108) Flavonoids 
Apigenin 4'-O-J3-D-
glucoside 
Hispidulin (117) 
Isorhamnetin (127) 
Isorhamnetin 7-0-J3-D-
glucoside 
Kaempferol 7-0-J3-D-
glucoside 
Kaempferol (122) 
Luteolin (112) 
Quercetin (125) 
17 
C. cyanus Aerial Caffeic acid Phenyl propane 72 
L. derivatives 
Chlorogenic acid (168) Quinic acid 
N eochlorogenic derivatives 
Isochlorogenic acids 
C. diffusa Lam. Aerial Cnicin (17) Sesquiterpene 74 
Cnicin 4' -O-acetate (18) lactones 
1,2-Diangelyloxyglucose 
(163) 
1-(3-Methylbutanoyloxy) 
2-angelyloxyglucose 
(164) 
C. furfuracea Aerial Apigenin (108) Flavonoids 75-76 
Coss. Et Kral Apigenin 7-0-glucoside 
Apigenin 7-0-
methyl glucuronide 
Cirsimaritin (110) 
Hispidulin (117) 
Hispidulin 7-0-glucoside 
Patelutin 7-0-glucoside 
C. glomerata Aerial Arctigenin (139) Lignans 49,77 
Vahl. 
I-Hydroxy-3-methyl-2- Sesquiterpene 
butenoic acid ester of lactones 
salonitenolide (22) 
Isomer of 22 (23) 
11,13-Dihydro butenoic 
acid ester of 
salonitenolide (33) 
Dihydroonopordopicrin 
(34) 
Apigenin (108) Flavonoids 
Luteolin (112) 
Quercetin (125) 
C. granata L. Aerial 8a-Hydroxy-l1p,13- Sesquiterpene 78 
dihydro onopordaldehyde lactones 
(102) 
5-Hydroxy-6, 7,3',4'- Flavonoids 
tetramethoxyflavone 
18 
C. granatensis Aerial Cnicin (17) Sesquiterpene 61 
lactones 
C. hermannii F. Aerial Cynaropicrin (47) Sesquiterpene 79 
Hermann Chlorojanerin (61) lactones 
Janerin (78) 
P-Sitosterol (155) Steroids 
C. horrida Bad. Aerial Horridin (136) Flavonoids 80 
C. incana Aerial Janerin (78) Sesquiterpene 61,81- 82 
Onopordopicrin (19) lactones 
Repin (77) 
3,5'-Dimethyl myricetin Flavonoids 
7 -O-glucoside 
2" -O-glucosyl-6-C-
glucosylapigenin 
3'Methyl myricetin 7-0-
glucoside 
6-Methoxyapigenin 
6-Methoxyluteolin 
6-Methoxykaempferol 
6-Methoxyquercetin 
Apigenin-7-
methylgalacturonide 
Hispidulin 7-0-glucoside 
6-Methoxyquercetin 7-0-
glucoside 
C. isaurica Hub. Aerial Janerin (78) Sesquiterpene 83 
Mor. lactones 
P-Sitosterol 3-0- Steroids 
glucoside 
Protocatechuic acid Coumarins 
Scopoletin (140) 
Chlorogenic acid (168) Quinic acid 
derivatives 
Jacein (119) Flavonoids 
Centaurein 
Kaempferol-3 -O-P-
glucopyranoside (123) 
quercetin-3-0-~-
glucopyranoside (126) 
Arctiin (137) Lignans 
19 
C. inermis Velen Aerial Astragalin (123) Flavonoids 84 
Nepetin (113) 
C. kotschyi (var. Aerial Cynaropicrin (47) Sesquiterpene 85 
kotschyi) Boiss. Deacylcynaropicrin (46) lactones 
Linichlorin B (48) 
Linichlorin B derivative 
(49) 
C. pabotii Aerial Aguerin A (51) Sesquiterpene 64 
Wagenitz Dihydrodeacylcyaropicrin lactones 
(53) 
Deacylcynaropicrin 8-0-
(3-hydroxy-2-
methylpropionate) (52) 
C. pallescens Astragalin (123) Flavonoids 49 
Del. Apigenin (108) 
Kaempferol (122) 
Luteolin (112) 
Quercetin (125) 
C. paniculata Aerial Stigmasterol (156) Steroids 86 
ssp. castellana ~-sitosterol (155) 
T araxasterol 
Cirsiliol (114) Flavonoids 
Cirsimaritin (110) 
Cnicin (17) Sesquiterpene 
Cnicin 4'-0-acetate (18) lactones 
C. persica Boiss. Aerial Stigmasterol (156) Steroids 87 
Taraxasterol 
Lupeol (157) 
Matairesinol (140) Lignans 
C. monticola Cnicin (17) Sesquiterpene 61 
Cnicin 4' -a-acetate (18) lactones 
C. macrocephala Seed Arctigenin (139) Lignans 88,89 
Muss. Puschk. Ex 
Willd. Isoorientin (128) Flavonoids 
Isovitexin (129) 
Isoquercitrin (126) 
Trifolin (124) 
Rutin 
20 
C. maroccana Cnicin (17) Sesquiterpene 61 
Cnicin 4' -0- acetate (18) lactones 
Salonitenolide (16) 
Dihydrosalonitenolide 
(32) 
C. marschalliana Aerial Chlorojanerin (61) Sesquiterpene 44 
Spreng. Cebellin D lactones 
Acroptilin (79) 
Janerin (78) 
C. malacifana Cnicin (17) Sesquiterpene 90 
Cnicin 4'-0- acetate (18) lactones 
Malacitanolide (95) 
8-0-( -acetoxyangeloyl) 
salonitenolide (24) 
C. melitensis L. Aerial Arctiopicrin (21) Sesquiterpene 91,92 
Melitensin (82) lactones 
Melitensin-~-
hydroxyisobutyrate (83) 
Dehydromelitensin-~-
hydroxyisobutyrate (84) 
Onopordopicrin (19) 
Salonitenolide (16) 
C. moschata L. Seeds Moschamine (148) Alkaloid 93-96 
cis-Moschamine (149) 
Moschamindole (150) 
Moschamindolol (151) 
Moschamide (152) 
Moschatine (162) 
20-Hydroxyecdysone Ecdysteroids 
(169) 
C. musimomum Aerial 3 Oxo-4a-acetoxy-15- Sesquiterpene 97 
hydroxy-1 aH, 5aH, 6~H, lactones 
7aH,11pH-gui-1O(14)-
ene-6, 12-olide (56) 
3 Oxo-4a-hydroxy-15-
hydroxy-l aH, 5aH, 6~H, 
7aH, 11~H-gui-1O(14)-
ene-6, 12-olide (57) 
21 
C. napifolia L. Aerial Cnicin (17) Sesquiterpene 98,99 
Cnicin 4'-O-acetate (18) lactones 
Melitensin (82) 
Lappaol A (143) Lignans 
Cirsimaritin (110) Flavonoids 
Hispidulin (117) 
Quercetin (125) 
1,2-Diacylated glucose 
(165) 
C. nervosa Roots Apigenin (108) Flavonoids 100 
Willd. and Kaempferol 3-methyl 
Flower ether 
laceidin (120) 
Hispidulin (117) 
laceosidin (118) 
C. nicaensis Aerial Amarin (20) Sesquiterpene 101,102 
Cnicin (17) lactones 
Dihydroamarin (35) 
Elemadienolide (93) 
IIP(H),13-Dihydrocnicin 
Melitensin (82) 
Onopordopicrin (19) 
llP(H),13-
Dihydrosalonitenolide 
(32) 
Lappol A (143) Lignans 
C. nicolai Bald. Aerial Kandavanolide (39) Sesquiterpene 103,104 
Salograviolide A (38) lactones 
3 -O-deacetyl-9-0-
acetylsalograviolide A 
(41) 
9-0-acetylsalograviolide 
A (42) 
Salograviolide B (45) 
Matairesinol (140) Lignans 
Arctinal Dithiophenes 
22 
C. nigra L. Seed Arctigenin (139) Lignans 105 
Arctiin (137) 
Matairesinol (140) 
Matairesinoside (138) 
Thujaplicatin methyl ester 
(141) 
Moschamine (148) Alkaloids 
N-(p-Coumaroyl)-
serotonin (145) 
C. orphan idea Aerial Salonitenolide (16) Sesquiterpene 106 
Heldr. & Sart. Ex Cnicin (17) lactones 
Boiss. Cnicin 4' -O-acetate (18) 
Malacitenolide (97) 
8 a-O-4-epi-
Sonchucarpolide (94) 
8 a-O-( 4-Acetoxy-3-
hydroxy-2-methylene-
butanoyloxy)-4-epi-
sonchucarpolide (96) 
8a-O-(3,4-Dihydroxy-
methylene-butanoyloxy)-
dehydromelitensin (88) 
Apigenin (108) Flavonoids 
Cirsimaritin (110) 
Luteolin (112) 
3-Methoxykaempferol 
Pinoresinol (144) Lignans 
C. Aerial Chlorojanerin (61) Sesquiterpene 44 
phaeopappoides Cynaropicrin (47) lactones 
Bordz. lanerin (78) 
C. phrygia Roots, Apigenin (108) Flavonoids 100 
Green Kaempferol 3-methyl 
parts, ether 
Flower Kaempferol 3,6-dimethyl 
ether 
laceidin (120) 
Centaureidin 
Hispidulin (117) 
laceosidin (118) 
Arctigenin (139) Lignans 
23 
C. 
pseudoscabiosa 
subsp. 
Pseudoscabiosa 
Boiss. et Buhse 
C. Roots 
ptosimopappoides 
Wagenitz 
Aerial 
Chrysin (107) 
Chrysin 7 -O-glucuronide 
Chrysin 6-C-glucoside 
Chrysin 8-C-glucoside 
Chrysin 7-glucuronide, 
Hispidulin (117) 
Luteolin 7-glucoside, 
Pinocembrin 7-0-a-
arabinopyranosyl-( 1 ~2)-
p-glucopyranoside (130) 
Chrysin 7-0- P -
glactopyranuronoside 
(131) 
Baicalein 6-methyl ether 
Baicalein 6-methylether-
7-0- p-
galactopyranuronoside 
(132) 
17p,21P-Epoxy-16a-
ethoxy-hopan-3p-ol (159) 
3 p-acetoxyhop-17(21 )ene 
(158) 
17p,21 P -Epoxyhopan-3 
p-ol (160) 
3- p-Acetoxy-17,24-
dioxo-baccharane (161) 
11,13-Dihydro-
desacetylcynaropicrin 
(53) 
Cynaropicrin (47) 
Scopoletin (154) 
Stigmasterol (156) 
Flavonoids 
Triterpenes 
Sesquiterpene 
lactones 
Coumarins 
Steroids 
107 
108 
24 
C. raphanina ssp. Aerial Cnicin (17) Sesquiterpene 109 
Mixta (DC.) lactones 
Runemark Apigenin (108) 
Eriodictyol 7-0-~-D- Flavonoids 
glucoside 
Kaempferol 3-0-~-D-
glucopyranoside 
Apigenin 7 -O-~-D-
glucopyranoside 
Apigenin 4'-O-~-D-
glucopyranoside 
7,4 Dimethoxykaempferol 
Eriodictyol 
Matairesinol (140) Lignans 
C. repens L. Aerial Cynaropicrin (47) Sesquiterpene 110 
Janerin (78) lactones 
Repin (71) 
C. saloni/ana Aerial Salonitenolide (16) Sesquiterpene 111-114 
Salonitolide (37) lactones 
Salograviolide A (38) 
Salograviolide B (45) 
Kandavanolide (39) 
Salograviolide C (40) 
Aguerin A (51) 
Centaurea Seed Arctigenin (139) Lignans 115 
scabiosa L. Matairesinol (140) 
Matairesinoside (138) 
7 (S)-hydroxy-arctigenin 
(142) 
C. scoparia Sieb. Chlorojanerin (62) Sesquiterpene 116-121 
Chloroscoparin (63) lactones 
8-Deacylcentaurepensin 
8-0-( 4-hydroxy)-
tiglate(64) 
Chlorohyssopifoli B (65) 
Diain (70) 
Janerin (78) 
Cynaropicrin (47) 
Deacylcynaropicrin (46) 
Janerin (78) 
Cynaropicrin (47) 
Deacylcynaropicrin (46) 
25 
C. scoparia Sieb. Aerial 4-~-(Chloromethyl)- Sesquiterpene 
3p,4a-dihydroxy-8a-(3- lactones 
formyl-2-methyl-
propenoyloxy)-
laH,5aH,6~H, 7aH-
guai-1O(14),II(13)-dien-
6, 12-olide (66) 
4-~-(Chloromethyl)-
3 ~,4a-dihydroxy-8a­
(sarracenoyloxy)-
1 aH,5aH,6~H, 7aH-guai-
1O(14),II(13)-dien-6,12-
olide (67) 
8a-Hydroxy-3P-
(benzoyloxy)-
1 aH,5aH, 6 ~ H, 7 aH -guai-
4(15),1O(14)11(13)-trien-
6, 12-olide (71) 
3~-Hydroxy-8a-(3,4-
dimethoxybenzoyloxy)-
11~, 13-dihydro-
1 aH,5aH,6~H, 7aH-guai-
4( 15), 1 Q( 14 )dien-6, 12-
olide (72) 
3~,8a-O-Di-(4-
hydroxytigloyl)-
1 aH,5aH,6~H, 7aH-guai-
4(15),1 Q( 14),11 (13 )triene-
6, 12-olide (73) 
Cebellin F 
8-Angelyloxy-3-hydroxy 
guai-
3(15),IQ(14),11(13)triene-
6, 12-o1ide (75) 
Desacylcynaropicrin (46) 
8a,4' -(Hydroxytiglinate)-
8-deacyloxysubliteolide 
(81) 
8-Desacylrepin (80) 
Chlorohyssopifolin A 
(68) 
Chlorohyssopifolin B (65) 
116-121 
26 
C. scoparia Sieb. Apigenin (108) Flavonoids 118 
Luteolin (112) 
Salvigenin (115) 
Cirsimaritin (110) 
Matairesinol (140) Lignans 
Acrtigenin (139) 
C. solslitialis L. Aerail Cynaropicrin (47) Sesquiterpene 122 
subsp. schouwii Aguerin B (50) lactones 
(DC.) Dostal 
Arctiin (137) Lignans 
Matairesinol (140) 
C. sonchifolia Aerial Artemisiifolin Flavonoids 67 
Acetyl-artemisiifolin 
C. Aerial Cnicin (17) Sesquiterpene 44 
sphaerocephala 3a, 15- lactones 
subsp. Lusitanica Dihydroxycostunolide 
(Boiss. el. Reule) (27) 
Nyman 
C. Aerial Cnicin (17) Sesquiterpene 123 
sphaerocephala Cnicin 4'-0-acetate (18) lactones 
subsp Epoxylactone (30) 
sphaerocephala Dehydromelitensin (87) 
4' -Acetate of 
elemadienolide (89) 
C. sulphurea Cnicin (17) Sesquiterpene 61,67 
Willd. lactones 
Pectolinarigenin (116) Flavonoids 
C. tagananensis Aerial Cynaropicrin (47) Sesquiterpene 67 
Svent. Onopordopicrin (19) lactones 
Dehydromelitensin 8-0-
4(4'-
Hydroxymethacrylate) 
(84) 
Melitensin (82) 
Deacylcynaropicrin (46) 
C. Ihracica Aerial Chlorojanerin (61) Sesquiterpene 44 
(Janka) Hayek Cynaropicrin (47) lactones 
Janerin (78) 
27 
C. thessala ssp. Aerial 8a.-(3,4-dihydroxy-2- Sesquiterpene 40,58 
drakiensis methylene-butanoylo~y lactones 
melitensine (88) 
8a.-(3-hydroxy-4-acetoxy 
-2-methylene-
butanoyloxy melitensine 
(89) 
Acetate derivative of 99 
(100) 
C. tweediei Hook. Aerial Onopordopicrin (19) Sesquiterpene 124 
lactones 
8-(4'-
Hydroxymethacryloxy)-
15-oxohelianga-l (l0), 4, 
11 (13)-trien-6, 12-olide 
(26) 
I-Hydroxy-8-
methacryloxy-15-
oxoeudesm-l1 (l3)en-
6, 12-olide (98) 
Methyl 1,6-dihydroxy-8-
methacryloxyeudesm-
11(13)-en-15-oic acid-12-
oate (101) 
15-Hydroxy-8-( 4'-
hydroxymethacroyloxy)-
10(14), 11 (13)-
guaiadien-6,12-olide (60) 
Lignans 
Arctigenin (139) 
Matairesinol (140) 
C. uniflora subsp. Leaves Santamarin (105) Sesquiterpene 125 
nervosa Reynosin (106) lactones 
Epoxy guianolide (81) 
C. urvillei Leaves Apigenin (108) Flavonoids 126 
Stepposa Cirsimaritin (110) 
Wagenitz Cirsiliol (114) 
Hispidulin (117) 
Luteolin (112) 
Nepetin (113) 
Salvigenin (115) 
28 
C. virgata Lam Aerial Apigenin (108) Flavonoids 84 
Astragalin (123) 
Hispidulin (117) 
Jaceosidin (118) 
Nepetin (113) 
Isovitexin (128) 
C. zuccariniana Aerial 80.- Sesquiterpene 40 
DC. hydroxysonchucarpolide lactones 
(99) 
R R 
16 H 
0' "OR 
0 OH 0 
~H 21 ArOH 17 0 
n OH 0 OH 18 ~AC 22 yC 0 ~OH ~ H 19 23 0 
0 yOAC 
20 ~OAC 24 
HO 
2S 
JjOAC 
Figure 1. Structures of the sesquiterpene lactones from the genus Centaurea 
29 
26 27 
OH 
.' 
"OH 
.,,'\, 
0 0 0 
28 29 30 
.' 
"OH 
31 o 32 
R R 
"OR ~OH ~OAC .' 3S 33 
,."" +H 0 
0 34 
0 
Figure I (Cont.). Structures of the sesquiterpene lactones from the genus Centaurea 
30 
36 o 
RO "'''OR' 
0 
R R' 
38 Ac H 
39 Ac H 
40 H epoxy-methacryl 
41 H H 
42 Ac H 
HO .. ,'O~ HO 
---.--H 0 
o 
43 
o 
37 
R" 
OH 
H 
H 
OAc 
OAc 
,,'O~ 
~-H 0 
o 
44 
Figure 1 (Cont.). Structures of the sesquiterpene lactones from the genus Centaurea 
31 
AeO 
45 0 
R 
46 H 
0 
HO ""IOR 47 ~OH 
0 
0 48 ~CI 
OH 
0 
49 ~OH 
OH 
0 
50 ~ 
51 ~ 
Figure 1 (Cont.). Structures of the sesquiterpene lactones from the genus Centaurea 
32 
HO 
o 
o 
52 
o 
59 
o 
54 
. I",,, 
0 
~ OH 
OAc 
56 
57 
HO 
R 
Ac 
H 
HO 
0 
o 
60 
55 
--H 
Olf" " 
53 0 
o 
58 0 
Figure 1 (Cont.). Structures of the sesquiterpene lactones from the genus Centaurea 
33 
R 
0 
61 ArOH 
HO '''IIOR 0 
62 ArH 
0 0 
~oy 63 
o 0 
64~OH 
65 H 
70 
"'IIOH HO 
rIl ~O 
o 
71 o 
o 
72 
R 
0 
66 ~H 
0 
~ 67 0 
68 ~"-CI 
OH 
0 
69 ~CI 
OH 
o 
~OMe 
.. ,~ U OMe 
Figure 1 (Cont.). Structures of the sesquiterpene lactones from the genus Centaurea 
34 
R R' 
0 
0 ~OH 73 ~OH 
R'O ""'OR" 0 
74 H 
~OH 
0 0 
75 ~ H 
R R 
J< OH HO 76 '1 .::0 79 ~CI 
0 0 
77 R=2'-epimer 80 H 
0 
yCOH 78 
0 
HQ 
HO "'''O~CH20H 
0 
0 
81 
"Me 
...• O~OH 
0 
.' 
,,'IMe 
0 83 0 82 
Figure 1 (Cont.). Structures of the sesquiterpene lactones from the genus Centaurea 
35 
§" ~'" 
.-/..' , ~'" 
"OR 
" 
0 
o 
85 
84 o 
o 
HO 
o 86 
R 
87 H 
0 OH 
88 ~H 
0 OH 
89 ~AC 
90 5rOH 
Figure 1 (Cont.). Structures of the sesquiterpene lactones from the genus Centaurea 
36 
HO 
OH 
.... J.J: 
CY TI 6H '/", ~'" 
OH 
91 
.' 
"OR 
0 
94 
95 
96 
OH 
92 
,0 il .-
.. ' YY"OH 
o OH 
93 o 
R 
H OH 
0 OH 
~H 
;y; 
OAc 
0 OH 
"'~AC 
COOMe 
97 
Figure 1 (Cont.). Structures of the sesquiterpene lactones from the genus Centaurea 
37 
R 
0 OH 
Jly '0)l "OR 98 ", CH3 
" 
0 
99 H 
o OH 0 
0 ~AC 100 101 
R R' 
H 
"OH -
"OR ~OAC " Me, H " 103 ... ", R' 104 CH2 OH 
102 0 0 
OH 
OH 
o 
105 o 106 
Figure 1 (Cont.). Structures of the sesquiterpene lactones from the genus Centaurea 
38 
1.4.2 Flavonoids 
The flavonoids are a large group of natural products which are widespread in higher 
plants but found in some lower plants including algae. 127 They are 1S-carbon 
compounds consisting of two aromatic rings A and B, and oxygen containing 
heterocyclic ring C. Depending on the central heterocyclic ring, flavonoids can be 
unsaturated e.g. flavones and flavonols or saturated e.g. flavanones and flavans. 128 
Flavonoids are commonly associated with sugars in conjugation form and within any 
one class may be characterised as monoglycosidic, diglycosidic, etc. There are over 
2,000 glycosides of the flavones and flavonols that have been isolated to date. 
Shikimate pathways, hydroxycinnamoyl-CoA and malonyl-CoA are the precursors 
for the biosynthesis of flavonoids. Biosynthesis of kaempferol and apigenin from 
these two precursors are shown in Scheme 2. 129 About 50 flavonoids have been 
reported from the genus Centaurea until now (Table 1). 
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1.4.3 Lignans 
Lignans are a class of secondary metabolites widely encountered in the plant 
kingdom and are associated with a range of biological activities. Lignans are 
characterised as phenylpropanoid dimer linked by free-radical coupling through 8-8' 
bonds. 130 Lignans are found in roots, leaves seeds, fruits and wooden parts of plants. 
They are assumed to function as phytoalexins that is to provide protection for the 
plants against disease and pests such as wood rot fungi. 13l Secoisolariciresinol and 
matairesinol are the two most studied plant lignans. However, podophyllotoxin and 
structurally related lignans have drawn potential interest towards scientist worldwide 
because of their antitumor activities. 132 Usually, lignans exist in nature as glycosides 
and naturallignans are optically active. 
1.4.3.1 Biosynthesis of Lignans 
Monolignols such as coniferyl alcohol which is converted from phenylalanine by a 
five step enzymatic reaction-deamination, aromatic hydroxylation, O-methylation, 
CoA-dedicated ligation and NADPH mediated reduction. 133,134 The phenylpropanoid 
monolignols are thought to dimerise to C I8 structures via oxidative phenolic coupling 
reactions followed by various oxidation, reduction or alkylation steps to give the 
lignans. The Scheme 3 represents the biosynthesis of lignan in Forsythia species 
described by Lewis and coworkers. 135-138 So far about 8 lignans have been isolated 
from the genus Centaurea (Table 1). 
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1.4.4 Alkaloids 
Alkaloids are a large group of nitrogen containing secondary metabolites of plant, 
microbial or animal origin. More than 10000 alkaloids have been reported until 
now. 139 Alkaloids are usually found in the seeds, root, leaves, or bark of the plant, 
and generally occur as salts of various plant acids. They can be extracted from plant 
with acidified water or organic solvents (e.g. chloroform, methanol etc.). Usually, 
alkaloids are classified on the basis of the heterocyclic ring system they possess, e.g. 
pyrrolidine, piperidine, quinoline, isoquinoline and indole etc. Alkaloids are 
produced by secondary metabolism of primary metabolites, usually amino acids. 139 
L-Tryptophan, originating from the shikimate pathway via anthranilic acid, acts as a 
precursor of a wide range of indole alkaloids. Biosynthesis of two indole alkaloids, 
tryptamine and 5-hydroxytryptamine is shown in Scheme 4. 129 About 8 alkaloids 
have been reported from the genus Centaurea until now (Table I). 
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1.4.5 Other Secondary Metabolites 
In addition to the major classes of secondary metabolites described above several 
coumarins, steroids, terpenoids and simple phenol derivatives have been reported 
from the genus Centaurea. 
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1.5 Centaurea Species under Investigation 
1.5.1 C. americana Nutt. 
C. americana Nutt, commonly known as "Jolly Joker" or "Basket flower", is 
indigenous to Northern Americana-Coahuila and Nuevo Leon in Mexico and 
Arizona, Arkansas, Kansas, Louisiana, Missouri, New Mexico, Oklahoma and Texas 
in the USA, and also cultivated in several other countries. 140 
1.5.2 C. bornmuelleri Hausskn. Ex. Bornm. 
e. bornmuelleri Hausskn. Ex. Bornm (Section: Psephelloideae) is endemic to 
Turkey. This plant has natural growth in East Anatolia, Turkey (B7 Erzincan, 30.5 
km from Erzincan to Gumushane, 2024 m, 39°53'29" N 39°21 '6" E).141 It is a 
perennial plant with erect stems, 35-70 cm. Flowers are violet or purple. Aches and 
pappus are 7 mm and 7-9 mm respectively. 142 
1.5.3 C. cyanus L. 
e. cyanus L. (Section: Cyanus) well known as "corn flower" or bachelor's button", is 
a flowering weed endemic to Iran, Iraq, Turkey and Pakistan in Asia, and Albania, 
Bulgaria, Greece, Italy and Yugoslavia in Europe, and also cultivated and naturalised 
in many other countries of the world. It is an annual plant (15-80 cm) with blue 
flowers. 142 
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1.5.4 C. dealbata Willd. 
C. dealbata Willd. (Section: Psephellus) commonly known as "Whitewash 
fl . . d' T k 142 corn ower 1 In 1genous to ur ey. 
Figure 6. C. cyanus seeds Figure 7. C. dealbata seeds 
1.5.5 C. gigantea Schultz Bip. ex Boiss. 
C. gigantea Schultz Bip. ex Boiss. , (Section: Cynaroides) is endemic to South East 
Anatolia Turkey. The plant like dry rocky slopes. Plant is biennial with erect stem 
up to 1-1. 0 m. Leaves are densely adpressed-tomentose, Flowers are pale purplish 
but become white aft r drying. Usually flowers for a period of 7-8 months. Aches 
142 5.5-6 mm' pappus 7-8 mm. 
1.5.6 C. huber-morathii Wagenitz. 
C. huber-morathii Wagenitz (Section: Psephelloideae) is endemic to E. Anatolia, 
Turkey. The plant ha natural growth in East Anatolia, Turkey (B7 Erzincan, 30.5 
km from Erzincan to Gumu hane 2024 m, 39°53'29" N 39°21 '6" E). Plants are 
perennial with erect tern (50-70 cm). Flowers are lilac-pink with marginal radiant. 
Ache ar immatur and pappu 11-13 cm. C. huber-morathii is closely related to C. 
If . 142 bornmue .en. 
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1.4.7 C. macrocephala Muss. Puschk. Ex WilId. 
C. macrocephala Muss. Puschk. Ex Willd., (Section: Grossheimia) commonly 
known as "big-head knapweed", is a splendid border plant with large, yellow, thistle-
like flower heads, endemic to Armenia, Azerbaijan and Turkey, and also naturalised 
in many other countries of the world. 140 
1.5.8 C. montana L. 
C. monfana L., commonly known as "mountain knapweed", is an erect plant with 
large, reddish, blue center flower heads, native to Australia, Belgium and Italy, and 
also cultivated in many other countries of the world. 140 
1.5.9 C. mucronifera DC. 
C. mucronifera DC. (Section: Psephelloideae) is an endemic speCIes which is 
distributed in the Mediterranean, the Middle and the Eastern Anatolian regions of 
Turkey. It is Perennial plant with flowering stems 3-40 cm. Flowers are rose-purple, 
marginal radiant. Aches and pappus are 5-7 and 2-5 mm respectively. This plant 
I · k .. 142 prefers ca carIOUS roc y communities. 
1.5.10 C. pamphy/ica Boiss. & Heldr. 
C. pamphylica Boiss. & Heldr. (Section: Calcitrapa) is an endemic species which is 
distributed in the Mediterranean, Anatolian regions of Turkey. 142 
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1.5.11 C. chischkillii Tzvelev. 
C. schischkinii Tzvelev. (Section: Psephelloideae) is an endemic plant species to 
East Anatolia Turkey and located in Erzurum city between 1800-2060 m. It is a 
perennial plant, the stem is erect (40-80 cm), and flowers are pink, distinctly radiant. 
Aches 6-7 mm and pappus 7-8 mm. 142 This plant prefers steppy areas and road sites 
in terms of environmental characteristics. In Turkey, the natural distributing areas of 
the specie are Erzurum, Hinis, 1806 m, N 39°42'56" E 41 °48'01", Erzurum, Hinis, 
1830 m 39°42'92" E 41 °48'75", Erzurum, Tekman, 2025 m, N 39°42'23" E 
41 °48'51" , Erzurum Tekman, 2040 m, N 39°41'57" E 41°47'69" and Erzurum, 
Palandoken Mountain, 2057 m, N 39°44'32" E 41 °23'42" . 141 
Figure 8. C. schischkinii seeds Figure 9. C. bornmuelleri seeds 
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1.5.12 C urvillei subsp. armata Wagenitz 
C. urvillei subsp. armata Wagenitz (Section: Acrocentron DC.) is widely distributed 
in the steppe and calcarious rocky communities in the eastern Mediterranean, the 
Middle and the Eastern Anatolian regions of Turkey. 142 
Figure 10. C. mucronifera Figure 11. C. urvillei 
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1.6 Aims and Objective of the Present Study 
There are more than 250,000 species of higher plants existing on this planet and only 
a small portion has been explored phytochemically. It is believed that plants can 
provide potential bioactive compounds for the development of new 'leads' to combat 
diseases. Literature review has showed that Centaurea species have medicinal value 
and are used as folk medicine in Turkey and other countries. Various bioactive 
compounds have been isolated from this genus and many of the species have 
chemical diversity. However, it is believed that many of the Centaurea species have 
not been explored yet for potential cytotoxic compounds. Therefore, the primary aim 
of the present work is to investigate Centaurea species for cytotoxic compounds. 
Therefore, the objectives ofthe present work are to: 
i) extract Centaurea species and assess general toxicity of different extracts; 
ii) separate, purify and isolation of active compound (s) from extracts; 
iii) identify and elucidate structures of isolated compounds by different 
spectroscopic techniques including one dimensional and two dimensional NMR; 
iv) assess general toxicity (using brine shrimp lethality assay) and cytotoxicity 
(using MTT assay) of isolated compounds; 
v) perform antioxidant activity assays of the extracts and pure compounds. 
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CHAPTER TWO 
Materials and Methods 
2 Materials and Methods 
2.1 Plant Materials 
Aerial parts and seeds of twelve plant species of the genus Centaurea were collected 
from Turkey, and B & T, World Seeds Sari, Paguignan, 34210 Olonzac, France, for 
complete phytochemical studies. Voucher specimens for all the collections have been 
deposited in the herbarium of the Plant and Soil Science Department, University of 
Aberdeen, UK (Table 2). 
2.2 Extraction of Plant Materials 
The air dried aerial parts of each plant sample and seeds were finely ground and 
subjected to exhaustive Soxhlet extraction using, successively, n-hexane, 
dichloromethane (DCM) and methanol (MeOH). The individual extracts were 
concentrated separately, using a rotary evaporator at a maximum temperature of 
40°C and under reduced pressure. 
2.3 Isolation of Compounds 
Modem chromatographic techniques, e.g. thin layer chromatography, preparative 
thin layer chromatography, vacuum liquid chromatography, column chromatography 
and high performance liquid chromatography were applied for separation, 
purification and isolation of pure and active compounds from the crude extracts. 
2.3.1 Thin Layer Chromatography (TLC) 
Commercially available pre-coated silica gel 60 PF2s4 plates were used for initial 
screening of extracts and column fractions, checking the purity of the isolated 
compounds and for confirming the identification of known compounds by co-TLC 
60 
with authentic samples. Different types of solvent systems, ranging from non-polar to 
polar were frequently used (Table 3). 
Table 2. List of Centaurea species investigated 
Species Voucher Parts Amount (g) Source 
number 
Centaurea macrocephala PHSHOOOl Seeds 100 B&T 
Centaurea cyanus PHSHOO02 Seeds 100 B&T 
Centaurea dealbata PHSHOO03 Seeds 100 B&T 
Centaurea americana PHSHOO04 Seeds 100 B&T 
Centaurea huber-morathii PHSHOO05 Seeds 80 Turkey 
Centaurea montana PHSHOO06 Seeds 100 B&T 
Centaurea schischkinii PHSHOO07 Seeds 80 Turkey 
Centaurea bornmulleri PHSHOO09 Seeds 80 Turkey 
Centaurea gigantea PHSH0010 Aerial 100 Turkey 
Centaurea pamphylica PHSHOOll Aerial 100 Turkey 
Centaurea urvillei PHSHOO12 Aerial 100 Turkey 
Centaurea mucronifera PHSHOO13 Aerial 100 Turkey 
2.3.2 Preparative Thin Layer Chromatography (PTLC) 
PTLC was applied for separation and final purification of compounds. Plates were 
prepared by coating glass plates (20 x 20 cm) to a thickness of 0.5 mm using slurry 
made from 40 g of silica gel (Kiselgel 60 PF2S4) and 80 mL of distilled water. The 
plates were allowed to air dry and then activated in an oven at 60° C for overnight. 
The sample to be analysed was dissolved in a small amount of suitable solvent and 
applied to the plates as a uniform band 2 cm apart from the bottom edge. The plates 
were then developed in an appropriate solvent system (Table 3). Developed plates 
were allowed to dry and visualised under UV light (254 nm and 366 nm) or by 
spraying on both edges of the plate with an appropriate spray reagent. Bands of 
interest were scraped from plates and the compounds were eluted from silica with 
DCM or ethyl acetate (EtOAc) or DCM-MeOH mixture. 
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Table 3. List of solvent systems used for TLC and PTLC 
Code number Solvent system Proportion 
A n-Hexane:EtOAc 95:5 
B n-Hexane:EtOAc 90:10 
C n-Hexane:EtOAc 85:15 
0 n-Hexane:EtOAc 80:20 
E n-Hexane:EtOAc 70:30 
F n-Hexane:EtOAc 60:40 
G n-Hexane:EtOAc 50:50 
H EtOAc 100 
I n-Hexane:DCM 50:50 
J n-Hexane:DCM 30:70 
K n-Hexane:DCM 20:80 
L n-Hexane:DCM 10:90 
M DCM 100 
N DCM:MeOH 95:5 
0 DCM:MeOH 90:10 
P DCM:MeOH 80:20 
Q DCM:MeOH 70:30 
R DCM:MeOH 50:50 
S MeOH 100 
2.3.3 Vacuum Liquid Chromatography (VLC) 
VLC involves a short column, packed with TLC grade silica (Kieselgel 60 H) and 
operates under reduced pressure. 143,144 The size of the column and the height of the 
adsorbent layer were variables throughout this study and were dependent upon the 
amount of extract analysed. The column was always dry-packed with silica gel under 
suction. The sample to be separated was adsorbed onto a small amount of silica gel 
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(Kieselgel 60, mesh 70-230) and dried to free-flowing particles which were then 
applied uniformly on the top of the packed column. Elution was carried out with 
solvents of increasing polarity (Table 3). 
2.3.4 Column Chromatography (CC) 
Different types of column chromatography were used during this study. They are 
mentioned below. 
2.3.4.1 Normal Column Chromatography 
The traditional column chromatography (CC) was used for fractionation and further 
purification of extract and fractions using normal phase column grade silica gel 
(mesh 70-230). The column was packed with the slurry of silica gel in an appropriate 
solvent (e.g. n-hexane or DCM). Dry sample or solution of sample (in minimum 
volume of column packing solvent) applied to the top of the column. The column 
was then eluted with different solvent with increasing polarity. 
2.3.4.2 Sephadex LH-20 Column (Gel filtration) 
Gel filtration or size exclusion chromatography was adopted to remove pigments 
(i.e., chlorophyll) and separate compounds from VLC fractions. A simple glass 
column was packed with the slurry of Sephadex LH-20 in appropriate solvents and 
the separation was achieved according to the molecular size of the compounds. The 
sample to be separated or purified were dissolved in a small amount of solvent and 
applied to the top of the adsorbent. The column was then eluted with 20% n-hexane 
in DCM followed by 100% DCM and the DCM-MeOH mixture of increasing 
polarity. The column was finally washed with 100% MeOH to make it suitable for 
further use. 
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2.3.4.3 Solid Phase Extraction (Sep-Pak) Column 
Sep-Pak column was packed with reversed-phase silica (C I8) which is used for the 
pre-HPLC fractionation of Me OH extracts under suction. Sep-Pak columns with the 
following specification were used. 
Column- Waters Sep-Pak Cartridge, vac 35 cc, C18-lO gm 
Column size-5.5 x 2.5 cm 
Packing materials-silica, reversed-phase 
Manufacturer-Waters, USA 
2.3.5 High Performance (or Pressure) Liquid Chromatography (HPLC) 
HPLC is a sophisticated technique for analysing samples qualitatively and 
quantitatively. Both analytical and preparative reversed-phased HPLC were used 
routinely for separation and purification of compounds in this study. 
2.3.5.1 Analytical HPLC 
Reversed-phased analytical HPLC was used for the chemical profiling of the Sep-
Pak fractions, and development of a suitable mobile phase for preparative HPLC as 
well as analysis of the purity of isolated compound. A JASCO PU-1580 Intelligent 
HPLC Pump, coupled with JASCO DG-1580-53 Degasser and JASCO LG-1580-02 
Ternary Gradient Unit. and Luna CI8 column (5 J.lm, 250 mm x 4.6 mm) were used 
for this purpose. 
2.3.5.2 Preparative HPLC 
Preparative-HPLC separation was performed using a Dionex prep-HPLC system 
coupled with Gynkotek GINA50 autosampler and Dionex UVD340S Photo-Diode-
Array detector. A Luna CI8 column (10 J.lm, 250 mm x 21.2 mm) was used for this 
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purpose. This system is mentioned as Prep-HPLC-l for describing isolation of 
compounds. In some cases, semi-preparative column (Luna CI8 column; 5 J.1m,250 
mm x 10.0 mm) was used with preparative HPLC system instead of preparative 
column to purify minor fractions. This system is mentioned as Semi-Prep HPLC-l. 
2.3.5.3 Semi-Preparative HPLC 
Semi-Preparative HPLC separation was carried out using JASCO PU-2087 Plus 
intelligent Preparative Pump coupled with JASCO UV -2070 Plus Intelligent UV NIS 
detector. A Luna CI8 column (5 J.1m, 250 mm x 10.0 mm) was used with this system 
to purify minor fractions obtained from preparative HPLC. Usually, isocratic solvent 
system was used for this purpose. This system is mentioned as Semi-Prep HPLC-2 to 
describe isolation of compounds. 
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2.4 Detection of Compounds 
The following techniques were used for the detection of compounds on TLC and 
PTLC plates. 
2.4.1 UV Light 
The developed and dried plates, either TLC or PTLC, were placed under UV light 
(254 and 366 nm) to observe quenching or fluorescing compounds. 
2.4.2 Spray Reagents 
Different types of spray reagents were used depending upon the chemical nature of 
compounds expecting to be present in the crude extracts or fractions. 
2.4.2.1 Vanillin in SuI/uric acidl45 
This reagent was prepared by dissolving 1 g vanillin in 100 mL of concentrated 
sulfuric acid (H2S04)-ethanol (EtOH) mixture (1: 1) and it was used as a general 
spray reagent to detect mainly non-alkaloidal compounds. TLC or PILC plates, 
sprayed with this reagent were heated at 110°C for 15 minutes to develop a specific 
colour, indicating the type of compounds. 
2.4.2.2 Anisaldehyde-Sul/uric acid 
A mixture of 10 mL conc. H2S04 and 20 mL glacial acetic acid were poured into 
170 mL MeOH containing 1 mL anisaldehyde. The ILC plate was sprayed with this 
reagent and heated at 110°C for 15 min to visualize the spot. 
2.4.2.3 Modified Dragendorffs Reagenl46 
This reagent was prepared by mixing equal parts (v/v) of 1.7% bismuth subnitrate 
dissolved in 20% acetic acid in water and a 40% aqueous solution of potassium 
iodide. Alkaloids gave positive colour reaction (usually orange-red colour) with this 
spray reagent instantly. 
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2.5 Instrumentation 
2.5.1 General Laboratory Instrument 
2.5.1.1 Melting Point Apparatus 
Melting point of solid compounds was determined by using a Griffin melting point 
apparatus. 
2.5.1.2 Polarimeter 
The optical rotation was measured on ADP 220 Polarimeter, Bellingham, Stanley, 
Ltd. 
2.5.2 Spectroscopic Instruments 
2.5.2.1 UV Spectrophotometer 
Ultra violet (UV) spectra were obtained in methanol using a Hewlett-Packard 8453 
UV-Vis spectrometer. 
2.5.2.2IR Spectrophotometer 
Infra red (IR) spectra were obtained on AV A TAR 360 FT -IR spectrophotometer. 
2.5.2.3 Mass Spectrometry 
MS analyses were performed on a Quattro 11 triple quadrupole instrument. 
2.5.2.4 NMR Spectroscopy 
'H and 13C NMR spectra were obtained from Varian Unity Inova 400 MHz, Bruker 
AC-250, AMX 400 and DRX 600 MHz NMR spectrometer. 2D experiments ('H-'H 
COSY, HSQC, HMBC, NOESY and ROESY) were observed mainly on the Varian 
400 MHz and Bruker DRX 600 MHz NMR. Different types of deuterated solvents, 
e.g. CDCh, CD30 D and DMSO-d6 were used to prepare the sample solution for 
these experiments. 
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2.6 Structure Elucidation of Compounds 
Modem NMR techniques are the main tools for structure elucidation of unknown 
compounds. The first step is to get 'H and 13C NMR spectra. To distinguish between 
the methyl, methylene, methine and quartemary carbons, in addition to a simple 
decoupled 13C spectrum, the technique called Distortionless Enhachment by 
Polarisation Transfer (DEPT), available as DEPT 45°, 90° and 135° can be very 
useful.'47 UV and IR can be used to identify the presence of different chromophores 
and functional groups. Fast atom bombardment mass spectroscopy (F ABMS) and 
electro-spray ionisation mass spectrometry (ESIMS) are the two commonly used 
techniques for mass analysis.'48 By high resolution mass spectrometry an exact mass 
of the compound can be obtained. From UV, IR, 'H and 13C NMR data and mass 
spectra, a tentative molecular formula can be derived. A database search is 
performed based on taxonomy, to yield biological activity and known compounds 
isolated from the plant materials studied. From the database it can be determined 
whether the isolated compound has previously been reported using molecular 
formula and spectral data. This process is known as dereplication. The databases 
Dictionary of Natural Products, containing publication on most natural products, and 
NAPRALERT are the most popular databases.'49 The process of structure 
determination is illustrated in Figure 12. 
Many two dimensional NMR experiments are used to elucidate the structure. The 
first experiment commonly used is the heteronuclear single quantum coherence 
(HSQC)'47.'50 experiment that shows which proton and carbons are directly attached 
to each other. This experiment uses an inverse detected probe designed for maximum 
'H sensitivity. The same data can be yielded from a 'H-13C COSY, J=140 Hz 
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correlated spectroscopy (COSy)147.ISI experiment but this is less sensitive than the 
HSQC. This, in conjunction with data from DEPT establishes all corresponding C-H 
connectivities. 
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Figure 12. General scheme for structure elucidationl47 
All spin-spin coupled protons can be identified from an experiment called IH_IH 
COSY. This experiment gives mainly geminal (two bond) and vicinal (three bond) 
correlation. With this information, possible substructures can be generated. These 
substructures can be linked together by long range correlation data. The inverse 
detected equivalent of the IH_I3C COSY (J=9 Hz) is called the heteronuclear 
multiple bond correlation (HMBC)147 experiment which can detect two and three 
bond carbon to hydrogen connectivities. Sometimes heteronuclear single quantum 
coherence total correlation spectroscopy (HSQC-TOCSY) can be useful to assign 
crowded and mutually coupled spins. In this experiment all the protons in the same 
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spin system are linked together by J3C chemical shifts on one axis and by IH 
chemical shifts on the other. 
In cases where the interpretation of data is hindered by an inadequate number of 
protons in the spectra an alternative strategy is to use C-C correlations from a two 
dimensional incredible natural abundance double quantum transfer experiment (2D 
INADEQUATE). This allows the construction of the carbon skeleton of the molecule 
relatively easily, except in cases of extreme overlap in the J3C spectrum. The Nuclear 
Overhauser Effect (NOE), which offers indirect measurement of dipolar coupling 
between nuclei that are in close proximity in space is a technique which helps to 
define the three dimensional structure. The interaction is by a through-space dipole-
dipole relaxation mechanism, which is distance dependent (IIn6r). The experiments 
are available in one dimensional (lD difference nOe) and two-dimensional (2D 
NOESY or ROESY). If the compound is crystalline, X-ray crystallography is the 
best way to determine the structure. 
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2.7 Isolation of Compounds 
All Centaurea species listed in Table 2 (page 61) were finely ground and Soxhlet-
extracted with n-hexane (1.1 L), DCM (1.1 L) and MeOH (1.1 L) as described in 
Section 2.2. Thus n-hexane extract, DCM extract and MeOH extract were obtained 
separately from twelve Centaurea species and were stored at -20°C until further 
required for phytochemical or biological activity studies. 
2.7.1 Isolation of Compounds from Centaurea macrocephala 
The MeOH extract (2.0 g) of C. macrocephala obtained from Soxhlet-extraction 
process, was fractionated by solid phase extraction method using a Sep-Pak C18 (10 
g) cartridge eluting with a step gradient: 30, 60, 80 and 100% MeOH in water (200 
mL each). Prep-HPLC-l (eluted with a linear gradient- water:MeOH= 70:30 to 20:80 
over 50 min followed by 80% Me OH for 10 min, 20 mLlmin) of the Sep-Pak 
fraction, which was eluted with 30% MeOH, yielded fraction Mal (70.5 mg, tR = 
14.1 min) and CMal (314.1 mg, tR= 16.5 min). 
Fraction Mal was further purified by Prep-HPLC-I (isocratic elution with 40% 
MeOH in water, 20 mLlmin) to obtain CMa2 (5.8 mg, tR = 6.8 min). Pre-HPLC-I, 
using the same condition as for the Sep-Pak 30% MeOH fraction, of 60% Sep-Pak 
fraction afforded more of CMal (49.5 mg), CMa3 (33.2 mg, tR= 21.6 min) and 
fraction Ma2 (47.2 mg, tR= 23.6 min). Compound CMa4 (5.2 mg, tR= 23.4 min) was 
purified from fraction Ma2 by Pre-HPLC-l, eluted with a linear gradient 
water:acetonitrile (MeCN)= 75:25 to 40:60 over 50 min, 20 mLlmin in addition to 
CMa3 (Figure 13). 
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Figure 13. HPLC chromatogram of fraction Mal from C. macrocephala 
The n-hexane and DCM extracts were processed and their IH and I3C NMR spectra 
showed that they contained mainly essential oil like phytol, caryophyllene oxide and 
long chain fatty acids and hydrocarbons. As a result, no compound of our interest 
was isolated from them. 
2.7.2 Isolation of Compounds from Centaurea cyanus 
The MeOH extract (2.0 g) of C. cyanus was fractionated by solid phase extraction 
method using a Sep-Pak CI8 (10 g) cartridge eluting with a step gradient: 30, 40, 60, 
80 and 100% MeOH in water (200 mL each). Prep-HPLC-l (eluted with a linear 
gradient- water:MeCN= 80:20 to 40:60 over 50 min followed by 60% MeCN for 10 
min, 20 mLlmin) of the Sep-Pak fraction, which was eluted with 40% MeOH, 
yielded CCI (4.7 mg, tR = 17.1 min), CC2 (10.3 mg, tR = 22.2 min), CC3 (12.2 mg, 
tR = 26.2 min) and CC4 (19.0 mg, tR= 29.0 min). 
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The I H and BC NMR spectra together with preliminary TLC screening of n-hexane 
extract showed that it contained mainly long chain fatty alcohol, ester and acids. So 
this extract was not investigated further for isolation of compounds. However, the 
DCM extract showed interesting peaks in high and low field of the IH and BC NMR 
spectra. The DCM extract (100 mg) was subjected to vacuum liquid chromatography 
(procedure previously described on page 62). The column was packed in n-hexane 
and gradually increased in polarity from 0 to 100% DCM in n-hexane and finally 
washed with 100% MeOH and 7 fractions were obtained. Fraction obtained from 
90% DCM in n-hexane was further purified by PTLC (page 61) using a solvent 
mixture of EtOAc and n-hexane (50/50) to afford pure compound CC5 (5.4 mg). 
2.7.3 Isolation of Compounds from Centaurea dealbata 
The MeOH extract (2.0 g) was fractionated by solid phase extraction method using a 
Sep-Pak CI8 (10 g) cartridge eluting with a step gradient: 40, 60, 80 and 100% 
MeOH in water (200 mL each). Prep-HPLC-l (eluted with a linear gradient-
water:MeOH= 70:30 to 20:80 over 50 min followed by 80% MeOH for 10 min, 20 
mLlmin) of the Sep-Pak fraction, which was eluted with 60% MeOH, yielded CD! 
(13.9 mg, tR= 15.6 min), CD2 (203.4 mg, tR = 17.2 min), CD3 (8.2 mg, tR= 20.7 
min). 
The TLC, I H and BC NMR spectra of DCM extract showed the presence of similar 
compounds (in a negligible amount) isolated from the MeOH extract. So this extract 
was not processed. The IH and I3C NMR spectra of n-hexane extract revealed that it 
contained mainly long chain fatty alcohol, fatty ester and acids. As a result, this 
extract was not processed further for isolation of compound. 
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2.7.4 Isolation of Compounds from Centaurea americana 
The MeOH extract (2.0 g) was fractionated by solid phase extraction method using a 
Sep-Pak C18 (10 g) cartridge eluting with a step gradient: 40, 60, 80 and 100% 
MeOH in water (200 mL each). Prep-HPLC-l (eluted with a linear gradient-
water:MeOH= 40:60 to 20:80 over 50 min followed by 80% MeOH for 10 min, 20 
mLlmin) of the Sep-Pak fraction, which was eluted with 60% MeOH, yielded CA! 
(8.8 mg, tR = 16.5 min), CA2 (13.9 mg, tR= 21.0 min), CA3 (203.4 mg, tR = 25.0 
min), CA4 (8.2 mg, tR= 27.1 min), CAS (8.0 mg, tR= 29.0 min), CA6 (15.5 mg, tR= 
31.8 min), CA7 (12.1 mg, tR= 33.0 min) and CAS (9.2 mg, tR= 34.2 min). 
The TLC pattern of n-hexane and DCM extracts showed that these extracts contained 
mostly long chain alcohol and acids which were not compounds of our interest. So 
they were not processed for further investigation. 
2.7.S Isolation of Compounds from Centaurea huber-morathii 
The MeOH extract (2.0 g) of C. huber-morathii was subjected to a Sep-Pak C18 (10 
g) column eluting with a step gradient: 30, 40, 60, 80 and 100% Me OH in water (200 
mL each). Fraction resolved from 40% aqueous MeOH was further purified by Prep-
HPLC-l (eluted with a linear gradient-water:MeOH= 70:30 to 20:80 over 50 min 
followed by 80% Me OH for 10 min, 20 mLlmin) to afford CH! (9.0 mg, tR = 15.1 
min), CH2 (180.0 mg, tR= 17.3 min), CH3 (11.0 mg, tR = 26.1 min), CH4 (5.0 mg, 
tR= 21.2 min) and CHS (3.0 mg, tR= 31.3 min). 
The TLC pattern of the n-hexane extract showed that it contained mainly fatty 
alcohol and was not processed further. The DCM extract was fractionated by normal 
column chromatography (page 63) using n-hexane, DCM and MeOH with gradual 
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increase in polarity. Fractions eluted with DCM-MeOH (18:2) afforded compounds 
CHI (7.2 mg) and CH2 (4.8 mg) which were also isolated from MeOH extract. 
2.7.6 Isolation of Compounds from Centaurea montana 
The MeOH extract (2.0 g) was fractionated by solid phase extraction method using a 
Sep-Pak CI8 (10 g) cartridge eluting with a step gradient: 30, 40, 60, 80 and 100% 
MeOH in water (200 mL each). Prep-HPLC-l (eluted with a linear gradient-
water:MeCN=90: 10 to 60:40 over SO min followed by 40% MeCN for 10 min, 20 
mLlmin) of the Sep-Pak fraction, which was eluted with 30% MeOH (Figure 14), 
yielded seven fractions: Ml (30.4 mg, tR=6.1 min), M2 (78.2 mg, tR=11.2 min), M3 
(50.9 mg, tR=12.2 min), M4 (60.0 mg, tR=18.2 min), M5 (925.0 mg, tR=19.0 min), 
M6 (45.4 mg, tR=26.S min) and M7 (68.2 mg, tR=27.3 min). Following the same 
HPLC system (Figure 15), 40% Sep-Pak fraction of the MeOH extract gave three 
pure compounds CM14 (14.1 mg, tR=31.S min), CM15 (3.2 mg, tR=33.S min) and 
CM16 (4.1 mg, tR=3S.0 min) in addition to previous seven fractions. 
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Figure 14. HPLC chromatogram of 30% Sep-Pak fraction of C. montana 
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Figure 15. HPLC chromatogram of 40% Sep-Pak fraction of C montana 
Fraction Ml was further purified by Semi-Prep-HPLC-2 (isocratic elution with 10% 
MeCN in water, 2.0 mLlmin) to obtain CMl (7.0 mg, tR=9.0 min), CM2 (4.5 mg, 
tR=1O.0 min), CM3 (3.0 mg, tR=16.0 min) and CM4 (2.0 mg, tR=23.0 min) (Figure 
16). 
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Figure 16. HPLC chromatogram of fraction Ml from 30% Sep-Pak of C montana 
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Fraction M2 was further purified by Semi-Prep-HPLC-2 (isocratic elution with 12% 
MeCN in water, 2.0 mLlmin) to obtain CMS (12.3 mg, tR=42.0 min) and CM6 (9.8 
mg, tR=70.0 min) (Figure 17). Pure compounds CM7 (25.0 mg, tR=74.0 min) and 
CMS (20 mg, tR=84.0 min) were obtained from fraction MS by Prep-HPLC-l 
(isocratic elution with 15% MeCN in water, 20 mLlmin). 
,v 
-
Figure 17. HPLC chromatogram of fraction M2 from 30% Sep-Pak of C. montana 
Fraction M4 was purified by Semi-Prep HPLC-2 (isocratic elution with 17% MeCN 
in water, 2.0 mLlmin) to obtain CM9 (19.9 mg, tR=48.0 min) in addition to CM6 
(10.1 mg, tR=60.0 min) (Figure IS). CMIO (3.5 mg, tR=40.5 min), CMU (4.5 mg, 
tR=49.0 min), CM12 (6.0 mg, tR=56.0 min) and CM13 (22.5 mg, tR=67.0 min) were 
obtained from fraction M6 by Semi-Prep HPLC-2 (isocratic elution with 20% MeCN 
in water, 2.0 mLlmin) (Figure 19). 
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Figure 18. HPLC chromatogram of fraction M4 from 30% Sep-Pak of C. montana 
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Figure 19. HPLC chromatogram of fraction M6 from 30% Sep-Pak of C. montana 
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Prep-HPLC-I (eluted with a linear gradient-water:MeOH= 70:30 to 0:100 over 50 
min followed by 100% MeOH for 10 min, 20 mLlmin) of the Sep-Pak fraction, 
which was eluted with 60% MeOH, yielded two fractions M8 (32.0 mg, tR=17.5 
min) and M9 (33.0 mg, tR=19.8 min) in addition to pure compound CM13 (54.7 mg, 
tR=14.3 min) (Figure 20). Fraction M8 was further purified by Semi-Prep HPLC-2 
(isocratic elution with 25% MeCN in water, 2.0 mLlmin) to obtain CM17 (2.0 mg, 
tR=92.0 min). CM18 (5.0 mg, tR=31.0 min) and CM19 (4.0 mg, tR=34.0 min) were 
obtained from fraction M9 by Prep-HPLC-I (isocratic elution with 30% MeCN In 
water, 20 mLlmin). 
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Figure 20. HPLC chromatogram of 60% Sep-Pak fraction from C. montana 
The n-hexane and DCM extracts were processed and found that they contained 
mainly long chain fatty alcohol and acids. These extracts were not further 
investigated. 
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2.7.7 Isolation of Compounds from Centaurea schischkinii 
The MeOH extract (2.0 g) obtained from Soxhlet-extraction method previously 
described on page 64 was fractionated using a Sep-Pak C 18 (lOg) cartridge eluting 
with a step gradient: 30, 40, 60, 80 and 100% MeOH in water (200 mL each). Prep-
HPLC-I (eluted with a linear gradient- water:MeOH= 75:25 to 30:70 over 50 min 
followed by 70% Me OH for 10 min, 15 mLlmin) of the Sep-Pak fraction, which was 
eluted with 40% MeOH, yielded fraction SI (14.0 mg, tR = 8.1 min), CS2 (59.2 mg, 
tR= 24.4 min), CS3 (518.6 mg, tR = 28.5 min), CS4 (11.7 mg, tR= 32.2 min), CS5 
(29.9 mg, tR= 33.4 min) and CS6 (11.5 mg, tR= 36.1 min) (Figure 21). 
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Figure 21. HPLC chromatogram of 40% Sep-Pak fraction from C. schischkinii 
Fraction SI was further purified by Semi-Prep-HPLC-l (eluted with a linear 
gradient-water:MeCN= 90: 1 0 to 60:40 over 50 min followed by 40% acetronitrile for 
10 min, 15 mLlmin) to obtain CSI (7.0 mg, tR=14.5 min). Prep-HPLC-I (eluted with 
a linear gradient-water:MeOH= 60:40 to 20:80 over 50 min followed by 80% Me OH 
for 10 min, 15 mLlmin) of the Sep-Pak fraction, which was eluted with 60% MeOH, 
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afforded CS7 (13.7 mg, tR=23.l min) and CS8 (27.3 mg, tR=29.3 min) in addition to 
CS3 and CS5 (Figure 22). 
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Figure 22. HPLC chromatogram of 60% Sep-Pak fraction from C. schischkinii 
The TLC pattern of DCM extract sho~ed the presence of similar compounds (in a 
negligible amount) isolated from methanol extract. So this extract was not processed 
further. The IH and I3C NMR spectra of n-hexane extract suggested that it contained 
long chain fatty acids and alcohol which were not compounds of our interest and was 
not processed for further investigation. 
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2.7.8 Isolation of Compounds from Centaurea bornmuelleri 
The MeOH extract (2.0 g) of C. bornmuelleri were applied to the reversed-phase 
Sep-Pak column as previously described on page 64. A step gradient of 20 to 100% 
aqueous MeOH in 20% increments (200 mL per each step) was used to elute 
different metabolites from the column and collected in five different flasks. Fraction 
obtained from 40% aqueous MeOH was further purified by Prep-HPLC-1 (eluted 
with a linear gradient- water:MeOH= 75:25 to 30:70 over 50 min followed by 70% 
MeOH for 10 min, 20 mLlmin) to yield fraction CBI (13.9 mg, tR= 21.0 min), CB2 
(535.4 mg, tR = 25.0 min), CB3 (5.1 mg, tR= 27.1 min), CB4 (10.0 mg, tR= 29.0 
min), CB5 (25.1 mg, tR= 31.8 min) and CB6 (8.8 mg, tR= 34.0 min). 
The n-hexane extract was processed, but no compound of our interest was isolated. 
However, the DCM extract was fractionated by normal column chromatography 
(page 63) using n-hexane, DCM and Me OH with gradual increase in polarity. 
Fraction obtained from DCM-MeOH (19:1) was further purified by PTLC (page 61) 
using a solvent mixture of n-hexane-EtOAc (7:3) to afford pure compound CB7 (4.7 
mg). 
2.7.9 Isolation of Compounds from Centaurea gigantea 
The MeOH extract (2.0 g) was fractionated by solid phase extraction method using a 
Sep-Pak CI8 (10 g) cartridge eluting with a step gradient: 30, 60, 80 and 100% 
MeOH in water (200 mL each). Prep-HPLC-1 (eluted with a linear gradient-
water:MeCN= 90: 10 to 60:40 over 50 min followed by 40% MeCN for 10 min, 20 
mLlmin) of the Sep-Pak fraction, which was eluted with 30% MeOH (Figure 23), 
yielded compounds CGl (15.5 mg, tR = 7.3 min), CG2 (34.9 mg, tR = 13.3 min), 
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CG3 (33.5 mg, tR = 14.3 min), CG4 (7.9 mg, tR = 15.3 min), and CG5 (3.5 mg, tR = 
18.0 min). 
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Figure 23. HPLC chromatogram of 30% Sep-Pak fraction from C. gigantea 
Prep-HPLC-I (eluted with a linear gradient- water:MeOH= 75:25 to 30:70 over 50 
min followed by 70% MeOH for 10 min, 15 mLlmin) of the Sep-Pak fraction, which 
was eluted with 60% MeOH (Figure 24), afforded CG6 (9.0 mg, tR=22.3 min) CG7 
(21.4 mg, tR=24.6 min) and CG8 (12.1 mg, tR=25.9 min). 
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Figure 24. HPLC chromatogram of 60% Sep-Pak fraction from C. gigantea 
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The I H and BC NMR spectra of n-hexane extract revealed that it contained long 
chain fatty alcohol and hydrocarbons which were not potential candidate for our 
investigation. So this extract was not examined further. The DCM extract was 
subjected to nonnal phase column chromatography. The column packed in DCM and 
gradually increased in polarity from 0 to 50% MeOH in DCM and finally washed 
with 100% MeOH. After monitoring by TLC, similar fractions were pooled together 
and 3 pure compounds (CG6, CG7 and CG8), which were also isolated from 60% 
Sep-Pak fraction of MeOH extract, were obtained. 
2.7.10 Isolation of Compounds from Centaurea pamphylica 
The methanol extract was fractionated by solid phase extraction method using a Sep-
Pak CI8 (10 g) cartridge eluting with a step gradient: 40,60, 80 and 100% MeOH in 
water (200 mL each). Preparative-HPLC-I (Luna CI8 column 10 J.1m, 250 mm x 21.2 
mm, eluted with a linear gradient-water:MeOH= 75:25 to 30:70 over 50 min 
followed by 70% MeOH for 10 min, 15 mLlmin) of the Sep-Pak fraction, which was 
eluted with 40% MeOH, yielded compound CPl (19.7 mg, tR = 22.1 min), CP2 
(44.2 mg, tR = 26.5 min) and CP3 (12.6 mg, tR = 30.5 min). 
The n-hexane extract was fractionated by VLC (page 62). The column was packed in 
n-hexane and increased polarity from A to H (Table 3) and eight fractions were 
obtained. The IH and 13C NMR spectra revealed that all eight fractions contained 
mainly long chain fatty alcohol and acids. So they were not processed further. 
However, DCM extract was subjected to normal phase column chromatography. The 
column packed in n-hexane-DCM (1: 1) and gradually increased in polarity from I to 
S (Table 3). After monitoring by TLC, similar fractions were pooled together and 
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pure compound CP4 (4.7 mg) was obtained from fraction eluted with DCM-MeOH 
(19: I) in addition to CPI and CP2. 
2.7.11 Isolation of compounds from Centaurea urvillei 
The MeOH extract (2.0 g) was fractionated by solid phase extraction method using a 
Sep-Pak CIK (10 g) cartridge eluting with a step gradient: 40, 60, 80 and 100% 
Me OH in water (200 mL each). Prep-HPLC-I (eluted with a linear gradient-
water:MeOH= 75:25 to 30:70 over 50 min followed by 70% MeOH for 10 min, 20 
mLlmin) of the Sep-Pak fraction, which was eluted with 40% MeOH, yielded 
compound CUI (12.4 mg, IR = 20.6 min) and CU2 (56.0 mg, IR = 24.5 min). 
The n-hexane extract was processed, and found that this extract contained mainly 
long chain fatty alcohol, fatty acids and esters. As a result, no compound of our 
interest was isolated. IH and \3C NMR of DCM extract revealed that it contained 
similar compounds isolated from MeOH extract and was not investigated further. 
2.7.12 Isolation of Compounds from Centaurea mucronifera 
The n-hexane (100 mg) extract of C. mucronifera was subjected to normal phase 
flash chromatography. The column was packed in n-hexane and gradually increased 
in polarity from 0 to 100% DCM in n-hexane and finally washed with 100% MeOH. 
After monitoring by TLC, similar fractions were pooled together and 5 fractions 
were obtained. The fraction obtained from DCM-n-hexane (3:2) was washed several 
times with the same solvent mixture and collected as pure compound CMul (6.2 
mg) which gave single spot on TLC. The DCM extract was subjected to normal 
phase column chromatography. The column packed in n-hexane-DCM (1:1) and 
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gradually increased in polarity from I to S (Table 3). After monitoring by TLC, 
similar fractions were pooled together and pure compound CMu2 (15.8 mg) and 
CMu3 (8.7 mg) were obtained from fraction eluted with DCM-MeOH (18:1). 
The TLC, IH and I3C NMR spectra of MeOH extract showed the presence of similar 
compounds (CMu2 and CMu3) isolated from the DCM extract. So this extract was 
not processed further. 
86 
CHAPTER THREE 
Results and Discussion 
3 Results and Discussion 
3.1 Lignans 
A total of fifteen lignans were isolated from Centaurea species in this study. Six 
were dibenzylbutyrolactone-type (SM1-SM6) and nine were epoxy-type (SM7-
SM15) lignans. Lignan SM5, isolated from C. americana, is a new natural product. 
3.1.1 Dibenzylbutyrolactone Lignans 
Six dibenzylbutyrolactone-type lignans isolated from different Centaurea species 
were given new code in Table 4. 
Table 4. Dibenzylbutyrolactone-type lignan isolated from Centaurea species 
Code (structure) Source and isolation code Page 
SMI (137) e. macrocephala (CMal). e. schischkinii (CS3), 71,80, 
e. huber-morathii (CHl), C. bornmuelleri (CBl), 74,82, 
e. mucronifera (CMu3), e. urvillei (CUl), 86,85, 
e. americana (CA3), e. dealbata (COl), e. pamphy/ica (CPl) 74,73,84 
SMl (138) C. macrocephala (CMal). e. schischkinii (CS2), 71,80, 
e. huber-morathii (CHI), C. bornmuelleri (CBI), 74,82, 
e. mucronifera (CMul), e. urvillei (CUI), 86,85, 
e. americana (CAI), e. dealbata (COl), e. pamphylica (CP1) 74,73,84 
SM3 (139) e. schischkinii (CS7), C. bornmuelleri (CB6), 81,82, 
e. americana (CA6), e. dealbata (C03) 74, 73 
SM4 (140) e. macrocephala (CMa3). e. schischkinii (CSS), 71,80, 
e. huber-morathii (CH3), C. bornmuelleri (CB4), 74,82, 
e. pamphylica (CAS) 84 
SMS (170) e. americana (CA 7) 74 
SM6 (143) e. macrocephala (CMa4),C. americana (CA8) 71,74 
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3.1.1.1 Characterisation of SM1, SM2, SM3 and SM4 as Arctiin (137), 
Matairesinoside (138), Arctigenin (139) and Matairesinol (140), 
respectively 
All four compounds (SM1-SM4) displayed characteristic UV absorption maxima of 
dibenzylbutyrolactone type lignans. The presence of two strong UV absorbance 
signals at 279-282 and 225-228 nm in the UV spectrum indicated that they had 
aromatic benzene rings and typical of a lignan type structure. 1S2 A strong absorption 
band at 1765 cm-I in the IR spectrum of each compound could be attributed to the 
carbonyl functionality of the lactone ring. The HRCIMS spectrum of SMl revealed 
the [M+NH4t ion peak at m/z 552.2441. suggesting Mr=534 and the molecular 
formula C27H34011 (calculated 552.2439 for C27H3SNOIl). The l3C NMR spectrum 
(Figure 79; Table 5) showed the presence of twentyseven carbons. The DEPT -135 
spectrum indicated three methoxy groups (B 55.7, 55.6, 55.5), four methylenes (B 
71.9,61.6, 38.0, 34.4), thirteen methines (B 122.0, 121.1, 117.0, 113.9, 112.7. 112.2. 
102.0, 77.2, 77.0, 74.0, 70.4, 46.7, 41.5), six quartemary carbons (B 149.8, 149.6. 
148.3,145.9,133.3,131.8) and one carbonyl (B 180.4). 
Figure 25. 
137 (SM1) 
138 (SM2) 
OR 
R 
Me 
H 
Structure of arctiin (SMl) and matairesinoside (SM2) 
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The 1 H NMR spectrum (Figure 78; Table 5) revealed the presence of two ABX 
benzene ring systems by the signals at CH 7.04 (d, J=8.2 Hz), 6.64 (dd, J= 8.2, 1.8 
Hz), 6.74 (d, J=1.8 Hz), and C 6.81 (d, J=8.4 Hz), 6.58 (d, J=2.0 Hz) and 6.59 (dd, 
J=8.4, 2.0 Hz). The IH NMR spectrum also showed additional signals for one 
oxymethylenes [CH 4.18 (dd, J=8.9, 7.6 Hz) and 3.93 (dd, J=7.8, 7.6 Hz)] , two 
methylenes [CH 2.89 (dd, .1=14.1, 7.3 Hz) and 2.83 (dd, J=14.1, 6.2 Hz), and 2.56 
(m)], and two methines [CH 2.67 (m) and 2.49 (m)]. The IH and \3C NMR data 
suggested that SMl was a dibenzylbutyrolactone lignan. 152 This was further 
confirmed by IH_IH COSY and IH_ 13C HMBC experiments (Figure 80 and 81). Six 
carbon signals at C 102.0, 77.2, 77.0, 74.0, 70.4 and 61.6 in the \3C NMR could be 
assigned to a glucose moiety, and the doublet at CH 4.84 (J=7.6 Hz) was attributable 
to the anomeric proton with a J3-configuration. 153 A 3 J I H- \3C long-range correlation 
between the anomeric proton, H-l" (c 4.84) and the aromatic quartemary Cc 145.9 
(C-4) in the HMBC spectrum confirmed that the glucose moiety was connected to C-
4 of the dibenzylbutyrolactone ring. This was further confirmed by NOE interaction 
between the anomeric proton (H-l") and H-5 (c 7.04) of benzene ring in the IH_IH 
NOESY experiment (Figure 26). The IH)H NOESY spectrum (Figure 82) of SMl 
also showed strong NOE interactions between H-7 (c 2.89) and H-2 (c 6.74), H-8 (c 
2.67) and H-7' (c 2.56), H-8 and H-7, H-9' (c 4.18) and H-7', and H-5 (c 7.04) and 
H-6. The IH and \3C NMR spectral data of SMl were similar to those published for 
arctiinl54.155 and a combination of COSY, HMBC and NOESY 2D NMR spectral 
analyses confirmed unequivocally its identity as arctiin (137). Arctiin was previously 
isolated from C. americana51 , C. isaurica83 and C. nigral05 (Table 1). 
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Figure 26. Key NOE interactions ofSMI (137) based on IH)H NOESY experiment 
The 1 H and \3C NMR spectra of SM2 (Table 5) displayed signals similar to those of 
SMI with the exceptions that SM2 had signals for two methoxy groups instead of 
three. The ESIMS spectrum of SM2 revealed the pseudomolecular ion, [M+Nat 
peak at mlz 543, suggesting Mr=520, and the molecular formula C26H320\l. This 
mass data confirmed the findings from the NMR data of SM2 that this compound 
contained 14 mass units less than arctiin (SMI). The IH and l3C NMR data of SM2 
were in good agreement with the published data of matairesinoside.154,155 Thus, the 
structure of SM2 was elucidated as matairesinoside (138). Matairesinoside was 
previously isolated from C. americanaS1 , C. nigralOS, C. scabiosa\lS (Table I). 
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Table 5. IH NMR (chemical shift, multiplicity, coupling constant J in Hz) and \3C 
NMR data for SMl (137) and SM2 (138) 
Chemical shift 8 in ppm 
Carbon 
'H I3C 
number 
SM26 SMl1 SMl1 SM26 
1 133.3 130.1 
2 6.74, d, 1.8 6.54, d, 1.6 113.9 112.1 
3 149.6 147.8 
4 145.9 145.7 
5 7.04, d, 8.2 6.66, d, 8.4 117.0 115.0 
6 6.64, dd, 8.2, 1.8 6.64, dd, 8.4, 2.0 122.0 121.8 
7 2.89, dd, 14.1, 7.3 2.84, dd, 14.0,5.3 34.4 34.1 
2.83,dd,14.1,6.2 2.76, dd, 14.0,6.5 
8 2.67, m 2.64, m 46.7 46.4 
9 180.4 180.2 
1 ' 131.8 133.1 
2' 6.58, d, 2.0 6.72, d, 2.0 112.7 113.7 
3' 149.8 149.5 
4' 148.3 145.0 
5' 6.81, d, 8.4 7.2, d, 8.0 112.2 116.7 
6' 6.59, dd, 8.4, 2.0 6.48, dd, 8.0, 2.0 121.1 121.0 
7' 2.56, m 2.58, m 38.0 37.8 
8' 2.49, m 2.46, m 41.5 41.4 
9' 4.18, dd, 8.9, 7.6 4.15, dd, 8.7, 7.5 71.9 71.7 
3.93, dd, 7.8, 7.6 3.90, dd, 8.4, 7.5 
}" 4.84, d, 7.3 4.80, d, 7.6 102.0 101.7 
2" 3.45, m 3.44, m 74.0 73.7 
3" 3.41, dd, 6.8, 4.8 3.44, m 77.2 76.6 
4" 3.38, dd, 4.8, 3.2 3.36, m 70.4 70.1 
5" 3.37, m 3.35,m 77.0 76.9 
6" 3.84, m 3.76, m 61.6 61.3 
3.67, m 3.66, m 
O-CH3(3) 3.73, s 3.77, s 55.6 55.5 
O-CH3 (3') 3.78, s 3.74, s 55.5 55.2 
O-CH3 (4') 3.78, s 55.7 
IIH NMR (600 MHz) and J3C NMR (150 MHz) in CD30D 
b IH NMR (400 MHz) and J3C NMR (100 MHz) in CD30D 
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The IH and I3C NMR spectra (Table 6) of SM3 and SM4 showed signals similar to 
those of SMI and SM2, but lacked signals for the glucose moiety. This was further 
confirmed from their mass analyses. The ESIMS spectra of SM3 and SM4 showed 
[M+Nat ions at m/z 395 and 381, respectively, suggesting their molecular formula 
found to be identical with arctigenin (139) and matairesinol (140), respectively.154,155 
However, detailed 2D NMR spectral analyses were carried out to assign 
unambiguously all the IH and I3C NMR signals of SM3 (139) and SM4 (140). 
Arctigenin (139) was previously isolated from C. afjinis47, C. ealcitrapa65 , C. 
maeroeephala89 , C. nigra lOS and C. phrygia100 whereas C. afjinis47, C. ealcitrapa65 , 
. 87 C . I .104 C' 105 d Ch' 109 f~ d d ., I C. perSlea , . meo al , . mgra an . rap anma Ssp a lor e matanesmo 
(140) (Table I). 
MeO 3 
139 (SM3) 
140 (SM4) 
OR 
o 
o 
R 
Me 
H 
Figure 27. Structures of arctigenin (SM3) and matairesinol (SM4) 
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Table 6. IH NMR (chemical shift, multiplicity, coupling constant J in Hz) and \3C 
NMR data for SM3 (139) and SM4 (140) 
Chemical shift 8 in ppm 
Carbon 
'H I3C 
number 
SM3- SM4- SM3a SM4a 
129.5 130.2 
2 6.63, d, 1.6 6.63, d, 2.0 112.7 112.7 
3 148.0 147.8 
4 145.2 145.0 
5 6.66, d, 8.4 6.67, d, 8.4 114.9 114.9 
6 6.55, dd, 8.4, 1.6 6.54, dd, 8.4, 2.0 121.8 121.8 
7 2.85, dd, 14.0,5.6 2.81, dd, 14.0,5.6 34.2 34.1 
2.77, dd, 14.0, 7.2 2.78, dd, 14.0,6.8 
8 2.66, m 2.61, m 46.5 46.5 
9 180.3 180.4 
1 ' 131.6 129.5 
2' 6.52, d, 2.0 6.51, d, 1.6 111.9 112.1 
3' 147.8 147.8 
4' 149.3 145.2 
5' 6.78, d, 8.0 6.64, d, 8.0 112.4 115.0 
6' 6.56, dd, 8.0, 2.0 6.46, dd, 8.0, 1.6 120.8 121.0 
7' 2.50, m 2.50, m 37.7 37.7 
8' 2.47, m 2.48, m 41.2 41.3 
9' 4.13, dd, 9.2, 7.6 4.11, dd, 9.2, 7.6 71.7 71.7 
3.89, dd, 7.2, 7.6 3.82, dd, 8.8, 7.6 
O-CH) (3) 3.75, s 3.70, s 55.3 55.1 
O-CH) (3') 3.74, s 3.70, s 55.2 55.1 
O-CH) (4') 3.72, s 55.1 
alH NMR (400 MHz) and IJC NMR (lOO MHz) in CD30D 
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3.1.1.2 Characterisation of SM5 as 3"-O-Caffeoyl-(9"'-+3")-arctiin (170) 
An ESIMS spectrum of SM5 displayed the pseudomolecular ion peak at m/z 719 
[M+Nat, suggesting Mr=696 and the molecular fonnula C36H400 14. The HRCIMS 
spectrum showed m/z 714.2759 [M+NH4t (calculated 714.2756 for C36H44NOI4). 
The 1 H and I3C NMR data (Table 7) indicated that SM5 was an arctiin (SMl) 
derivative. The Arctiin (SMI) moiety was also confinned by IH.IH COSY (Figure 
89) and IH_13C HMBC experiments (Figure 90; Table 7). The signals for a 
trisubstituted benzene ring [OH 7.03 (d, J=2.0 Hz), 6.93 (dd, J=8.0, 2.0 Hz) and 6.74 
(d, J=8.0 Hz)], and two olefinic protons [OH 7.57 (d, J=16.0 Hz) and 6.32 (d, J=16.0 
Hz)] in the IH NMR spectrum together with signals at Oc 167.8, 149.3, 148.3, 145.6, 
126.7, 121.8, 115.3, 114.2 and 114.0 for nine carbons in the I3C NMR spectrum 
suggested that the other part of the molecule was a caffeoyl moiety. The 3J IH_13C 
long-range correlations from OH 6.74 (H-5"') to Oc 126.7 (C-l'''), OH 6.93 (H-6"') 
to Oc 114.2 (C-2''') and 148.3 (C-4'''), OH 7.57 (H-?,") to Oc 114.2 (C-2"') and 
167.8 (C-9"') in the IH_13C HMBC spectrum also confinned the presence of the 
caffeoyl moiety. A 3J IH_I3C long-range HMBC correlation between OH 5.12 (H-3") 
and 167.8 (C-9''') confinned that caffeoyl group was attached to glucose molecule at 
C-3". Thus, SM5, isolated from C. americana, was confinned as 3" -O-caffeoyl-
(9"'~3 ")-arctiin (170). To the best of our knowledge this is a new natural product. 
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o 
6'" 
170 
o 
o 
Figure 28. Structure of 3" -O-caffeoyl-(9'" ~3 ")-arctiin (SM5) 
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Table 7. IH NMR (chemical shift, multiplicity, coupling constant J in Hz), J3C NMR 
data and long-range HMBC for SM5 (170) 
Carbon Chemical shift cS in p~m HMBC correlations eH~13C) 
number (Ha JCa 2J 3J 
1 131.5 
2 6.57, d, 2.0 112.4 C-3' C-6 
3 149.6 
4 148.0 
5 6.79, d, 8.8 111.9 C-l, C-3 
6 6.56, m 121.0 C-5 
7 2.81, dd, 14.1,6.1 34.2 C-l C-2, C-6, C-9 
2.87, dd, 14.1,6.8 
8 2.65, m 46.4 C-9, C-8' 
9 180.2 
1 ' 133.5 
2' 6.88, d, 2.0 109.2 
3' 149.3 
4' 145.8 
5' 7.04, d, 8.4 116.8 C-l', C-3' 
6' 6.71, m 121.7 C-5' C-4' 
7' 2.50,m 37.7 
8' 2.41, m 41.3 
9' 4.16, 7.6, 9.2 71.7 C-9 
3.91, 7.6, 9.2 
I" 4.96, d, 7.2 101.1 C-4 
2" 3.65, m 68.4 
3" 5.12, m 77.4 C-4" C-9'" 
4" 3.62, m 72.1 C-2'" 
5" 3.48, m 76.8 
6" 3.84, m 61.0 
3.71, m 
1 ,,, 126.7 
2'" 7.03, d, 2.0 114.2 
3'" 149.3 
4'" 148.3 
5'" 6.74, d, 8.0 115.3 C-l ", 
6'" 6.93, dd, 8.0, 2.0 121.8 C-2''', C-4'" 
7'" 7.57, d, 16.0 145.6 C-l ,,, C-2"', C-9'" 
8'" 6.32, d, 16.0 114.0 C-l ", 
9'" 167.8 
O-CH3 (3) 3.72, s 55.4 C-3 
O-CH3 (3') 3.71, s 55.5 C-3' 
O-CH3 (4') 3.70, s 55.6 C-4 
a(HNMR (400 MHz) and (lC NMR (100 MHz) in CD30D 
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3.1.1.3 Characterisation of SM6 as Lappaol A (143) 
The ESIMS spectrum of SM6 revealed the pseudomolecular ion, [M+Nat peak at 
mlz 559, indicating Mr=536, and the molecular formula C30H3209. Signals at bH 6.95 
(d, J=2.0 Hz), 6.82 (dd, .1=8.0,2.0 Hz), 6.76 (d, J=8.0 Hz), 6.70 (m), 6.68 (d, J=8.0 
Hz) and 6.57 (brs) observed in the 'H NMR spectrum (Table 8) could be assigned to 
two (1,3,4)- trisubstituted benzene rings, while the signals at bH 6.59 (d, J=2.0 Hz) 
and 6.55 (d, J=2.0 Hz) were due to the protons of a (l,3,4,5)-tetra-substituted 
benzene ring. The 'H NMR spectrum also showed additional signals for one 
oxymethylenes [bH 4.20 (dd, J=9.0, 7.5 Hz) and 3.92 (dd, J=9.0, 7.0 Hz)] , two 
methylenes [bH 2.92 (dd, J=14.0, 5.4 Hz) and 2.85 (dd, J=14.0, 6.6 Hz), and 2.67 (dd, 
J=13.5, 6.5 Hz) and 2.56 (m)] and two methines [bH 2.54 (m) and 2.52 (m)]. The 'H-
13C HMBC correlations (Table 8) from H-7 to C-9 and C-8', H-7' to C-9', C-2' and 
C-6', H-8' to C-9' and C-l', and H-9' to C-9, C-7' and C-8 confirmed the presence 
of dibenzylbutyrolactone structure, similar to that ofSM1-SM4. 
143 
Figure 29. Structure of lappaol A (SM6) 
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The IH NMR signals at OH 5.54, 3.46 and 3.82, and the 13C NMR chemical shifts at 
Oc 89.2, 55.0 and 65.2 could be assigned to the protons and carbons of a 
dihydrofuran ring system, and a primary alcohol group. The IH_IH COSY spectrum 
displayed correlation between H-T' and H-8", and H-8" and H-9". The IH)3C 
HMBC correlations from H-T' to C-2", C-6", C-4' and C-5', H-8" to C-T', C-9", 
C-I", C-4' and C-5', and H-2" to C-T' confirmed that the dihydrofuran system was 
fused with one of the two phenyl rings of the dibenzylbutyrolactone system to form 
the structure of lappaol A (143). The spectroscopic data of SM6 were in good 
agreement with the published data of sesquilignan lappaol A (143).156,157 The relative 
stereochemistry at the chiral centres in SM6 was assigned by direct comparison of its 
IH and \3C NMR data with published data. 156 The unambiguous assignment of all IH 
and \3C NMR chemical shifts, based on extensive 2D NMR analysis of SM6, has 
been presented here for the first time. Lappaol A (143) was previously isolated from 
C. napijolia98 and C. nicaensis10l (Table 1). 
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Table 8. 'H NMR (chemical shift, multiplicity, coupling constant J in Hz), 13C NMR 
and long-range HMBC for SM6 (143) 
Carbon Chemical shift 8 in ppm HMBC correlations (,H413C) 
number 'Ha I3Ca 2J 3J 
1 130.9 
2 6.57, brs 113.6 C-3 C-4, C-6, C-7 
3 149.1 
4 146.5 
5 6.68, d, 8.0 115.1 C-4, C-6 C-l, C-3 
6 6.70, m 119.2 C-l C-4, C-7 
7 2.92, dd, 14.0,5.4 35.7 C-l, C-8 C-6, C-9, C-8' 
2.85, dd, 14.0,6.6 
8 2.54, m 48.0 C-9 
9 181.8 
1 ' 131.2 
2' 6.59, d, 2.0 113.2 C-7' 
3' 146.6 
4' 147.5 
5' 132.0 
6' 6.55, d, 2.0 123.0 C-2', C-7' 
7' 2.67, dd, 13.5,6.5 39.1 C-8' C-2', C6', C-9' 
2.56,m 
8' 2.52, m 42.8 C-9' C-l ' 
9' 4.20, dd, 9.0, 7.5 73.1 C-8' C-8, C-9, C-7' 
3.92, dd, 9.0, 7.0 
I" 134.9 
2" 6.95, d, 2.0 110.7 C-l ", C-3" C-4", C-6", C-7" 
3" 149.2 
4" 147.7 
5" 6.76, d, 8.0 116.4 C-4", C-6" C-l ", C-3 " 
6" 6.82, dd, 8.0, 2.0 119.9 C-2", C-4", C-7" 
7" 5.54, dd, 6.0 89.2 C-l ", C-8" C-4', C-5', C-2", C-6", 
C-9" 
8" 3.46, br. qr., 6.0 55.0 C-5', C-7", C- C-4', C-6', C-l" 
9" 
9" 3.82, m 65.2 C-5' 
O-CH3 (3) 3.73, s 56.9 C-3 
O-CH3 (3') 3.90, s 56.5 C-3' 
O-CH3 (3") 3.75, s 56.5 C-3" 
alH NMR (400 MHz) and IlC NMR (lOO MHz) in CD)OD 
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3.1.1.4 Properties of Dibenzylbutryolactone Lignans (SMl to SM6) 
3.1.1.4.1 Properties of Arctiin, 137 (SM1) 
Gum, [a]23D -55.3° (c 0.0033, MeOH) (Lit. 154 -52.3°, MeOH); UV Amax (MeOH): 
279,225 run; IR V max (neat): 3459, 1765, 1591, 1514,1460 and 1266 cm-I; CIMS mlz 
552 [M+NH4t; HRCIMS mlz 552.2441 [M+NH4t (calculated 552.2439 for 
C27H3SNO ll); IH NMR (600 MHz, CD30D): Table 5; l3C NMR (150 MHz, 
CD30D): Table 5. 
3.1.1.4.2 Properties of Matairesinoside, 138 (SM2) 
Gum, [a]23D -48.8° (c 0.002, MeOH) (Lit. 154 -43.2°, MeOH); UV Amax (MeOH): 279, 
222 run; IR Vmax (neat): 3373, 1760, 1600, 1514, 1452 and 1270 cm-I; ESIMS mlz 
543 [M+Nat; Molecular formula C26H32011, IH NMR (400 MHz, CD30D): Table 5; 
l3C NMR (100 MHz, CD30D): Table 5. 
3.1.1.4.3 Properties of Arctigenin, 139 (SM3) 
Gum, [a]23D -42.6° (c 0.0015, MeOH) (Lit. 154 -30.0°, MeOH); UV Amax (MeOH): 
281,220 run; IR V max (neat): 3367, 1757, 1595, 1512, 1449 and 1267 cm-I; ESIMS 
mlz 395 [M+Nat; Molecular formula C21H2406; IH NMR (400 MHz, CD30D): 
Table 6; l3C NMR (100 MHz, CD30D): Table 6. 
3.1.1.4.4 Properties of Matairesinol, 140 (SM4) 
Gum, [a]23D -47.2° (c 0.0022, MeOH) (Lit. 154 -50.0°, MeOH); UV Amax (MeOH): 
282, 228 nm; IR Vmax (neat): 3430, 1760, 1610 and 1525 cm-I; ESIMS m/z 381 
[M+Nat; Molecular formula C2oH2206; IH NMR (400 MHz, CD30D): Table 6; l3C 
NMR (100 MHz, CD30D): Table 6. 
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3.1.1.4.5 Properties of 3"-O-Caffeoyl-(9"'~3")-arctiin, 170 (SM5) 
Amorphous, [a]2JD -34.5° (c 0.001, MeOH); UV Amax (MeOH): 282,225 nm; IR Vmax 
(neat): 3410, 1765, 1591, 1514 and 850 cm-I; ESIMS m/z 719 [M+Nat; HRCIMS 
714.2759 [M+NH4t (calculated 714.2756 for CJ6~4NOI4); IH NMR (400 MHz, 
C0300): Table 7; I3C NMR (lOO MHz, COJOO): Table 7. 
3.1.1.4.6 Properties of Lappaol A, 143 (SM6) 
Amorphous, [a]2JD -17.6° (c 0.0021, MeOH) (Lit.157 -17.4°, MeOH); UV Amax 
(MeOH): 281, 225 nm; IR Vmax (neat): 3425,1764,1591,1520 and 858 cm-I; ESIMS 
m/z 559 [M+Nat; Molecular fonnula C30H3209; IH NMR (400 MHz, C0300): 
Table 8; I3C NMR (100 MHz, C030D): Table 8. 
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3.1.2 Epoxy Iignans 
Nine epoxy lignans have been isolated from C. cyanus and C. montana (Table 9). 
Table 9. Epoxy lignans isolated from Centaurea species 
Code (structure) 
SM7 (171) 
SMS (172) 
SM9 (173) 
SMI0 (144) 
SMII (174) 
SM12 (175) 
SM13 (176) 
SMI4 (177) 
SMI5 (17S) 
Source and isolation code 
C. cyanus (CCI) 
C. cyanus (CC2), 
C. montana (CM7) 
C. montana (CMS) 
C. montana (CMI4) 
C. montana (CMlS) 
C. montana (CMI6) 
C. montana (CMS) 
C. montana (CM6) 
C. montana (CM9) 
Page 
72 
72, 
77 
77 
75 
75 
75 
77 
77 
77 
3.1.2.1 Characterisation of SM7, SMS and SM9 as Lariciresinol 4'-O-P-D-
glucopyranoside (171), Berchemol (172) and Berchemol 4'-O-P-D-
glucopyranoside (173), respectively 
The UV, IH and l3C NMR (Table 10) of lignans SM7-SM9 revealed structural 
similarities among them. The CIMS analysis of SM7 showed the molecular ion peak 
at m/z 540 [M+NH4t, and the HRCIMS showed mlz at 540.2437 [M+NH4t 
(calculated 540.2439 for C26H3SNOII). The IH NMR spectrum revealed that SM7 
had two (1,3,4)-trisubstituted benzene ring systems [OH 7.08 (d, J=8.2 Hz), 6.88 (d, 
J=1.8 Hz), 6.73 (dd, J=8.2, 1.8 Hz) and 6.90 (d, J=1.8 Hz), 6.75 (d, J=8.2 Hz), 6.74 
(dd, J=8.2, 1.8 Hz)], one methylene [OH 2.98 (dd, J=13.S, 4.7 Hz) and 2.54 (dd, 
J=13.5, 11.3 Hz)], three methines [(OH 4.74 (d, J=6.9 Hz), 2.73 (m) and 2.37 (m)] 
and two oxygenated methylenes [OH 3.96 (dd, J=8.0, 5.2 Hz), 3.70 (dd, .1=8.0, 6.6 
Hz) and 3.82 (m), 3.64 (dd, J=11.6 Hz). All these data suggested that SM7 possessed 
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a lariciresinol type skeleton. 158 The lariciresinol skeleton was further confinned by 
showed cross peaks between H-5 (OH 6.75) and H-6 (OH 6.74), H-5' (OH 7.08) and H-
6' (OH 6.73), H-7 (OH 4.74) and H-8 (OH 2.37), H-8 and H-8' (OH 2.73), and H-8' and 
H-7' (OH 2.98) and H-9' (OH 3.96). The 3J IH_\3C long range correlations were 
observed between H-2 (OH 6.90) and C-4 (oc 147.1), C-6 (oc 119.8) and C-7 (oc 
84.1), H-7 (OH 4.74) and C-2 (oc 110.7), C-6 and C-9 (oc 60.5), H-9 (OH 3.82) and C-
7, H-7' (OH 2.98) and C-2' (oc 114.4) and C-6' (oc 122.3), and H-9' (OH 3.96) and C-
7' (oc 33.7) (Figure 92). 
171 (SM7) 
172 (SM8) 
MeO 
7' 9' 
OH 
R 
H 
OH 
R' 
J3-o-glucopyranosyl 
H 
Figure 30. Structures of lariciresinol 4' -O-~-o-glucopyranoside (SM7) and 
berchemol (SMS) 
The IH NMR signal at OH 4.84 and the \3C NMR signal at Oc 103.1 could be 
attributed to an anomeric proton and anomeric carbon, respectively, of a glucose 
moiety.ls3 The 3J IH_\3C long range correlation, observed in the HMBC spectrum 
(Figure 92) between OH 4.84 (H-l") and Oc 146.4 (C-4') confirmed the attachment 
of the glucose moiety at C-4' of the aglycone unit. Although the IH and \3C NMR 
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data of SM7 were identical to the published data of lariciresinol 4'-O-~-D­
glucopyranosidels9, all IH and 13C NMR signals were completely assigned on the 
basis of DEPT-135, COSY, HMQC and HMBC experiments. Thus, SM7 was 
identified unequivocally as lariciresinol 4' -O-~-D-glucopyranoside (171).159 This is 
the first report of the occurrence of this compound in C. cyanus and even in the 
genus Centaurea. 
OH 
Figure 31. Key HMBC eH~I3C) correlations ofSM7 (171) 
The CIMS spectrum of SM8 showed an mlz at 394 [M+NRtt, indicating the 
molecular formula C20H2406. The IH and l3C NMR data (Table 10) of SM8 showed 
structural similarities with SM7, but lacking a glucose moiety and one methine. The 
l3C NMR data (Table 10) showed the presence of twenty carbons. The DEPT-135 
indicated two methoxy (8 56.1, 55.9), two methylenes (0 72.1, 35.2), nine methines 
(0 122.5, 121.7, 116.4, 115.7, 113.8, 112.8,85.8, 83.4,52.0), six quartemary carbons 
(8149.2, 148.8, 147.5, 146.0, 133.4, 130.9), and one primary alcohol group (064.6). 
The IH NMR data (Table 10) showed the presence of two trisuhstituted benzene ring 
systems [8H 6.92 (d, J=1.8 Hz), 6.72, 6.72 and 6.77 (d, )=1.8 Hz), 6.68 (d, J=8.0 Hz) 
and 6.61 (dd, )=8.0, 1.8 Hz)], two oxymethylenes [OH 4.03 (dd, )=8.0, 5.2 Hz) and 
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3.62 (dd, )=8.0, 6.6 Hz), and 3.76 (d, )=11.6 Hz) and 3.56 (d, )=11.6 Hz)], one 
oxymethine (OH 4.80, s), one methylenes [OH 3.05 (dd, .1=12.8, 12.4 Hz) and 2.43 (t, 
)=12.8, 12.4 Hz)] and one methine [OH 2.54, m)] (Figure 93). The 3) IH_I3C long-
range HMBC correlations were observed between H-2 (OH 6.92) and C-4 (147.5), C-6 
(oc 121.7) and C-7 (oc 85.8), H-6 (oc 6.72) and C-2 (oc 112.8) and C-7, H-7 (OH 4.80) 
and C-2, C-6, C-9 (oc 64.6) and C-9' (oc 72.1), H-T (OH 3.05) and C-8 (oc 83.4) , C-
2' (oc 113.8), C-6 and C-9', and H-9' (OH 4.03) and C-7, C-8 and C-T. The relative 
stereochemistry at the chiral centres was determined from the IH_IH NOESY 
experiment (Figure 32). The IH_IH NOESY spectrum (Figure 94) showed strong 
NOE interactions between H-7 (OH 4.80) and H-2 (OH 6.92) and H-6 (OH 6.72), H-T 
(OH 3.05) and H-2' (OH 6.77) and H-9 (OH 3.76), H-2 and 3-0CH3 (OH 3.80), and H-2' 
and 3'-OCH3 (OH 3.81). The relative stereochemistry of SM8 was determined by 
direct comparison of its IH and l3C NMR data with published data. l60 The IH and I3C 
NMR data of SM8 were in good agreements with published data of berchemol. 160 
The UV, MS, 1 H NMR, I3c NMR, HSQC and HMBC analyses, unequivocally 
confirmed SM8 as berchemol (172). This is the first report on the occurrence of 
berchemol from any species of the genus Centaurea. 
HO 4' 
H 
Figure 32. Key NOE interaction ofSM8 (172) based on IH)H NOESY experiment 
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Table 10. IH NMR (chemical shift, multiplicity, coupling constant J in Hz), l3C 
NMR data for SM7 (171) and SMS (172) 
Chemical shift cS in ppm 
Carbon 
number IH I3C 
SM7· SMS6 SM7· SMSb 
1 135.7 130.9 
2 6.90, d, 1.8 6.92, d, 1.8 110.7 112.8 
3 149.0 148.8 
4 147.1 147.5 
5 6.75, d, 8.2 6.72c 116.0 115.7 
6 6.74, dd, 8.2, 1.8 6.72c 119.8 121.7 
7 4.74, d, 6.9 4.80, s 84.1 85.8 
8 2.37, m 54.0 83.4 
9 3.82 3.76, d, 11.6 60.5 64.6 
3.64, dd, 11.6 3.56, d, 11.6 
1 ' 137.2 133.4 
2' 6.88, d, 1.8 6.77, d, 1.8 114.4 113.8 
3' 150.9 149.2 
4' 146.4 146.0 
5' 7.08, d, 8.2 6.68, d, 8.0 118.3 116.4 
6' 6.73, dd, 8.2, 1.8 6.61, dd, 8.0, 1.8 122.3 122.5 
7' 2.98, dd, 13.5,4.7 3.05, dd, 12.8, 12.4 33.7 35.2 
2.54, dd, 13.5, 11.3 2.43, t, 12.8, 12.4 
8' 2.73,m 2.54, m 43.7 52.0 
9' 3.96, dd, 8.0, 5.2 4.03, dd, 8.0, 5.2 73.5 72.1 
3.70, dd, 8.0, 6.6 3.62, dd, 8.0, 6.6 
1" 4.84c 103.1 
2" 3.47c 75.0 
3" 3.44c 77.9 
4" 3.30c 71.4 
5" 3.38c 78.2 
6" 3.88c 62.6 
3.68c 
O-CH3 (3) 3.83, s 3.80, s 56.4 55.9 
O-CH3 (3') 3.84, s 3.81, s 56.8 56.1 
• IH NMR (600 MHz) and I3C NMR (150 MHz) in CD30D 
b IH NMR (400 MHz) and DC NMR (100 MHz) in CD30D 
C Overlapped signals, assignments was confirmed from IH_IH COSY and IH_ 13C HSQC correlations 
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The IH and I3C NMR spectrum (Figure 95; Table 11) of SM9 displayed signals 
similar to those of berchemol (172) with the exception that there were additional 
signals which could be attributed to a glucose moiety in SM9. The ESIMS spectrum 
of SM9 also confirmed the presence of a glucose moiety by displaying the 
pseudomolecular ion peak m/z at 561 [M+Nat indicating the molecular formula 
C26H340 12 [HRESIMS mlz 561.1934 [M+Nat]. The IH NMR signal at 3H 4.81 (d, 
)=7.2 Hz, H-l") could be assigned to the anomeric proton of a glucose moiety.153 
The IH_I3C 3) long-range correlation between the anomeric proton (H-l") and 3c 
145.2 (C-4') in the HMBC spectrum (Figure 96; Table 11) confirmed that the 
glucosyl unit was attached to C-4'. Thus, the structure of SM9 was elucidated as 
berchemol 4' -O-J3-D-glucopyranoside (173). The relative stereochemistry at the 
chiral centres in SM9 was assigned by direct comparison of its IH and I3C NMR data 
with published data. 161 This compound (173) was first isolated from Valeriana 
ofjicinalis. 161 However, this is the first report on the occurrence of this compound in 
C. montana and even in the genus Centaurea. 
MeO 
HO 
HO'" 
OH 
173 
7' 
OH 
. 7 
\. 1 
.Q-OMe 
OH 
Figure 33. Structure ofberchemoI4'-O-J3- o-glucopyranoside (SM9) 
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Table 11. IH NMR (chemical shift, multiplicity, coupling constant J in Hz), I3C 
NMR data and long-range HMBC for SM9 (173) 
Carbon Chemical shift B in ppm HMBC correlations (IH~13C) 
number (Ha I3Ca zJ 3J 
1 129.5 
2 6.92, s 111.5 C-3 C-4, C-6, C-7 
3 147.4 
4 146.0 
5 6.72, S 114.3 C-l, C-3 
6 6.72, s 120.3 C-l C-2, C-7 
7 4.80, S 84.4 C-l C-6, C-2, C-9 
8 82.0 
9 3.76,d,I1.6 63.3 
3.56, d, 11.2 
1 ' 135.6 
2' 6.86, d, 2 113.1 C-3' C- 4', C-6', C-T 
3' 149.7 
4' 145.2 
5' 7.06, d, 8.0 117.1 C-4' C- 3', C- l' 
6' 6.74, dd, 8.0, 2.0 121.1 C-2', C-4' 
7' 3.12, dd, 12.4,2.4 33.8 C-l ' C-2', C-6' 
2.52, dd, 12.4,3.4 
8' 2.58, m 50.5 
9' 4.05, dd, 8.0, 6.0 70.6 C-7', C-7, C-8 
3.61, dd, 8.0, 3.2 
I" 4.81, d, 7.2 101.8 C-4' 
2" 3.44, m 73.7 
3" 3.43, m 76.6 
4" 3.34,m 70.1 
5" 3.35, m 77.0 
6" 3.82, m 61.3 
3.64, m 
O-CH3 (3) 3.81, S 55.5 C-3 
O-CH3(3') 3.82, S 55.1 C-3' 
a'H NMR (400 MHz) and \3C NMR (100 MHz) in CD30D 
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3.1.2.2 Characterisation of SMI0, 5MB and SM12 as Pinoresinol (144), 
Pinoresinol monomethyl ether (174) and Pinoresinol dimethyl ether 
(175), respectively 
The \3C NMR and DEPT-135 spectra of SMI0 (Figure 97 and 98) displayed 10 
carbon signals consisting of one methylene (0 71.4), five methines (0 118.8, 114.9, 
109.8, 86.3, 54.1), two oxygenated quartemary carbons (0 147.9, 146.1), one 
quartemary carbon (0 132.8) and one methoxy groups (0 55.2). All protonated 
carbons were assigned by IH_\3C HSQC experiments. ISO The IH NMR spectrum 
showed signals for a methine proton at 0 3.10 (m), a benzylic oxymethine proton at 0 
4.66 (d, J=4.8 Hz), an oxyrnethylene at 8 4.19 (m) and 3.80 (m), and a 1,3,4 
trisubstituted phenyl group [06.90 (d, J=1.6 Hz), 6.77 (dd, J=8.0, 1.6 Hz) and 6.72 
(d, J=8.0 Hz)], which could be assigned to a Iignan of the 3,7-
dioxobicyclo[3.3.0]octane type, containing a furofuran ring (Table 12).162,163 The 
presence ofa furofuran skeleton was also confirmed by the IH_IH COSY and IH_\3C 
HMBC experiments (Table 12). The IH_IH COSY spectrum showed cross peaks 
between H-5 (OH 6.72) and H-6 (OH 6.74), and H-6 (OH 6.74) and H-7 (OH 4.66). A 2 J 
IH_I3C correlation between H-7 (OH 4.66) to C-8 (oe 54.1) and a 3 J correlations from 
H-7 (OH 4.66) to C-9 (oe 71.4), and H-9 (8H 4.22) to C-7 (oe 86.3) and C-8 (8e 54.1) 
were observed in the IH_\3C HMBC spectrum (Figure 99), and thus confirmed the 
furofuran structure. A singlet at OH 3.81 in the IH NMR spectrum, together with the 
signal oe 55.2 in the I3C NMR spectrum, could be assigned to a methoxy group 
attached to the aromatic ring. The 3J IH_I3C long range correlation between OH 3.81 
and Oe 147.9 (C-3) in the HMBC spectrum confirmed the attachement of the 
methoxy group at C-3 position. The relative configuration at H-7 and H-8, and H-7' 
and H-8' were determined as frans-form from the coupling constant, J=4.48 Hz of 
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H-7 and H-T, and from the IH_IH ROESY experiment (Figure 35).164 The IH_IH 
ROESY spectrum showed strong NOE interactions between H-2 (OH 6.90) and 3-
OMe (OH 3.81), H-7 (OH 4.66) and H-2, H-6 (OH 6.74) and H-9 (OH 4.22). However, 
no NOE correlations were observed between H-7 and H-8 (OH 3.10). The molecular 
formula of SM 1 0 was determined as C20H2206 on the basis of the [M-Hr ion peak at 
m/z 357.1344 in the HRESIMS. Taking the IH and I3C NMR data, and the molecular 
mass into account, it was clear that this molecule had two equal parts or symmetry. 
The IH and I3C NMR data were identical to published data ofpinoresinol. 165,166 
144 (SMIO) 
174 (SMll) 
175 (SMI2) 
OMe 
OOR' ~ l' I 80 .. ,"'~ 9 7' 8 8' ~"~"70 9' 
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Me 
Figure 34. Structures of pinoresinol (SMIO), pinoresinol monomethyl ether (SMII) 
and pinoresinol dimethyl ether (SM12) 
Figure 35. Key HMBC correlations eH-~nC) ofSMI0 (144) 
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A positive optical rotation was observed for SMI0. A combination of ID and 2D 
NMR analyses confinued the identity of SMI0 as (+)-pinoresinol (144). (+)-
Pinoresinol was previously isolated from many other plant speciesI65-166, including C. 
calcitrapa64 and C. orphanidea106 (Table 1). 
Table 12. IH NMR (chemical shift, multiplicity, coupling constant J in Hz), l3C 
NMR data, IH_IH COSY and IH_l3C long range HMBC for 8MI0 (144) 
Carbon Chemical shift 0 in ppm 
number IHa I3Ca COSyeH)H) 
111 ' 132.6 -
2/2' 6.90, d, 1.6 109.8 H-2 to H-6 
3/3' 147.9 -
4/4' 146.1 -
5/5' 6.72, d, 8 114.9 H-5 to H-6 
6/6' 6.77, dd, 8, 1.6 118.8 H-6 to H-5 
7/7' 4.66, d, 4.8 86.3 H-7 to H-8 
8/8' 3.10, m 54.1 H-8 to H-7, H-9 
9/9' 4.19, m 71.4 Ha-9 to Hb-9, H-8 
3.80, m 
O-CH3 (3/3') 3.81, s 55.2 
alH NMR (400 MHz) and i3C NMR (lOO MHz) in CD30D 
C-l, C-3,C-5, C-6, C-7 
C-l, C-3, C-4 
C-2, C-4, C-7 
C-2, C-6, C-8, C-9 
C-7, C-8 
C-3/C-3' 
The IH and I3C NMR spectra of 8MB and 8M12 indicated that they were the 
pinoresinol (144) derivatives. Their IH NMR spectra showed the presence of two 
1,3,4, trisubstituted benzene rings [OH 7.02 (d, J=8.0 Hz), 6.94 (d, J=2.0 Hz), 6.84 
(dd, J=8.0, 2.0 Hz), 6.91 (d, J=2.0 Hz), 6.77 (dd, J=8.0, 2.0 Hz) and 6.72 (d, J=8.0 
Hz)] and furofuran rings [OH 4.71 (d, J=4.8 Hz), 4.65 (d, J=4.4 Hz), 4.21 (m),3.83 
(m) and 3.10 (m)].162.163 The IH NMR spectrum of 8MB and SM12 also showed 
additional signals at OH 3.81, and 3.81 and 3.82, respectively, for the presence one, 
and two of methoxy groups. All spectroscopic data of SMll and 8M12 were 
compared with published data of pinoresinol monomethyl ether (174) and 
pinoresinol dimethyl ether (175) and found identical.l67-169 This is the first report on 
the occurrence of compounds 174 and 175 in the genus Centaurea. 
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3.1.2.3 Characterisation of SM13, SM14 and SM15 as Pinoresinol 4-0-P-o-
glucopyranoside (176), Pinoresinol 4,4'-di-O-P-o-glucopyranoside (177) 
and Pinoresinol 4-0-p-o-apiofuranosyl-(1 ..... 2) glucopyranoside (178), 
respectively 
The IH and \3C NMR spectra (Figure 101; Table 13-14) of SM13, SM14 and 
SM15 indicated that they were the pinoresinol (144) derivatives having one and two 
glucose units, and one apiose-glucose moiety, respectively. This fact was confirmed 
by mass analyses. The ESIMS spectrum of SM13 revealed the pseudomolecular ion 
peak at mlz 543 [M+Nat, suggesting the molecular fonnula C26H32011. An 
additional 162 mass units compared to pinoresinol (144) indicated the presence of a 
glucose moiety in SM13. In the IH NMR spectrum, a doublet observed at 0 4.82 
(J=7.6 Hz) was attributable to the anomeric proton of the glucopyranose with a ~ 
configuration. 153 A 3J IH_13C long range correlation observed in the HMBC spectrum 
(Table 13) from the anomeric proton at OH 4.82 (H-l") to Oc 149.8.1 (C-4) 
confirmed the attachment of the glucose unit at C-4 of the pinoresinol structure. A 
positive optical rotation was observed for the compound. Thus, the structure of 
SM13 was confirmed as (+) pinoresinol 4-0-~-D-glucopyranoside (176). This 
compound was previously reported from Forsythia leaves and Osmanthus 
. t' 170.171 asza lCUS. 
The ESIMS spectrum of SM14 revealed the pseudomolecular ion peak at mlz 705 
[M+Nat, suggesting the molecular formula C32H42016. It was clear that SM14 had 
an extra 324 mass units compared to pinoresinol (144) and is due to the presence of 
two glucosyl moieties in SMI4. However, due to the symmetry of the molecule both 
glucosyl units showed similar signals in the IH NMR spectrum (Table 13). A 
doublet at OH 4.84 (J=7.6 Hz) was attributable to the anomeric proton of a 
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glucopyranose with r3 configuration. l53 A 3 J 'H- J3C long range correlation observed 
in the HMBC spectrum from the anomeric proton, ~H 4.84 (H-l") to ~c 149.2 (C-4) 
confirmed that the glucosyl unit was linked C-4 of pinoresinol. Thus, SM14 was 
confirmed as pinoresinol 4,4' -di-O-r3-D-glucopyranoside (177). This compound was 
previously isolated from Eucommia ulmoides. 172 
176 (SMI3) 
177 (SMI4) 
178 (SMI5) 
OMe 
OOR' 'Y, 80 .... ,~ 9 7' l' 8 8' ~"~"7 0 9' 
RO~ 
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r3-D-gI ucopyranosyl 
r3-D-glucopyranosyl 
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Figure 36. Structures of pinoresinol glycosides (SMI3-SMI5) 
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Table 13. 'H NMR (chemical shift, multiplicity, coupling constant J in Hz) for 
SM13 (176), SM14 (177) and SM1S (178) 
Carbon Chemical shift 8 in ppm 
number SM131 SM148 SM1S8 
2 6.99, d, 1.6 6.98, d, 2.0 6.96, d, 2.0 
5 7.10, d, 8.4 7.02, d, 8.4 7.04, d, 8.4 
6 6.86, dd, 8, 2 6.85, dd, 8, 2 6.84, dd, 8.0, 2.0 
7 4.72, d, 4.4 4.71, d, 4.8 4.70, d, 4.8 
8 3.10, m 3.10, m 3.1, m 
9 4.20,m 4.20, m 4.2,m 
3.88,m 3.84, m 3.82, m 
2' 6.90, d, 2.0 6.98, d, 2.0 6.90, d, 2.0 
5' 6.74, d, 8.0 7.02, d, 8.4 6.72, d, 8.4 
6' 6.76, dd, 8.2 6.85, dd, 8, 2 6.77, dd, 8.4 
7' 4.66, d, 4.4 4.71, d, 4.8 4.66, d, 4.4 
8' 3.10, m 3.10, m 3.10, m 
9' 4.20, m 4.20, m 4.20, m 
3.78, m 3.84, m 3.82, m 
I" 4.82, d, 7.6 4.84, d, 7.6 4.93, d, 7.6 
2" 3.42, m 3.44, m 3.3, m 
3" 3.15, m 3.20, m 3.93, m 
4" 3.32, m 3.35,m 3.35, m 
5" 3.32, m 3.32, m 3.61, m 
6" 3.80, m 3.79, m 3.82, m 
3.62, m 3.64, m 3.79, m 
1" , 4.84, d, 7.6 5.50, d, 1.0 
2'" 3.44, m 3.25, m 
3 ,,, 3.20, m 3.89, m 
4'" 3.35, m 4.1 0, d, 10.0 
3.70, d, 10.0 
5'" 3.32,m 3.52, d, 8.0 
3.48, d, 8.0 
6'" 3.79, m 
3.64, m 
O-CH3 (3) 3.82, s 3.82, S 3.81, s 
O-CH3 (3') 3.81, s 3.82, s 3.80, S 
• IH NMR (400 MHz) in CDlOD 
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Table 14. I3C NMR data for SM13 (176), SMI4 (177) and SMI5 (178) 
Carbon Chemical shift 8 in ppm 
number SM13a SMI4a SMIS8 
1 136.3 136.0 135.8 
2 110.4 110.6 110.3 
3 146.1 146.4 146.1 
4 149.8 149.2 149.8 
5 116.8 116.3 116.0 
6 118.6 118.4 118.3 
7 85.9 85.9 86.0 
8 54.3 54.3 54.1 
9 71.5 71.5 71.5 
1 ' 132.6 136.0 132.6 
2' 109.8 110.6 109.7 
3' 146.2 146.4 146.3 
4' 147.9 149.2 147.9 
5' 114.9 116.3 114.9 
6' 118.8 118.4 118.8 
7' 86.3 85.9 86.3 
8' 54.3 54.3 54.3 
9' 71.5 71.5 71.5 
I" 101.7 101.7 99.8 
2" 73.7 73.7 76.8 
3" 77.0 77.0 76.6 
4" 70.1 70.1 70.2 
5" 76.6 76.6 75.9 
6" 61.3 61.3 61.3 
1" , 101.7 109.0 
2'" 73.7 77.6 
3'" 77.0 79.6 
4'" 70.1 74.3 
5'" 76.6 65.0 
6'" 61.3 
O-CH3(3) 55.5 55.2 55.2 
O-CH3C3') 55.2 55.2 55.2 
• DC NMR (100 MHz) in CD30D 
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The ESIMS spectrum of SM1S showed the pseudomolecular ion peak at m1z 675 
[M+Nar, and the molecular formula was determined as C31~OOIS from HRESIMS 
(m1z 675.2263 [M+Na]\ calculated value 675.2259) revealing that this compound 
had an extra 294 mass units compared to pinoresinol (SMI0). This extra mass could 
be attributed to an apiose and a glucose moiety. In the IH NMR spectrum (Table 14), 
a doublet at B 4.93 (J=7.6 Hz) was attributable to the anomeric proton of a 
glucopyranosyl unit with a p configuration. ls3 In the IH_13C HMBC spectrum 
(Figure 102) the glucose anomeric proton at BH 4.93 was correlated with the carbon 
signal at Bc 149.8 (C-4) indicating that the glucose unit was attached to C-4 of 
pinoresinol (SMI0). Additional signals in the IH NMR (8 5.50, d, J=l.O Hz and 
4.10-3.52, m) and I3C NMR (8 109.0, 79.6, 77.6, 74.3, 65.0) could be assigned to an 
apiose unit. 173 The J3 orientation of apiose was considered by comparing the I3C 
NMR data of SM1S with those of a-o-(Bc 104.5) and J3-o-apiofuranoside (Bc 111.5), 
respectively.173,174 A 3 J I H-l3c HMBC correlation between anomeric proton of 
apiose (H-l ''', BH=5.50) and Bc 76.8 (C-2") of glucose confirmed the linkage of 
apiose-(l ~2)-glucose (Figure 102). Thus SM1S was established as 4-0-P-o-
apiofuranosyl-( 1 ~2)-P-D-glucopyranosyl pinoresinol (178). This compound was first 
isolated from Parsansia laevigata. 17S However, this is the first report on the 
occurrence of this compound and other pinoresinol glycosides in C. mantana and 
even in the genus Centaurea. 
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3.1.2.4 Properties of Epoxylignans (SM7-SMI5) 
3.1.2.4.1 Properties of LariciresinoI4'-O-(3-D-glucopyranoside, 171 (SM7) 
Gum, UV Amax (MeOH): 279, 225 run; IR Vmax (neat): 3439, 1595, 1510, 1460 and 
1260 cm-I; ESIMS m/z 540 [M+NH4t; HRESIMS m/z 540.2437 [M+Na.t 
(calculated 540.2439 for C26H3SNOII); IH NMR (400 MHz, CD30D): Table 10; I3C 
NMR (lOO MHz, CD30D): Table 10. 
3.1.2.4.2 Properties of Berchemol, 172 (SM8) 
Gum, [a]23D + 37.8° (c 0.021, MeOH) (Lit. 160 - 7.9°, MeOH); UV Amax (MeOH): 
281,228 nm; IR Vmax (neat): 3459, 1591, 1514, 1460 and 1266 cm-I; CIMS mlz 394 
[M+NH4t; HRCIMS m/z 394.1857 [M+Na.t (calculated 394.1865 for C2oH2SN07); 
IH NMR (400 MHz, CD30D): Table 10; I3C NMR (lOO MHz, CD30D): Table 10. 
3.1.2.4.3 Properties of BerchemoI4'-O-(3-D-glucopyranoside, 173 (SM9) 
Gum, [a]23D + 21.7° (c 0.015, MeOH) (Lit. 161 - 15.0°, DMSO); UV Amax (MeOH): 
279,228 run; IR Vmax (neat): 3459, 1591, 1514, 1460 and 1266 cm-I; CIMS m/z 556 
[M+NH4t, ESIMS m/z 561 [M+Nat, 375 [M-glucoset, 309, 149, 121; HRESIMS 
mlz 561.1934 [M+Nat (calculated for C26H34012Na); IH NMR (400 MHz, CD30D): 
Table 11; I3C NMR (100 MHz, CD30D): Table 11. 
3.1.2.4.4 Properties of Pinoresinol, 144 (SMI0) 
Gum, [a]23D + 80.4 (c 0.0033, MeOH) (Lit. 166 + 35.0°, CHCh); UV Amax (MeOH): 
280,227 run; IR Vmax (neat): 3455, 1596, 1518, 1464 and 1262 cm-I; ESIMS mlz 381 
[M+Nat, 341 [M-OHt, 235, 175, 137, 58; HRESIMS m/z 357.1339 [M-Ht 
(calculated 357.1344 for C20H21 0 6); IH NMR (400 MHz, CD30D): Table 12; I3C 
NMR (100 MHz, CD30D): Table 12. 
118 
3.1.2.4.5 Properties of Pinoresinol monomethyl ether, 174 (SMll) 
Gum, UV Amax (MeOH): 279, 225 run; IR Vmax (neat): 3455, 1597, 1512, 1462 and 
1267 cm-I; ESIMS mlz 395 [M+Nat, 175, 151, 137, 58; Molecular formula 
C21 H240 6, IH NMR (250 MHz, CD30D):( OH 6.91 (d, 2.0 Hz), 6.77 (dd, 8.0,2.0 Hz), 
6.72 (d, 8.0 Hz), 4.71 (d, 4.8 Hz), 4.65 (d, 4.4 Hz), 4.20(m), 3.83 (m), 3.81 (s),3.1O 
(m); 13C NMR (62.5 MHz, CD30D): (oc 148.5, 147.9, 147.2, 146.1, 132.8, 118.8, 
114.9, 109.9,86.3, 71.4, 55.5, 55.5, 55.4, 54.1). 
3.1.2.4.6 Properties of Pinoresinol dimethyl ether, 175 (SMI2) 
Gum, [a]23D +45.2° C (c 0.03, MeOH) (Lit. 168 + 46.0°, CHCh); UV Amax (MeOH): 
279,225 nm; IR V max (neat): 3451, 1591, 1514, 1460 and 1266 cm-I; ESIMS mlz 409 
[M+Nat, 137; Molecular formula C22H2606, IH NMR (250 MHz, CD30D): (OH 7.02 
(d, J=8.0 Hz), 6.94 (d, J=2.0 Hz), 6.94 (d, J=2.0 Hz), 6.91 (d, 2.0 Hz), 6.77 (dd, 8.0, 
2.0 Hz), 6.72 (d, 8.0 Hz), 4.71 (d, 4.8 Hz), 4.65 (d, 4.4 Hz), 4.20 (m), 3.83 (m), 3.82, 
3.81 (s), 3.10 (m); 13C NMR (62.5 MHz, CD30D): (oc 147.9, 147.9, 146.2, 146.1, 
132.8,118.8,114.9,109.9,86.3,71.4,55.5,55.5,55.5, 55.4, 55.4, 54.1). 
3.1.2.4.7 Properties of PinoresinoI4-0-P-D-glucopyranoside, 176 (SM13) 
Gum, [a]23D + 11.3 (c 0.044, MeOH) (Lit.17I + 10.8°, MeOH); UV Amax (MeOH): 
279,225 nm; IR Vmax (neat): 3459, 1591, 1514, 1460 and 1266 cm-I; ESIMS mlz 520 
[M+Nat, 367, 357 [M-glucose]+, 234, 157; HRESIMS mlz 538.2282 [M+NH4t 
(calculated 538.2283 for C26H36NOll); IH NMR (400 MHz, CD30D): Table 13; 13C 
NMR (100 MHz, CD30D): Table 14. 
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3.1.2.4.8 Properties of Pinoresinol 4, 4' di-P-o-glucopyranoside, 177 (SMI4) 
Gum, UV Arnax (MeOH): 281, 228 run; IR Vrnax (neat): 3459, 1591, 1514, 1460 and 
1266 cm-I; ESIMS mlz 705 [M+Nat; 519 [M-monoglucoset, 357 [M-diglucoset, 
151) HRESIMS mlz 700.2805 [M+NH4t (calculated 700.2811 for C32H46NO'6); 'H 
NMR (400 MHz, CD30D): Table 13; \3C NMR (lOO MHz, CD30D): Table 14. 
3.1.2.4.9 Properties of Pinoresinol 4-0-j3-o-apiosefuranosyl-(1 ~2)-P-o­
glucopyranoside, 178 (SMI5) 
Gum, [a]23D -47.1 (c 0.019, MeOH) (Lit. 175 - 47.5°, MeOH); UV Arnax (MeOH): 280, 
222 run; IR Vrnax (neat): 3459, 1591, 1514, 1460 and 1266 cm-I; ESIMS mlz 675 
[M+Nat, 538, 312,150; HRESIMS mlz 675.2263 [M+Nat (calculated 675.2259 for 
C3,H400,sNa); 'H NMR (400 MHz, CD30D): Table 13; \3C NMR (lOO MHz, 
CD30D): Table 14. 
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3.2 Sesquiterpene lactones 
Three sesquiterpene lactones (SMI6-SMI8) were isolated from two Centaurea 
species in this study. Of them, two were germacranolides (SMI6 and SMI7) and one 
eudesmane (SM18). 
3.2.1 Germacranolides 
Two germacranolides, SM16 (isolation code CG6) and SM17 (isolation code CG7) 
were isolated from C. gigantea (Section 2.7.9). 
3.2.1.1 Characterisation of SM16 and SM17 as Arctiopicrin (21) and 8-0-(4-
Hydroxy-3-methylbutanoyl)-salonitenolide (179), respectively 
The I3C NMR data (Table 15) revealed that SM16 had 19 carbons. The DEPT-135 
indicated the presence of six methylenes (8 124.8, 63.6, 59.6, 48.4, 34.0, 25.7), six 
methines (8 129.5, 128.5, 77.3, 72.8, 52.4, 42.7), two methyls (8 15.7, 12.8), three 
quartemary carbons (8 144.9, 135.9, 132.3) and two carbonyl carbons (8 174.7, 
171.0). All protonated carbons were assigned by IH_I3C HSQC experiments. ISO The 
ESIMS spectrum showed the pseudomolecular ion peak at m/z 373 [M+Nat, 
suggesting Mr=350 and the molecular formula C19H2606. The IR spectra of SM16 
exhibited bands indicative of hydroxyl (3410 cm-I), lactone carbonyl (1770 cm-I), 
cyclopentanone (1730 cm-I) and olefinic carbons (1445 cm-1).97 The UV absorption 
at A.max 218 om indicated the presence of an aJ3 unsaturated carbonyl moiety.176 All 
these spectroscopic information from UV, IR, and I3C NMR data indicated that 
SM16 was a germacranolide.91 The IH NMR data (Table 15) exhibited signals at 8 
6.20 (d, J=2.4 Hz) and 5.94 (d, J=2.4 Hz) for an exocyclic methylene group and at 0 
5.11 (dd, J=10.0, 8.4 Hz) for a proton geminal to the oxygen of the lactone ring. In 
the IH NMR spectrum, additional doublet at 8H 4.87 (J=IO.0 Hz) and multiplets at 8H 
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4.97,4.93, 3.16,2.39 and 2.34 suggested that the germacranolides are salonitenolide 
d · . 91 envatlves. 
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Figure 37. Structure of arctiopicrin (SM16) 
The salonitenolide moiety was also confirmed by the IH_I3C HMBC experiment 
which showed 3J IH_I3C long-range correlations between H-2 (82.24) and C-lO (8 
132.3), H-5 (84.87) and C-3 (8 34.0), H-6 (8 5.11) and C-8 (8 72.8), H-9 (8 2.39) 
and C-7 (852.4) and C-14 (8 15.7), H-13 (86.20) and C-7 (52.4) and C-12 (8171.0), 
and 2J correlation between H-3 (8 2.50) and C-4 (8 144.9), and H-9 (82.39) to C-8 
(872.7) and C-IO (8 132.3) (Table 15). Additional signals at 83.70 (m), 3.60 (m), 
2.58 (m) and 1.10 (d, J=7.2 Hz) in the IH NMR spectrum implied the presence of a 
3_hydroxy-2-methylpropanoyl group which was further confirmed by the IH_13C 
HMBC experiment. The HMBC spectrum (Figure 104) showed 2J IH_I3C long-range 
correlations between H-17 (8 2.58) and C-16 (8 174.7), C-18 (863.6) and C-19 (B 
12.8), and H-19 (8 1.10) and C-17 (B 42.7), and 3J correlations between H-18 (B 
3.70) and C-16 (8 174.7) and C-19 (812.8), and H-19 (8 I.lO) and C-16 (174.7) and 
C-18 (863.6). Thus, SM16 was elucidated as 8-0-(3-hydroxy-2-metbylpropanoyl)-
salonitenolide or arctiopicrin (21). Although arctiopicrin was previously isolated 
from C. melitensis91 , this is the first report of the occurrence of this compound in C. 
gigantea. 
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Table 15. 'H NMR (chemical shift, multiplicity, coupling constant) in Hz), \3C 
NMR data and long-range HMBC for SM16 (21) 
Carbon 
number 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
Chemical shift 0 in ppm 
'Ha DCa 
4.99, m 129.5 
2.24, d, m 25.7 
2.16, d, m 
2.50, m 34.0 
1.90, m 
144.9 
4.87,d,10 128.5 
5.11, dd, 8.4,10 77.3 
3.16, m 52.4 
4.97, m 72.8 
2.39,m 48.4 
2.34, m 
132.3 
135.9 
171.0 
6.20, d, 2.4 124.8 
5.94, d, 2.4 
1.49, s 15.7 
4.20, d, 14 59.6 
3.97, d, 14 
174.7 
2.58, m 42.7 
3.70, m 63.6 
3.60, m 
1.10, d, 7.2 12.8 
C-4 
C-lO 
C-3 
C-8 
C-8, C-I0 C-7, C-14 
C-11 C-7, C-12 
C-lO C-9 
C-4 C-3, C-5 
C-16, C-18, C-19 
C-17 C-16, C-19 
C-17 C-16, C-18 
• IH NMR (400 MHz) and IJC NMR (lOO MHz) in CD30D 
The UV, JR, 'H and \3C NMR data (Table 16) revealed that SM17 was a 
germacranolide like SMI6. The 'H NMR data (Table 16) suggested that 
germacranolide SM17 was a salonitenolide derivative by displaying the signals at 0 
6.06 (d, )=2.4 Hz), 5.74 (d, .1=2.4 Hz), 5.13 (dd, J=10.0, 8.4 Hz), 4.97 (m), 4.93 (m), 
4.77 (d, )=10.0 Hz) and 2.39 (m). The I3C NMR spectrum (Figure 106) displayed 20 
carbon signals instead of 19 carbons. The additional signal was due to the extra 
methylene on the side chain. The 'H NMR spectrum also showed the presence of 4-
hydroxy-3-methylbutanoyl group by showing the signals at 0 3.19, 2.35, 2.08, 1.90 
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and 0.81. This side chain was also confirmed by the IH)3C HMBC experiment. The 
HMBC spectrum (Figure 107; Table 16) showed correlations between H-17 (8 2.35) 
to C-19 (8 65.9), C-20 (8 17.0), H-18 (8 1.90) to C-17 (8 38.3), C-20 (8 17.0), and H-
20 (8 0.81) to C-17 (8 38.3) and C-19 (8 65.9). The ESIMS spectrum showed the 
pseudomolecular ion at mlz 387 [M+Nat, suggesting Mr=364, and the molecular 
formula C20H2S06. The mass analyses also proved that SM17 had an extra 14 mass 
units compared to SM16. Thus, SM17 was identified as 8-0-(4-hydroxy-3-
methylbutanoyl)-salonitenolide (179). This compound was previously isolated from 
Onopordon laconicum. 177 However, isolation of this compound from C. gigantea and 
even from the genus Centaurea is reported here for the first time. 
3 
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Figure 38. Structure of 8-0-( 4-hydroxy-3-methylbutanoyl)-salonitenolide (SM17) 
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Table 16. IH NMR (chemical shift, multiplicity, coupling constant J in Hz), \3C 
NMR data and long-range HMBC for SM17 (179) 
Carbon Chemical shift 0 in ppm HMBC correlation eH-+\3C) 
number IH8 13C8 2J 3J 
1 4.93, m 129.8 
2 2.11, d, 7.6 26.4 
2.06, d, 7.6 
3 2.45, m 38.3 C-15 
1.78, m 
4 144.9 
5 4.77, d, 10.0 128.3 C-3, C-7, C-15 
6 5.13, dd, 8.4, 10.0 76.9 C-8 
7 3.16, m 52.0 
8 4.97,m 72.7 
9 2.39,m 48.7 C-8, C-I0 C-7, C-14 
2.34, m 
10 132.7 
11 136.9 
12 170.2 
13 6.06, d, 2.4 124.7 C-ll C-7, C-12 
5.74, d, 2.4 
14 1.36, s 17.1 C-I0 C-9 
15 3.9, d, 9.6 59.7 C-4 
3.8, d, 9.6 
16 174.1 
17 2.35, m 38.3 C-16, C-18 C-19, C-20 
2.08, m 
18 1.90, m 33.4 C-17, C-19, C-20 -
19 3.19, m 65.9 
20 0.81, d, 6.4 17.0 C-18 C-17, C-19 
• lH NMR (400 MHz) and l3e NMR (100 MHz) in DMSO-d6 
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3.2.2 Eudesmane 
One eudesmane-type sesquiterpene lactone, SM18 (isolation code CP4), was isolated 
from C. pamphylica (Section 2.7.10). 
3.2.2.1 Characterisation of SM18 as Pterodontriol (180) 
The ElMS spectrum of SM18 showed the molecular ion peak at m/z 256, and the 
molecular fonnula was calculated as C1sH2S03. The I3C NMR spectrum (Section 
3.2.3.3) of SM18 indicated the presence of fifteen carbons. The IH NMR spectrum 
(Section 3.2.3.3) showed the presence of four methyl groups. Of them two were 
doublets at OH 1.34 and 0.96 (J=6.6 Hz) and the other two singlets at OH 1.22 and 
1.60. A signal at Oc 28.8 in the I3C NMR spectrum was attributable to methine C-ll 
which implied the presence of an isopropyl group. Thus, the I H and I3C NMR data of 
SM18 suggested the presence of an eudesmane skeleton. 178 The IH and I3C NMR 
data were also comparable to those published pterodontriol (180), previously isolated 
from Laggera pterodonta and found to be identical. 179 The occurrence. of 
pterodontriol in C. pamphylica and even in the genus Centaurea is reported here for 
the first time. 
180 
Figure 39. Structure of pterodontriol (SMI8) 
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3.2.3 Properties of Sesquiterpene lactones (SMI6-SMI8) 
3.2.3.1 Properties of 8-0-(3-Hydroxy-2-methylpropanoyl)-salonitenolide or 
Arctiopicrin, 21 (SMI6) 
Gum, UV Amax (MeOH): 218 run; IR Vmax (neat): 3410, 1770, 1730 and 1445 cm-I; 
ESIMS 373 [M+Nat; Molecular formula C'9H2606; 'H NMR (400 MHz, CD30D): 
Table 15; l3C NMR (100 MHz, CD30D): Table 15. 
3.2.3.2 Properties of 8-0-(4-Hydroxy-3-methylbutanoyl)-salonitenolide, 179 
(SMI7) 
Gum, UV Amax (MeOH): 218 run; IR Vmax (neat): 3410,1770, 1730 and 1445 cm-I; 
ESIMS mlz 387 [M+Nat; Molecular formula C2oH2S06; 'H NMR (400 MHz, 
CD30D): Table 16; l3C NMR (lOO MHz, CD30D): Table 16. 
3.2.3.3 Properties of Pterodontriol, 180 (SMI8) 
MP 1800 C, ElMS 256 [Mt; Molecular formula C,sH2S0 3; 'H NMR (250 MHz, 
CD30D): 4.22 (m), 3.67 (t, J=6.2 Hz), 2.25 (m), 2.14 (d, J=I1.0 Hz), 1.98 (m), 1.96 
(m), 1.88 (m), 1.57 (m), 1.34 (d), 1.04 (m), l.60 (s), 1.22 (s), 0.96 (d) ; l3C NMR 
(62.5 MHz, CD30D): 76.6 (C-l), 29.5 (C-2), 32.0 (C-3), 69.0 (C-4), 47.9 (C-S), 73.1 
(C-6), 51.2 (C-7), 24.7 (C-S), 34.0 (C-9), 34.0 (C-IO), 28.8 (C-l1), 24.S (C-12), 29.1 
(C-13), 14.1 (C-14) and 22.7 (C-15). 
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3.3 Quinic acid Derivatives 
A total of three quinic acid derivatives (SMI9-SM21) were isolated in this study. Of 
them, SM19 (isolation code CM1) and SM20 (isolation code CM2) were purified 
from C. montana (Section 2.7.6). C. giganfea affored SM21 (isolation code CGl) 
(Section 2.7.9). 
3.3.1 Characterisation of SM19 and SM20 as trans-3-0-p-Coumaroylquinic 
acid (181) and cis-3-0-p-Coumaroylquinic acid (182), respectively 
The 13C NMR and DEPT-13S spectra of both SM19 and SM20 displayed sixteen 
carbon signals, consisting of two methylenes (039.2,37.8), nine methines (0 14S.2, 
129.8, 129.8, IIS.6, IIS.6, 114.6, 73.9, 71.9, 71.S), three quartemary carbons (0 
160.0, 126.1, 67.8), and two carbonyl carbons (0 170.1, 167.9). All protonated 
carbons were assigned by IH_13C HSQC. 150 The ESIMS spectra ofSM19 and SM20 
revealed the similar pseudomolecular ion peaks at mlz 361 [M+Nat, suggesting the 
molecular formula as CI6H1gOg. Although the ESIMS and the 13C NMR spectra 
(Table 17) indicated that both SM19 and SM20 were similar compounds, the IH 
NMR spectrum (Figure 108) revealed that they were geometrical isomers or cis-
frans isomers. The IH NMR data (Table 17) confirmed the presence of olefinic 
protons by displaying the signals at 0 7.S9 (d, J=IS.S Hz) and 6.31 (d, J=IS.6 Hz) for 
SM19 and 0 6.79 (d, J=12.8 Hz) and S.77 (d, J=12.8 Hz) for SM20. The coupling 
constant, J=IS.6 Hz confirmed that the olefinic protons in SM19 were in frans 
. M20·· . 176 configuratIOn and S was Its C1S Isomer. 
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A 
Figure 40. Key HMBC correlations (IH~l3C) of substructure A and B of SM19 
(181) 
The use of 1 D and 2D NMR data of SM19 enabled the construction of two 
substructures, A and B (Figure 40). The IH NMR spectrum (Figure 108; Table 17) 
revealed that substructure A was a p-coumaroyl moiety, which was evident from the 
signals 8 7.41 (d, J=8.4 Hz) and 6.76 (d, J=8.4 Hz), and 8 7.S9 (d, J=IS.6 Hz) and 
6.31 (d, J=IS.6 Hz). 
Table 17. tH NMR (chemical shift, multiplicity, coupling constant J in Hz), l3C 
NMR data and long-range HMBC for SM19 (181) 
Carbon Chemical shift in ppm HMBC correlation CH~\3C} 
number IHa DCa 2J 3J 
1 67.0 
2 2.13, dd, 14.8,3.2 39.3 C-4 
1.92, m 
3 S.30, m 71.S C-4 C-9' 
4 3.63, dd, 9.6, 3.2 73.9 C-S 
S 4.0S, m 71.9 C-4 
6 2.04, m 37.8 C-S C-2, C-4 
1.98, m 
7 170.1 
l' 126.1 
2' 7.41, d, 8.4 129.8 C-4', C-6', C-
7' 
3' 6.76, d, 8.4 115.6 C-4' C-l',C-S' 
4' 160.0 
S' 6.76, d, 8.4 11S.6 C-6' C-l', C-3' 
6' 7.41, d, 8.4 129.8 C-2', C-4', C-
7' 
7' 7.S9, d, IS.6 14S.2 C-8' C-2', C-9' 
8' 6.31, d, 15.6 114.6 C-9' C-l ' 
9' 167.9 
IIH NMR (400 MHz) and I3C NMR (100 MHz) in CDlOD 
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The IH_IH COSY spectrum also showed cross peaks between H-2'/4' to H-3'/5' and 
H-7' to H-S' to prove this substructure. The IH_\3C HMBC correlation between H-7' 
to C-9', H-S' to C-l', C-9', and H-2' to C-7' further confinned the presence of a p-
coumaroyl moiety (Table 17). The signals at 05.30 (m), 4.05 (d, m), 3.63 (dd, J=9.6, 
3.2 Hz), 2.13 (dd, J=14.S, 3.2 Hz) and 2.04 (m) were observed in the IH NMR 
spectrum due to the presence of a quinic acid unit which was further confinned by 
IH)H COSY experiment. The IH)H COSY spectrum showed cross peaks between 
H-2 to H-3, H-3 to H-4, H-4 to H-5 and H-5 to H-6. Finally, the IH_\3C HMBC 
correlations between H-2 to C-4, H-3 to C-2, C-4, H-4 to C-5, H-5 to C-4, and H-6 to 
C-2, C-4 and C-5 confinned the presence of a quinic acid unit. 180 A 3 J long-range IH_ 
\3C correlation between H-3 (OH 5.30) and Oc 167.9 (C-9') attached p-coumaroyl 
moiety to quinic acid at C-3 (Figure 109). Thus, SM19 was elucidated as trans-3-0-
p-coumaroylquinic acid (181) and SM20 was its cis isomer, cis-3-0-p-
coumaroylquinic acid (182). This is the first report of the occurrence of these quinic 
acid derivatives in the C. gigantea and even in the genus Centaurea. 
OH 
7 
5' 
6' 
OH 
- 0 OH H OH H 
-
5' H OH 
181 182 
Figure 41. Structures of trans and cis quinic acid derivatives (SM19 and SM20) 
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3.3.2 Characterisation of SM21 as Chlorogenic acid (168) 
The ESIMS spectrum of SM21 revealed the pseudomolecular ion peak at mlz 353 
[M-Ht, suggesting Mr=354 and the molecular formula C'6H'809. The molecular 
mass indicated that it had an extra 16 higher mass units than compared to SM20 
which could be due to the presence of an additional hydroxyl group. The 'H and I3C 
NMR data (Table 18) also revealed that SM21 had two substructures like SM20 
(Figure 40). But instead of a p-coumaroyl moiety (SM20), one of them was a p-
caffeoyl moiety. The signals at 0 7.38 (d, J=15.6 Hz), 7.00 (d, J=2.0 Hz), 6.91 (dd, 
J=8.0, 2.0 Hz), 6.70 (d, J=8.0 Hz), 6.16 (d, J=15.6 Hz) in the 'H NMR spectrum 
(Table 18) were due to the presence of a p-caffeoyl moiety which was further 
confirmed by the 'H-'H COSY and 'H_\3C HMBC experiments. The 'H NMR (0 
5.08,4.11, 3.68, 2.43, 2.02) and I3C NMR (0 176.8, 74.0, 73.3, 71.9, 67.2, 39.4 and 
38.3) signals implied that the other part of the molecule was quinic acid as in SM20. 
The quinic acid unit was also confirmed by the 'H-IH COSY and long range 'H-13C 
HMBC experiments. A 3Jlong-range HMBC correlation between OH 5.08 (H-3) to Dc 
166.9 (C-9') indicated that the p-caffeoyl moiety was attached to quinic acid at C-3. 
Thus, the structure of SM21 was elucidated as trans 3-0-caffeoyl quinic acid (168) 
and it is commercially available as chlorogenic acid (168).18' 
OH 
168 
Figure 42. Structure of chlorogenic acid (SM21) 
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Chlorogenic acid, known as a defence compound against microorganism, is common 
in Compositae family'82 and was previously isolated from C. cyanus72, C. isaurica83 . 
Table 18. 'H NMR (chemical shift, multiplicity, coupling constant J in Hz), I3C 
NMR and long-range HMBC for SM21 (168) 
Carbon Chemical shift 0 in ppm 
number IH I3C 
1 69.2 
2 2.43, dd, 14.8,3.2 39.2 
1.92, m 
3 5.08, m 73.3 
4 3.68, dd, 9.6, 3.2 74.0 
5 4.11, m 71.9 
6 2.02, m 38.3 
1.98, m 
7 176.8 
1 ' 126.2 
2' 7.00, d, 2.0 115.4 
3' 146.3 
4' 149.1 
5' 6.70, d, 8.0 116.5 
6' 6.91, dd, 8.0,2.0 121.9 
7' 7.38, d, 15.6 145.3 
8' 6.16, d, 15.6 115.2 
9' 166.9 
a IH NMR (400 MHz) and I3C NMR (100 MHz) in CD)OD 
C-3 
C-4 C-9' 
C-5 
C-4 
C-5 C-2, C-4 
C-4' 
C-5' 
C-l', C-8' 
C-9' 
C-4', C-6', C-7' 
C-l',C-3' 
C-4' 
C-6', C-9' 
C-l ' 
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3.3.3 Properties of Quinic acid Derivatives (SMI9-SM21) 
3.3.3.1 Properties of trans- 3-0-p-Coumaroylquinic acid, 181 (SMI9) 
Gum, UV Amax (MeOH): 332,220 run; IR Vmax (neat): 3459, 1765, 1591, 1514, 1460 
and 1266 cm-I; ESIMS mlz 361 [M+Nat, 191, 163, 104, 60; HRESIMS 339.1079 
[M+Ht (calculated 339.1074 for CI6HI90S); IH NMR (400 MHz, CD30D): Table 
17; l3C NMR (100 MHz, CD30D): Table 17. 
3.3.3.2 cis-3-0-p-Coumaroylquinic acid, 182 (SM20) 
Gum, UV Amax (MeOH): 279,225 run; IR Vmax (neat): 3459, 1765, 1591, 1514, 1460 
and 1266 cm-I; ESIMS mlz 361 [M+Nat, 191, 163, 104, 60; HRESIMS 339.1071 
[M+Ht (calculated 339.1074 for CI6HI90S); IH NMR (400 MHz, CD30D) [8 7.57, 
(d, J=8.4 Hz), 6.68 (d, J=8.4 Hz), 6.79 (d, J=12.8 Hz), 5.77 (d, J=12.8 Hz), 5.38 (m), 
4.05 (d, J=3.2 Hz), 3.56 (dd, J=9.6, 3.2 Hz), 2.13 (dd, J=14.8, 3.2 Hz), 2.04 (m), 1.98 
(m), 1.92 (m)]; l3C NMR (100 MHz, CD30D): Table 17. 
3.3.3.3 Properties of trans-3-0-Caffeoylquinic acid, 168 (SM21) 
Gum, [a]23D -34.3° (c 0.004, MeOH) (Lit. ISO -38.0°, MeOH); UV Amax (MeOH): 328, 
218 nm; IR Vmax (neat): cm-I; ESIMS mlz 353 [M-Ht, 191, 85, 67; Molecular 
formula CI6HIS09; IH NMR (400 MHz, CD30D): Table 18; l3C NMR (lOO MHz, 
CD30D): Table 18. 
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3.4 Ecdysteroids 
Two ecdysteroids, SM22 (isolation code CA2) and SM23 (isolation code CA4) were 
isolated from the C. americana seeds (Section 2.7.4). 
3.4.1 Characterisation of SM22 and SM23 as 20-Hydroxyecdysone (169) and 
Makisterone A (183), respectively 
The I3C NMR spectrum (Table 19) revealed that SM22 had twenty-seven carbons. 
The DEPT-135 indicated eight methylenes (0 42.5,38.9,32.6,32.6,32.5,27.4,21.7, 
21.3), seven methines (0 122.2, 78.5, 68.9, 68.6, 51.9, 50.0, 33.0), six quartemary 
carbons (0166.1,85.4,78.1,71.5,48.3,39.4), five methyl (029.9,29.0,24.6,21.6, 
18.2) and a ketonic carbonyl (0 203.5). The IR spectrum of the compound showed 
absorption bands of a hydroxyl group (3430 cm-I) and a carbonyl group of an aj3-
unsaturated ketone (1660 cm-I). The ESIMS spectrum of SM22 revealed the 
pseudomolecular ion peak at mlz 503 [M+Nat, and suggested the molecular formula 
169 (SM22) 
183 (SM23) 
R 
H 
Me 
Figure 43. Structure of 20-hydroxyecdysone (SM22) and makisterone A (SM23) 
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Table 19. lH NMR (chemical shift, multiplicity, coupling constant J in Hz) and l3C 
NMR data for SM22 (169) and SM23 (183) 
Carbon Chemical shift 8 in gEm 
number 'Ha Ca 
SM22 SM23 SM22 SM23 
1 1.50, t, 12.6 1.50, t, 12.6, 38.9 36.7 
1.85, m 1.85, m 
2 3.79, m 3.79, m 68.9 63.4 
3 3.68, d, 11.0 3.68, d, 11.0 68.6 63.4 
4 1.75, m 1.72, m 32.5 33.7 
1.90, m 1.86, m 
5 2.33, dd, 11.0, 6.5 2.34, dd, 11.0, 6.5 51.9 55.4 
6 203.5 202.6 
7 5.74, d, 2.5 5.72, d, 2.0 122.2 121.0 
8 166.1 175.9 
9 3.12, m 3.62, m 33.0 34.9 
10 39.4 39.0 
11 1.75, m 1.75, m 21.3 22.1 
1.85, m 1.85, m 
12 1.95, m 1.95, m 32.6 33.7 
1.75, m 1.75, m 
13 48.3 44.5 
14 85.4 83.7 
15 2.00,m 2.00, m 32.6 34.2 
1.54, m 1.54, m 
16 1.85, m 1.85, m 21.7 26.6 
1.80, m 1.80, m 
17 2.33, m 2.90, m 50.0 48.0 
18 0.91, s 0.91, s 18.2 18.8 
19 0.94, s 0.93, s 24.6 22.0 
20 78.1 78.1 
21 1.19, s 1.19, s 21.6 22.0 
22 3.66, m 3.72, m 78.5 77.9 
23 1.33, m 1.33, m 27.4 34.8 
1.65, m 1.65, m 
24 1.52, m 2.0, m 42.5 22.0 
1.80, m 
25 71.5 72.3 
26 1.19, s 1.19, s 29.9 18.8 
27 1.20, s 1.19, s 29.0 17.9 
24' 1.05, s 13.0 
a IH NMR (250 MHz) and I3C NMR (62.5 MHz) in CDJOD 
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From JR, mass, IH and I3C NMR spectra (Table 19), and by comparison of these 
data with published data, SM22 was identified as 20-hydroxyecdysone (169).183-185 
This compound was previously isolated from C. americana.SI 
The JR, IH and I3C NMR data of SM23 were similar to those of SM22 except the 
signal for an additional methyl group present in SM23. The ESJMS spectra 
supported the presence of additional methyl group by showing the [M+Nat ion m/z 
at 517 corresponding to the molecular formula C28H460 7. The I H and I3C NMR 
spectra (Table 19) were compared with the published data of makisterone A (183) 
and found to be identical. 185,186 Although makisterone A was previously reported 
from Penstemon venustus and Leuzea carthamoides,185,187 the occurrence of this 
compound in the genus Centaurea is reported here for the first time. 
3.4.2 Properties of Ecdysteroids (SM22-SM23) 
3.4.2.1 Properties of 20-Hydroxyecdysone, 169 (SM22) 
Gum; UV Amax (MeOH): 328,218 run; IR Vmax (neat): 3430, 1660 cm-I; ESIMS m/z 
503 [M+Na]+, 479 [M-Ht, 463 [M+I-H20 t, 445 [M+I-2H20t, 427 [M+I-3H20t, 
409 [M+I-4H20t, 383, 353, 177, 137; Molecular formula C27~07; 1H NMR (250 
MHz, CD30D): Table 19; I3C NMR (62.5 MHz, CD30D): Table 19. 
3.4.2.2 Properties of Makisterone A or 20-Hydroxyecdysone-24 methyl, 183 
(SM23) 
Gum; UV Amax (MeOH): 328,218 run; IR Vmax (neat): 3430, 1660 cm-I; ESIMS m/z 
517 [M+Nat, 191, 85, 67; Molecular formula C28Rt607; IH NMR (250 MHz, 
CD30D): Table 19; l3C NMR (62.5 MHz, CD30D): Table 19. 
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3.5 Steroids 
Three steroids (SM24-SM26) were isolated in this study. SM24 (isolation code 
CB7) was purified from C. bornmuelleri (Section 2.7.8), SM25 (isolation code CC5) 
from C. cyanus (Section 2.7.2) and SM26 (isolation code CMul) from C. 
mucronifera (Section 2.7.12). 
3.5.1 Characterisation of SM24 as Stigmast-4-en-3-ol (184) 
The ElMS spectrum of SM24 revealed the molecular ion peak at m/z 414, 
corresponding to the molecular formula ofC29HsoO. The 'H NMR spectrum (Section 
3.5.2.1) showed the presence of six methyl groups (resonating between at ~H 0.72-
1.20), one olefinic proton (~H 5.35), several methine and methylenes (~H 0.78-2.34) 
and one methine (~H 3.51). The I3C NMR spectrum (Section 3.5.4.1) displayed 29 
carbon signals and the observed signal at ~c 73.1 was due to the presence of 3-~ 
hydroxyl group. On the basis of mass, 'H and I3C NMR data and their direct 
comparison with published data, SM24 was identified as stigmast-4-en-3-01 (184).'88 
HO 
184 
Figure 44. Structure of stigmast-4-en-3-o1 (SM24) 
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3.5.2 Characterisation of SM25 as 3-Hydroxystigmast-5, 22-dien-l-one (185) 
The ElMS spectrum of SM25 revealed the molecular ion peak mlz at 426, suggesting 
for the molecular formula of C29H4602. The 1 H NMR spectrum (Section 3.5.4.2) 
showed the presence of six methyl groups (0 0.72-1.20), one olefinic proton (0 
5.35), methine and methylene protons (00.78-2.34) and one methine (0 3.51). The 
l3C NMR spectrum (Section 3.5.4.2) displayed 29 carbon signals and the signal at Oc 
201.1 was due to the presence of a carbonyl group. On the basis of mass, 1 H and l3C 
NMR data and their direct comparison with published data, SM25 was identified as 
3-hydroxystigmast-5,22-dien-l-one (185).189 This is the first report of the occurrence 
of this compound in the genus Centaurea. 
185 
Figure 45. Structure of 3-hydroxystigmast-5,22-dien-l-one (SM25) 
3.5.3 Characterisation of SM26 as Asterosterol (186) 
The IH NMR data (Section 3.5.4.3) ofSM26 showed signals for a septet (0 3.90, m), 
two methyl singlets (OH 1.21 and 0.86), two methyl doublets (OH 1.28 and 1.21) and 
two olefinic protons (OH 5.18 and 5.20) which implied SM26 to be a steroid. 19o A 
molecular formula of C26H420 was calculated from the ElMS spectrum which gave a 
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molecular ion peak at m/z 370. On the basis of mass, 1 H NMR data and their direct 
comparison with published data, SM26 was identified as asterosterol (186).190 
HO 
186 
Figure 46. Structure of asterosterol (SM26) 
3.5.4 Properties of Steroids (SM24-SM26) 
3.5.4.1 Properties of Stigmast-4-en-3-ol, 184 (SM24) 
Gum; ElMS m/z 414; Molecular formula C29HSOO; IH NMR (400 MHz, CD30D): 
8 5.35, 3.51, 2.34, 1.20,0.78; I3C NMR (100 MHz, CD30D): 8 140.2, 122.5, 78.3, 
63.4, 39.0, 38.3, 38.4, 38.1, 37.0, 36.1,35.6,34.2, 33.5, 32.8, 32.2, 30.2, 30.0,29.8, 
29.6,29.5,29.4,29.1,28.0,26.7,25.7,237, 18.2, 15.4, 14.5. 
3.5.4.2 Properties of 3-Hydroxystigmast-5,22-dien-l-one, 185 (SM25) 
Gum; ElMS m/z 426; Molecular formula C29H4602; IH NMR (400 MHz, CD30D): 8 
5.35, 5.20, 5.17, 3.51, 2.34, 1.20, 0.78; I3C NMR (lOO MHz, CD30D): 8 203.0, 
140.4, 122.1, 121.2, 114.5,78.0,63.1,39.4,38.9, 38.8, 38.0, 37.1, 35.6, 34.2, 32.8, 
32.0,29.7,29.6,29.6,29.5,29.4,29.3,28.0,26.7, 25.7, 22.7,18.0,15.4, 14.1. 
3.5.4.3 Properties of Asterosterol, 186 (SM26) 
Gum; ElMS m/z 370; Molecular formula C26H420; IH NMR (400 MHz, CD30D): 8H 
5.34,5.20,5.18,3.9, 1.95-3.15, 1.28, 1.21, 1.21,0.86. 
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3.6 Flavonoids 
Ten flavonoids were isolated from five Centaurea species (Table 20). Of them, four 
were flavonols (SM27, SM28, SM29 and SM30), two flavones (SM31 and SM32), 
three flavonoid C-glycosides (SM33, SM34 and SM35) and one flavanone (SM36). 
Flavonoid SM36, isolated from C. montana, is a new natural product. 
Table 20. Flavonoids isolated from Centaurea species 
Code (structure) Source and isolation code Page 
SM27 (122) C. huber- morathi (CH5) 74 
SM28 (123) C. schischkinii (CS4), c. bornmuelleri (CB3) 80,82 
SM29 (187) C. huber-morathii (CH4), C. schischkinii (CS6), 74,80, 
C. bornmuelleri (CB5) 82 
SM30 (108) C. schischkinii (CS8) 80 
SM31 (126) C. gigantea (CG5) 83 
SM32 (114) C. gigantea (CG8) 83 
SM33 (188) C. gigantea (CG3) 82 
SM34 (129) C. gigantea (CG4) 83 
SM35 (189) C. gigantea (CG2) 82 
SM36 (190) C. montana (CM4) 76 
3.6.1 Characterisation of SM27, SM28 and SM29 as Kaempferol (122), 
Astragalin (123) and Afzelin (187), respectively 
The UV (Table 21), IR, IH and 13C NMR (Table 22) data of SM27, SM28 and 
SM29 indicated that they were flavonoids. 191 Their IR spectra showed absorption 
bands for conjugated carbonyl (1679 cm-I) and the UV maxima were observed at 
234,252,282 and 313 nm to support for flavonoid skeleton.191 ,192 In the IH NMR 
spectrum (Figure 111; Table 22) two singlets at 8 6.50 (s) and 6.20 (s), and two 
doublets at 8 7.71 (d, J=8.8 Hz) and 6.92 (d, J=8.8 Hz) indicated that they were 
I d · . 192,193 Th k c. I fl I kaempfero envatlves. e aemplero type avono structures were also 
confirmed by the IH_IH COSY correlations. The IH_IH COSY spectrum showed 
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cross peaks between H-2' to H-3' and H-5' to H-6'. The ESIMS spectrum ofSM27 
gave [M-Hr mlz ion at 285, suggesting Mr=286 which could be accounted for the 
molecular formula C1SHIO06. The spectroscopic data of SM27 were in good 
agreement with literature data of kaempferol (122).192.194 Kaempferol (122) was 
isolated previously from C. calcitrapa49, C. cyanus72 and C. pallescens 49 (Table 1). 
Table 21. UV absorbance offlavonoids in methanol 
Flavonoids 
SM27 (122) 
SM28 (123) 
SM29 (187) 
SM30 (108) 
SM31 (126) 
Amax(nm) 
215, 250, 278, 317 
213, 252, 280, 313 
214,250,284,314 
222,254,284,319 
213,248,285,313 
HO 
H 
122 (SM27) 
123 (SM28) 
187 (SM29) 
Flavonoids Amax(nm) 
SM32 (114) 213, 252, 280, 313 
SM33 (188) 254,272,334 
SM34 (129) 214,250,280,314 
SM3S (189) 233,252,295,314 
SM36 (190) 213,252,343 
H 
OH 
R 
H 
~-D-glucopyranosoyl 
a-o-rhamnopyranosoyl 
Figure 47. Structures offlavonols (SM27-SM29) 
The ESIMS spectrum of SM28 displayed the pseudomolecular ion peak mlz at 471 
[M+Na]\ suggesting Mr=448, accounted for by the molecular formula C21 H21011. 
SM28 is 162 mass units more than kaempferol (SM27). This extra mass could be 
assigned to a glucosyl moiety which implied that this compound was a kaempferol 
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glucoside. The NMR signals (Table 22) for the anomeric proton at OH 4.60 (d, )=7.4 
Hz) and carbon at Oc 101.6 also indicated the presence of p-glucose moiety.i53 A 3) 
IH_I3C long-range correlation between the anomeric proton, 0 4.6 (H-I") and Oc 
135.2 (C-3) in the HMBC spectrum confirmed that glucosyl unit was attached to C-3 
of aglycone. All spectroscopic data were in good agreement with the published data 
of astragalin.193.196 Thus 8M28 was confirmed as astragalin or kaempferol 3-0-P-o-
glucopyranoside (123). This compound was previously isolated from C. inermis84 , C. 
isaurica83 , C. pallescens49 and C. virgata84 (Table 1). 
Table 22. IH NMR (chemical shift, multiplicity, coupling constant) in Hz data for 
8M27 (122), 8M28 (123) and 8M29 (187) 
Carbon Chemical shift 0 in ppm 
number 8M271 8M281 8M291 
6 6.20, d,2.0 6.18, d,2.0 6.15, d,2.0 
8 6.50, d, 2.0 6.42, d, 2.0 6.32, d, 2.0 
2' 7.71, d, 8.8 7.74, d, 8.8 7.72, d, 8.8 
3' 6.92, d, 8.8 6.92, d, 8.8 6.90, d, 8.8 
5' 6.92, d, 8.8 6.92, d, 8.8 6.90, d, 8.8 
6' 7.71, d, 8.8 7.74, d, 8.8 7.72, d, 8.8 
I" 4.60, d, 7.4 5.33, d, 1.2 
2" 3.46b 4.18, dd, 3.2, 1.6 
3" 3.46b 3.71b 
4" 3.36b 3.32b 
5" 3.36b 3.24b 
6" 3.82b 0.88, d, 5.6 
3.62b 
a IH NMR (400 MHz) in CD)OD 
b Overlapped peaks 
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Table 23. I3C NMR data for SM27 (122), SM28 (123) and SM29 (187) 
Carbon Chemical Shift 0 in ppm 
number SM271 SM281 SM291 
2 158.2 158.1 158.0 
3 135.4 135.2 135.0 
4 182.5 178.6 178.3 
5 162.0 162.0 162.0 
6 99.3 98.6 98.7 
7 164.3 165.1 165.3 
8 94.6 93.2 93.7 
9 157.4 157.4 157.4 
10 104.1 104.2 104.2 
1 ' 122.0 121.4 121.4 
2' 130.7 130.7 130.7 
3' 115.8 115.5 115.3 
4' 161.6 160.8 160.4 
5' 115.8 115.7 115.3 
6' 130.7 130.7 130.7 
I" 101.6 102.3 
2" 73.7 70.7 
3" 76.6 70.8 
4" 70.1 72.0 
5" 76.9 71.0 
6" 61.3 16.4 
• \3c NMR (100 MHz) in CDJOD 
The ESIMS spectrum of SM29 gave the pseudomolecular ion at mlz 455 [M+Nat, 
calculated for the molecular formula C21H2001O. SM29 was 146 mass units larger 
than SM27, which implied that it had a rhamnose moiety. In the IH NMR spectrum 
(Table 22), the signals at 85.33 (d, J=1.2 Hz) and 0.88 (d, J=5.6 Hz), together with 
the 13C NMR signals (Table 23) at 8c 102.3 and 16.4 also suggested the presence of 
a rhamnose moiety. The rhamnose moiety was also confirmed by the IH)H COSY 
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and IH_\3C HMBC experiments (Figure 114). A long-range 3J IH_\3C correlation 
between the anomeric proton, 0 5.33 (H-l") and Oc 135.0 (C-3) in the HMBC 
spectrum confirmed that rhamnosyl unit was attached to C-3 of the aglycone. All 
spectroscopic data were further compared with published data of afzelin and found 
identical.l93-197 Thus SM29 was characterised as afzelin or kaempferol 3-0-a-L-
rhamnopyranoside (187). This is a new report on the occurrence of this compound in 
the genus Centaurea. 
3.6.2 Characterisation of SM30 and SM31 as Apigenin (108) and 
Isoquercetrin (126), respectively 
The UV (Table 21), JR, IH and I3C NMR (Table 24) data of SM30 indicated that it 
was a flavonoid. The pseudomolecular ion peak at mlz 271 [M+Ht in the ESJMS 
(positive mode) revealed the molecular mass of 270 for this compound. The 
molecular formula C1SHIOOS was assigned from the HRESJMS spectrum (m/z at 
271.0600 [M+Ht, calculated value 271.0601). SM30 had 16 lower mass units than 
SM27 due to the lack of a hydroxyl group. The I3C NMR spectrum (Figure 116) of 
SM30 revealed that it had fifteen carbons. The DEPT-135 spectrum indicated the 
presence of seven methines (0 129.1, 129.1, 116.6, 116.6, 103.5, 99.5, 94.6), six 
oxygenated quartemary carbons (0182.4,164.9, 164.4, 162.1, 161.8, 158.0) and two 
quartemary carbons (0 121.8, 104.3). The IH NMR spectrum (Figure 115) exhibited 
signals similar to those of SM27 (Table 22) with the exception that SM30 had an 
additional singlet at 0 6.72, which was attributable to H-3 of a flavone system. This 
was further confirmed by the IH_I3C HMBC experiment. The 3J IH_I3C long range 
correlations were observed between H-3 and C-2 (oc 164.4), C-I0 (oc 104.3) and C-
l' (oc 121.8). 
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HO 
H 
OH 0 
108 
H 
OH 
Figure 48. Structure of apigenin (SM30) 
Table 24. IH NMR (chemical shift, multiplicity, coupling constant J in Hz), \3C 
NMR data and long-range HMBC for SM30 (108) 
Carbon Chemical shift 0 in ppm HMBC eH~ 13C) 
number IHa I3Ca zJ 3J 
2 164.4 
3 6.72, s 103.5 C-2 C-l', C-I0 
4 182.4 
5 162.1 
6 6.13, d, 2.4 99.S C-I0 
7 162.1 
8 6.42, d, 2.4 94.6 C-9 C-6, C-I0 
9 158.0 
10 104.3 
1 ' 121.8 
2' 7.87, d, 8.8 129.1 C-2, C-4', C-6' 
3' 6.87, d, 8.8 116.6 C-l',C-S' 
4' 161.8 
5' 6.87, d, 8.8 116.6 C-l', C-3' 
6' 7.87, d, 8.8 129.1 C-2, C-2', C-6' 
5-0H 12.90, br s 
• IH NMR (400 MHz) and J3C NMR (lOO MHz) in DMSO-d6 
The IH_13C HMBC spectrum also showed key correlations between H-2' (OH 7.87) 
and C-3' (0 129.1), H-3' (0 6.87) and C-l' (0 121.8), H-6 (0 6.13) and C-I0 (0 
104.3), H-8 (0 6.42) and C-6 (0 99.5), C-I0 (0 104.3). By analysing the IH, I3C 
NMR, IH_IH COSY and IH_13C HMBC data and comparing with published data, the 
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structure of SM30 was elucidated as apigenin (108).198 Apigenin was previously 
isolated from C. pa/lescens49, C. nervosa 1 00, C. orphanidea l06 and C. phrygia lOO 
(Table I). 
The ESIMS spectrum of SM31 displayed the pseudomolecular ion peak mlz at 487 
[M+Nat, suggesting Mr=464, calculated for molecular formula C21H20012. SM31 
~as 16 mass unit larger than kaempferol 3-0-P-o-glucopyranoside, 123 (8M28) due 
to an additional hydroxyl group. The IH NMR spectra data of 8M31 indicated the 
presence of two doublets at 8 6.36 and 6.17, and an ABX benzene spin system [8 
7.66 (d, J= 2.0 Hz), 7.55 (dd, J=8.4, 2.0 Hz), and 6.83 (d, J= 8.4 Hz)] on flavone 
ring B. The signals for the anomeric proton at OH 5.20 (d, J=7.6 Hz) and carbon at 
8c 101.6 also indicated the presence of p-glucose moiety.ls3 The IH and I3C NMR 
data (Section 3.6.9.5) were in good agreement with the published data of quercetin 
3_0-p-o-glucopyranoside or isoquercetrin (126) .196 
OH 
OH 
HO 
H 
OH 0 
126 R=/3-o-glucopyranosyl 
Figure 49. Structure ofisoquercetrin (SM31) 
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3.6.3 Characterisation of SM32 as 6-Hydroxy-luteolin 6,7-dimethylether (114) 
The ElMS spectrum of SM32 showed the molecular ion m/z at 330, accounted for by 
the molecular formula C17HI407. The 13C NMR spectrum of SM32 (Table 2S) 
revealed that it had seventeen carbons. The DEPT-135 spectrum indicated the 
presence of five methines (0 119.7, 116.6, 114.1, 103.3, 92.1), eight oxygenated 
quartemary carbons (0 182.8, 164.9, 159.2, 153.2, 152.7, 150.6, 146.5, 132.5), two 
quartemary carbons (0 122.0, 105.7) and two methoxy groups (0 60.7, 57.1). All 
protonated carbons were assigned by IH_13C HSQC experiment. 150 
The 1 H NMR spectrum (Table 2S) indicated the presence of two singlets at 0 6.83 
and 6.68, and an ABX benzene spin system [07.40 (dd, J=8.0, 2.0 Hz), 7.39 (d, J= 
2.0 Hz) and 6.85 (d, J= 8.0 Hz)] on flavone ring B. Two 3H singlets at OH 3.87 and 
3.67 could be assigned to two methoxy groups linked directly to the aromatic rings. 
The signals at 0 6.83 (s) and 6.68 (s) were assigned to proton H-8 and H-3 of the 
flavone ring, and were confirmed by the IH_ 13C HMBC experiment (Table 2S). 
MeO 
MeO 
OH 0 
114 
OH 
OH 
Figure SO. Structure of cirsiliol (SM32) 
The key HMBC correlations were observed between OH 6.83 (H-8) to Oc 132.2 (H-6), 
159.2 (C-7), 153.2 (C-9) and 105.7 (C-I0). The 3J IH_13C long-range correlation 
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between OH 3.87 and Oc 159.2 (C-7), and OH 3.67 and Oc 132.5 (C-6) confirmed that 
methoxy groups were linked, respectively, to C-7 and C-6 on the flavone ring A. 
Thus the structure of SM32 was confirmed as 6-hydroxy luteolin 6,7-dimethylether 
or cirsiliol (114). Cirsiliol was previously isolated from many plants199 including C. 
. I t 86 pamcu a a . 
Table 25. IH NMR (chemical shift, multiplicity, coupling constant J in Hz), l3C 
NMR data and long-range HMBC for SM32 (110) 
Carbon Chemical shift 0 in ppm HMBC eH~l3C) 
number IHa I3Ca zJ 3J 
2 164.9 
3 6.68, s 103.3 C-2, C-4 C-l', C-1O 
4 182.8 
5 152.7 
6 132.5 
7 159.2 
8 6.83, s 92.1 C-7, C-9 C-6, C-I0 
9 153.2 
10 105.7 
1 ' 122.0 
2' 7.39, d, 2.0 114.1 C-3' C-4', C-6' 
3' 146.5 
4' 150.6 
5' 6.85, d, 8.0 116.6 C-6' C-l',C-3' 
6' 7.40, dd, 8.0, 2.0 119.7 C-5' C-2', C-4' 
O-CH3 (6) 3.67, s 60.7 C-6 
O-CH3 (7) 3.87, s 57.1 C-7 
5-0H 12.92, br s 
• IH NMR (400 MHz) and l3e NMR (lOO MHz) in DMSO-~ 
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3.6.4 Characterisation of SM33 and SM34 as orientin (188) and isoorientin 
(129), respectively 
The ESIMS spectrum of SM33 showed the pseudomolecular ion peak at mlz 471 
[M+Nat, suggesting Mr=448 and solving for C21H2001l. The UV (Table 21), IH 
and \3C NMR data (Table 26) indicated that SM33 was a flavone. In the IH NMR 
spectrum (Table 26), two singlets at 0 6.58 (s) and 6.21 (s), and signals at 07.48 (dd, 
J=8.4, 2.0 Hz), 7.42 (d, J=2.0 Hz) and 6.80 (d, J=8.4 Hz) associated with Bring 
protons suggested that the compound was a luteolin derivative?OO A singlet at OH 
12.93 was assigned to the hydroxyl group linked to the C-5 of the flavone. The IH 
and \3C NMR spectra also showed the presence of a glucose moiety. The anomeric 
proton signal was observed at OH 4.62 as a doublet (J=10.0 Hz) which was indicative 
of ~ configuration?OI In the I3C NMR spectrum (Figure 118; Table 26) six carbon 
signals at 0 82.6, 79.4, 74.0, 71.4, 71.3 and 62.3 suggested that SM33 was a flavone 
C_glucoside.202 The signals at OH 6.58 and 6.21 could be assigned to H-3 and H-6 of 
ring A. These assignments were confirmed by the IH}3C HSQC and IH_I3C HMBC 
experiments. In the HMBC spectrum (Figure 119) H-3 (OH 6.58) showed 3 J 
correlations to Oc 122.7 (C-l') and 104.7 (C-I0), and 2J correlations to Oc 182.7 (C-
4) and 164.7 (C-2). H-6 (OH 6.21) showed 3 J correlations to Oc 105.2 (C-8) and 104.7 
(C-lO), and 2 J correlations to Oc 163.2 (C-7) and 161.0 (C-5). The anomeric proton, 0 
4.62 (H-l") showed 3J correlations to Oc 163.2 (C-7) and 156.6 (C-9), and 2J 
correlation to Oc 105.2 (C-8) and confirmed C-glucosidation at C-S. Thus, the 
structure of SM33 was elucidated as orientin (188). All spectroscopic data of SM33 
were in good agreement with literature data for orientin.201-203 
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OH 
OH 
OH 0 
R R' 
188 (SM33) ~-D-glucopyranosoyl H 
129 (SM34) H ~-D-glucopyranosoyl 
Figure 51. Structure of C-glycosides (SM33 and SM34) 
The I H and I3C NMR data of SM34 were similar to those of SM33, a flavonoid C-
glycoside. The ESIMS spectrum revealed m/z at 471 [M+Nat, accounted for by the 
molecular formula C21H2001lNa which was the same as SM33. However, NMR data 
analyses revealed that SM34 was in fact a positional isomer of orientin (SM33). The 
signals at OH 6.45 (s) in the IH NMR spectrum and oe 94.0 in the I3C NMR 
spectrum were attributable to H-8 of flavone, indicating the site of C-glucosidation at 
C-6. This was also supported from the carbon chemical shift of C-6 at 0107.2. The 
I H and I3C NMR data were compared with published data of isoorientin (129) and 
d ·d . I 204-205 foun I entIca. 
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Table 26. IH NMR (chemical shift, multiplicity, coupling constant J in Hz), I3C 
NMR data and long-range HMBC for SM33 (188) 
Carbon Chemical shift 0 in ppm HMBC eH-+I3C) 
number IHa I3Ca 2J 3J 
2 164.7 -
3 6.58, s 103.0 C-2, C-4, C-lO C-l', C-1O 
4 182.7 -
5 161.0 -
6 6.21, s 98.8 C-5, C-7 C-8, C-I0 
7 163.2 -
8 105.2 -
9 156.6 -
10 104.7 -
1 ' 122.7 -
2' 7.42, d, 2.0 114.7 C-3' C-2, C-4', C-6' 
3' 146.4 -
4' 150.2 -
5' 6.80, d, 8.4 116.3 C-4' C-l', C-3' 
6' 7.48, dd, 8.4,2.0 120.0 C-2, C-2', C-4' 
1" 4.62, d, 10 74.0 C-2", C-8 C-7, C-9, C-3", C-5" 
2" 3.79, m 71.4 C-l ", C-3" 
3" 3.20, m 79.4 C-2", C-4" 
4" 3.29, m 71.3 C-2", C-4" 
5" 3.10, m 82.6 C-4" C-3' 
6" 3.75, m 62.3 
3.50, m 
5-0H 12.92, br s 
• 'H NMR (400 MHz) and BC NMR (lOO MHz) in DMSO-d6 
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3.6.5 Characterisation of SM35 as 2"-(4"'-Hydroxybenzoyl)-isoorientin (189) 
The ESIMS spectrum of SM35 showed the pseudomolecular ion peak at m/z 591 
[M+Nat, suggesting Mr=568 and was calculated for the molecular formula 
C2SH24013. The UV (Table 21), IH and 13C NMR data (Table 27) revealed that 
SM35 was a flavone C-glycoside like SM34. The spectroscopic data of SM35 were 
similar to those of isoorientin (SM34) with the exceptions that the 1 H NMR spectrum 
(Table 27) of SM35 showed additional resonances at OH 7.90 (d, J=8.8 Hz) and 6.87 
(d, J=8.8 Hz) which were assignable to a 4-hydroxybenzoyl moiety. In the 13C NMR, 
seven signals at Oc 165.4, 161.6, 128.9, 128.9, 122.1, 115.8 and 115.8 also confirmed 
the presence of this group. 
OH 
o 
HO 
H 
189 
Figure 52. Structure of 2" -(4'" -hydroxybenzoyl)- isoorientin (SM35) 
The attachment of this moiety at C-2" of the glucose unit was confirmed by a 3 J IH_ 
13C correlation from H-2" (OH 4.15) to the carbonyl carbon C-7''' (oc 165.4) 
observed in the HMBC spectrum (Figure 120), Thus, the structure of SM35 was 
determined as 2"-(4"'-hydroxybenzoyl)-isoorientin (189). This compound was 
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previously isolated from Gentiana asc!epiadea?06 However, this is a new report on 
the occurrence of this compound in C. gigantea and even in the genus Centaurea. 
Table 27. 'H NMR (chemical shift, multiplicity, coupling constant J in Hz), l3C 
NMR data and long-range HMBC for SM35 (189) 
Carbon Chemical shift 5 in ppm HMBC ('H~l3C) 
number IHa I3Ca 2J 3J 
2 165.0 -
3 6.45, s 102.6 C-2, C-4, C-IO C-l ' 
4 182.7 -
5 160.8 -
6 107.9 -
7 163.6 -
8 6.41, s 94.0 C-7, C-9 C-6, C-I0 
9 157.4 -
10 104.0 -
1 ' 122.3 -
2' 7.27, m 113.0 C-3' C-6' 
3' 145.8 -
4' 149.8 -
5' 6.83,m 115.7 C-l ' C-3' 
6' 7.28, m 119.1 - C-2', C-3' 
I" 4.98b 74.1 C-6, C-2" C-5, C-7, C-3", C-5" 
2" 4.15, m 75.3 C-7''' 
3" 3.50, m 78.9 
4" 4.05, m 71.2 
5" 3.49, m 81.4 C-4" C-3' 
6" 3.90, m 61.7 
3.75, m 
1" , 122.1 -
2'" 7.90, d, 8.8 128.9 C-7''' C-4"', C-6'" 
3 ,,, 6.87, d, 8.8 115.8 C-4'" C-l "', C-5'" 
4'" 161.6 -
5'" 6.87, d, 8.8 115.8 C-4'" C-l ", , C-3 " , 
6'" 7.90, d, 8.8 128.9 C-7''' C-2"', C-4'" 
7'" 165.4 -
alH NMR (400 MHz) and I3C NMR (lOO MHz) in CD30D 
b Overlapped peak 
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3.6.6 Characterisation of SM36 as Flavanone 7-0-apiofuranosyl (1 ~2)­
glucuronic acid (190) 
The ESIMS spectrum of SM36 showed the pseudomolecular ion peak at m/z 603 
[M+Nar suggesting Mr=580. The HRCIMS gave the pseudomolecular ion m/z at 
598.1769 [M+NH4r (calculated 598.1766 for C26H32NOIS). The UV absorptions at 
213,252 and 343 run and the IR absorption band for conjugated carbonyl (1679 cm-
I) were indicative of a flavanone skeleton. 19l ,207 The IH and l3C NMR spectra 
(Table 28) of SM36 showed the presence of one methylene [8H 3.12 (dd, )=13.0, 
17.0 Hz) and 2.73 (dd, )=2.0, 17.0 Hz); 8c=42.4], one oxymethine [8H 5.36 (dd, 
J=2.0, 13.0 Hz); 8c=79.0] and two methines [8H 6.15 (d, )=2.0 Hz); 8c=95.0 and 6.11 
(d, J=2.0 Hz); 8c=96.5] of the ring A, and 4 methines in a group of two chemically 
equivalent protons [8H 7.28 (d, J=8.4 Hz) and 6.77 (d, )=8.4 Hz)] of the ring B 
(Figure 121). These data also supported SM36 to be a flavanone.208 The presence of 
a 1,4-disubstituted benzene ring system was evident from these signals which was 
further confirmed by cross peaks between H-2'/6' and H-3'/5' in the IH-IH COSY 
spectrum. The IH_l3C HMBC correlations between H-6 (8H 6.11) and C-8 (8e 95.0) 
and C-I0 (8e 104.0), and H-8 (8H 6.15) and C-6 (8e 96.5), C-7 (8e 164.0) and C-1O 
(8e 104.0) further confirmed the flavanone skeleton. The IH and l3C NMR spectra 
(Table 28) also revealed signals representing two sugar moieties. A doublet at 85.05 
(d, )=7.2 Hz) and additional signals (8 3.47-3.72) in the IH NMR implied that one of 
the sugars was a ~-glucose derivative and the carbon signal at 8 173.0 in the l3C 
NMR confirmed that it was a ~-D-glucuronic acid moiety.209 Five more l3C NMR 
signals at 8 109.0, 79.9, 77.5, 74.0 and 65.0 could be assigned to the carbons of 
. 2\0 A 3J IH l3C I I' b h . another sugar, aplose. - ong range coup 109 etween t e anomenc 
proton of apiose, 8H 5.38 (H-l") and 8e 75.0 (C-4") in the HMBC spectrum 
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(Figure 123) confirmed that the apiose was connected to glucuronic acid at C-4". 
The presence of apiose-glucuronic acid was also confirmed by the loss of 309 mass 
units from the molecular mass of the compound in the ESIMS spectrum. The 3J IH_ 
I3C long-range HMBC correlation between OH 5.05 (H-l") and Oc 164.0 (C-7) 
confirmed that the glucuronic acid moiety was connected to C-7 of the flavanone 
skeleton. The specific optical rotation for SM36 was found -480 • Literature review 
showed that all natural (-)-flavanones have been found to have S-chirality at C-
2.211 •212 Comparing with other flavanones of established absolute configuration 
measured by using circular dichroism spectroscopy, SM36 was considered as S 
stereochemistry at C-2 due to its levorotatory nature?1I·212 Thus, SM36 was 
determined as flavanone 7-0-apiofuranosyl {l-+4)-glucuronic acid (190). To the 
best of our knowledge this is a novel compound. 
H 
HOOC 6" H 
4~O H~l" OHo~'H 71 
H OH 
o 
OHOH 
190 
Figure 53. Structure of flavanone 7-0-apiofuranosyl{l~4)-glucuronic acid (SM36) 
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Table 28. IH NMR (chemical shift, multiplicity, coupling constant J in Hz), I3C 
NMR data and long-range HMBC for SM36 (190) 
Carbon Chemical shift 0 in ppm HMBC eH~13C) 
number iHa I3Ca 2J 3J 
2 5.36, dd, 2.0, 13.0 79.0 
3 3.12, dd, 13.0, 17.0 42.5 C-4 C-l ' 
2.73,dd ,2.0, 17.0 
4 196.0 
5 162.0 
6 6.11, d, 2.0 96.5 C-8, C-I0 
7 164.0 
8 6.15, d, 2.0 95.0 C-7 C-6, C-I0 
9 162.0 
10 104.0 
1 ' 130.0 
2' 7.28, d, 8.4 129.0 C-3' C-2, C-4', C-6' 
3' 6.77, d, 8.4 115.1 C-4' C-l',C-5' 
4' 158.0 
5' 6.77, d, 8.4 115.1 C-4' C-l', C-3' 
6' 7.28, d, 8.4 129.0 C-5' C-2, C-2', C-4' 
I" 5.05, d, 7.2 99.0 C-7 
2" 3.47, m 73.0, C-3" 
3" 3.61, m 77.8 
4" 3.72, t, 9.2 75.0 
5" 3.65,m 78.0 C-l " 
6" 173.0 
1" , 5.38, d, 1.0 109.0 C-2'" C-4", C-3'" 
2'" 3.89, m 77.5 C-4"', C-5'" 
3 '" 79.9 
4'" 3.91, m 74.0 C-5'" 
5'" 3.47, m 65.0 C-3'" C-4'" 
IIH NMR (400 MHz) and \3c NMR (lOO MHz) in CDJOD 
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3.6.7 Properties of Flavonoids (SM27-SM36) 
3.6.7.1 Properties of Kaempferol, 122 (SM27) 
Gum; UV Amax (MeOH): Table 21; IR Vmax (neat): 3459, 1679 and 1205 cm-I; 
ESIMS m/z 285 [M-Ht; Molecular formula CIsHIO06; IH NMR (400 MHz, 
CD30D): Table 22; l3C NMR (100 MHz, CD30D): Table 23. 
3.6.7.2 Properties of Astragalin, 123 (SM28) 
Gum; UV Amax (MeOH): Table 21; IR Vmax (neat): 3459, 1679 and 1205 cm-I; 
ESIMS m/z 471 [M+Nat, 285 [M-glucose-Ht, 137, 70; Molecular formula 
C2I H200 11; IH NMR (400 MHz, CD30D): Table 22; l3C NMR (lOO MHz, CD30D): 
Table 23. 
3.6.7.3 Properties of Afzelin, 187 (SM29) 
Gum; UV Amax (MeOH): Table 21; IR Vmax (neat): 3459, 1679 and 1205 cm-I; 
ESIMS m/z 433 [M+Ht, 285 [M-rhamnose-Hr, 233, l37, 70; Molecular formula 
C21 H200 1O; IH NMR (400 MHz, CD30D): Table 22; l3C NMR (100 MHz, CD30D): 
Table 23. 
3.6.7.4 Properties of Apigenin, 108 (SM30) 
Gum; UV Amax (MeOH): Table 21; IR Vmax (neat): 3459, 1679 and 1205 cm-I; 
ESIMS m/z 271 [M+H]\ HRESIMS mlz 271.0600 (calculated 271.0601 for 
CIsHllOS; IH NMR (400 MHz, CD30D): Table 24; l3C NMR (lOO MHz, CD30D): 
Table 24. 
3.6.7.5 Properties of Isoquercetrin, 126 (SM31) 
Gum; UV Amax (MeOH): Table; IR Vmax (neat): 3459, 1679 and 1205 cm-I; ESIMS 
m/z 487 [M+Nat; Molecular formula C2IH20012; IH NMR (400 MHz, CD30D): 0 
7.66 (d, j=2.0 Hz), 7.55 (dd, j=8.4, 2.0 Hz), 6.83 (d, j=8.4 Hz), 6.36 (d, )=2 Hz), 
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6.17 (d, )=2 Hz), 5.2 (d, )=7.6 Hz), 3.82-3.20, m; I3C NMR (lOO MHz, CD30D): 0 
180.1 (C-4), 165.0 (C-7), 161.9 (C-5), 157.3 (C-2), 153.0 (C-9), 150.1 (C-4'), 144.7 
(C-3'), 134.4 (C-3), 122.0 (C-l '), 120.0 (C-6'), 116.3 (C-5'), 114.2 (C-2'), 104.1 (C-
10), 101.6 (C-l "), 98.6 (C-6), 93.5 (C-8), 77.2 (C-5"), 77.1 (C-3"), 74.5 (CA"), 
70.0 (C-2") and 61.3 (C-6"). 
3.6.7.6 Properties of Cirsiliol, 114 (SM32) 
Gum; UV "'max (MeOH): Table 21; IR V max (neat): 3459, 1679 and 1205 cm-I; ElMS 
mlz 330 [Mt 315, 75 (lOO); Molecular formula C17HI407; IH NMR (400 MHz, 
CD30D): Table 25; \3C NMR (100 MHz, CD30D): Table 25. 
3.6.7.7 Properties of Orient in, 188 (SM33) 
Gum; UV "'max (MeOH): Table; IR Vmax (neat): 3459, 1679 and 1205 cm-I; ESI-MS 
mlz 471 [M+Ht; Molecular formula C2IH200 10; IH NMR (400 MHz, CD30D): 
Table 26; I3C NMR (100 MHz, CD30D): Table 26. 
3.6.7.8 Properties of Isoorientin, 129 (SM34) 
Gum; UV "'max (MeOH): Table 21; IR Vmax (neat): 3459, 1679 and 1205 cm-I; 
ESIMS mlz 471 [M+Ht; Molecular formula C21H200\O; IH NMR (400 MHz, 
CD30D): 0 7.48 (dd, 8.4, 2.0 Hz), 7.42 (d, 2.0 Hz), 6.80 (d, 8.4 Hz), 6.58 (s), 6.45 
(s), 4.60 (d, 10), 3.78-3.10 (m); I3C NMR (lOO MHz, CD30D): 0 182.7, 164.5, 
161.0, 156.2, 150.2, 146.4, 122.8, 122.7, 116.3, 114.7, 114.5, 120.0, 107.2, 104.6, 
103.0,94.0,82.5, 79.4, 71.4, 71.3, 62.4. 
3.6.7.9 Properties of 4"'-Hydroxybenzoyl- isoorientin, 189 (SM35) 
Gum; UV "'max (MeOH): Table 21; IR Vmax (neat): 3459, 1679 and 1205 cm-I; 
ESIMS mlz 591 [M+Nat; Molecular formula C2sH240\3; IH NMR (400 MHz, 
CD30D): Table 27; \3C NMR (lOO MHz, CD30D): Table 27. 
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3.6.7.10 Properties of Flavanone 7-0-apiofuranosyl (1-+4)-glucuronic acid, 190 
(SM36) 
Yellow amorphous; [a]23D -480 (c 0.021, MeOH); UV Amax (MeOH): Table 21; IR 
Vmax (neat): 3459, 1679 and 1246 cm-I; ESI-MS mlz 603 [M+Nat, 307, 
[glucose+apiose+2Ht, 271 [M-glucose-apioset, 104, 60; HRCIMS mlz 598.1769 
[M+NH4t (calculated 598.1766 for C26H32NOlS); IH NMR (400 MHz, CD30D): 
Table 28; \3C NMR (lOO MHz, CD30D): Table 28. 
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3.7 Alkaloids 
Nine alkaloids (SM37-SM45) were isolated from three Centaurea species in this 
study. All of them were indole alkaloids. 
3.7.1 Isolation and Characterisation of Indole Alkaloids 
Eight indole alkaloids SM37 (isolation code CM3), SM38 (isolation code CMI0), 
SM39 (isolation code CMll), SM40 (isolation code CMI8), SM41 (isolation code 
CMI9), SM42 (isolation code CMI2), SM43 (isolation code CM13) and SM44 
(isolation code CMI7) were isolated from C. montana seeds (Section 2.7.6). SM42 
and SM43 were also purified from C. cyanus seeds (Section 2.7.2). C. schischkinii 
afforded alkaloid SM45 (isolation code CS1, Section 2.7.7). SM44 and SM45 were 
novel compounds. 
Table 29. UV absorptions of indole alkaloids in methanol 
Alkaloids 'A. max (nm) Alkaloids 'A. max (nm) 
SM37 (191) 226,290,318 SM42 (148) 228,260,292,313 
SM38 (145) 226,291,317 SM43 (149) 227,282,291,313 
SM39 (192) 227,280,303,320 SM44 (193) 213,271,274 
SM40 (146) 227,280,303,320 SM45 (194) 228,255,283,301,313 
SM41 (147) 228,257,283,301,313 
3.7.1.1 Identification ofIndole Alkaloids 
All nine compounds (SM37-SM45) gave orange-red colour with DragendorWs 
reagent and were visualised as blue fluorescent as well as quenching spots on TLC 
under UV light at 366 and 254 nm respectively indicating them to be alkaloids. The 
UV absorption maxima (Table 29) of them were typical of indole chromophore.95 
The characteristics band at 3479 cm-! for N-H stretching in the IR spectrum was also 
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indicative of indole alkaloids. The presence of indole moieties was further confirmed 
by I H and I3C NMR spectral data. 
Table 30. Mass spectral data for indole alkaloids 
Alkaloids LRMS HRMS [M+Ht Molecular 
[M+Nat Found Required formula 
SM37 (191) 183 ClOHION2O 
SM38 (145) 345 323.1391 323.1390 C19H18N203 
SM39 (192) 345 323.1390 323.1390 CI9H I8N203 
SM40 (146) 359 337.1551 337.1547 C20H20N203 
SM41 (147) 359 337.1551 337.1547 C20H20N203 
SM42 (148) 375 375.1320 3.75.1321a C20H20N204 
SM43 (149) 375 C20H20N204 
SM44 (193) 725 72S.2590a 725.2582a C40H38N408 
SM45 (194) 475 475.1857a 475.1858a C26H24N602 
a [M+Nat 
3.1.7.2 Characterisation of SM37 as Tryptamine (191) 
The l3C NMR spectrum of SM37 (Table 31) revealed that this compound had ten 
carbons. The DEPT-135 indicated the presence of two methylenes (055.5,27.5), five 
methines (8 124.0, 118.0, 118.5, 121.0, 111.0) and three quarternary carbons (8 
138.0, 127.0, 109.0). All protonated carbons were assigned by IH_I3C HSQC 
experiment. 150 The I H NMR spectrum showed that SM37 had four aromatic protons 
in an ABCD system. The l3C NMR and IH NMR signals (7.66, d, J=8.0 Hz; 7.32, d, 
J=8.0 Hz; 7.07, ddd; 7.01, ddd) suggested that SM37 was tryptamine.213 The IH)H 
COSY and IH_I3C HMBC correlations (Figure 124) confirmed the identity ofSM37 
as tryptamine (191). 
161 
H ~ 
H 
191 
Figure 54. Structure of tryptamine (SM37) 
Table 31. IH NMR (chemicals shift, multiplicity, coupling constant J in Hz), 13C 
NMR data and long-range HMBC for SM37 (191) 
Carbon Chemical shift 0 in ppm 
number 'Ha \3Ca 
2 7.14, s 124.0 
3 109.0 
3a 127.0 
4 7.66, d, 8.0 118.0 
5 7.01, ddd 118.5 
6 7.07, ddd 12l.0 
7 7.31,d,8.0 11l.0 
7a 138.0 
a-CH2 3.80, dd, 9.6,4.8 27.5 
~-CH2 3.48, d, 3.6 55.5 
alH NMR (400 MHz) and I3C NMR (100 MHz) in CDJOD 
C-3,C-3a, C-7a 
C-3, C-3a, C-6, C-7a 
C-3a, C-7 
C-4, C-7a 
C-3a, C-5 
C-3, C-J3C 
C-2, C-3a, C-4 
3.7.1.3 Characterisation of SM38 and SM39 as (E) N-(4-Hydroxycinnamoyl)-5-
hydroxytryptamine (145) and (Z) -N-(4-Hy~roxycinnamoyl)-5-
hydroxytryptamine (192), respectively 
The HRESIMS data (Table 30) of SM38 and SM39 revealed the pseudomolecular 
ion mlz 323.1391 [M+Ht (calculated 323.1390 for CI9HI9N203). Analysis of the IH 
and 13C NMR data revealed that SM38 and SM39 (Table 32) had a set of two 
identical absorption peaks, and enabled the construction of two substructures A and 
B (Figure 56). The I H NMR spectrum showed that substructure A had an ABX spin 
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system by displaying the signals at 8 7.11 (d, J=8.0 Hz), 6.91 (d, J=2.0 Hz) and 6.63 
(dd, J=8.0, 2.0 Hz). The substructure A also gave rise to additional signals at 8 6.98 
(s), 3.52 (t, J=7.2 Hz) and 2.89 (t, J=7.2 Hz) for SM38 and 6.91 (s), 3.47 (t, J=7.2 
Hz) and 2.83 (t, J=7.2 Hz) for SM39 in the 'H NMR spectrum. The 'H and BC NMR 
data (Table 32) confirmed that substructure A was identical to that of a tryptamine 
derivative, 5-hydroxytyptamine (or serotonin).95 
The 'H NMR signals at 8 7.33 (d, J=8.4 Hz) and 6.75 (d, J=8.4 Hz) for SM38, and 
7.35 (d J=8.0 Hz) and 6.67 (d, J=8.0 Hz) for SM39 in the 'H NMR spectrum 
revealed that substructure B had a 1,4-disubstituted benzene ring system. The 
presence of two olefinic protons was also evident from the signals at 8 7.41 (d, 
J=15.6 Hz) and 6.35 (d, J=15.6 Hz) for SM38 and 6.57 (d, J=12.0 Hz) and 5.77 (d, 
J=12.0 Hz) for SM39. The higher coupling constant (J=15.6 Hz) between olefinic 
protons for SM38 confirmed that it had a frans configuration and SM39 possessed 
fi . 2'4 cis con IguratlOn. 
Alkaloids 
145 (SM38) 
146 (SM40) 
148 (SM42) 
o 
R 
H 
Me 
H 
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OMe 
Figure SS. Structure of indole alkaloids (SM38, SM40 and SM42) 
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The I3C NMR signal at 0 168.0 indicated the presence of a carbonyl carbon. All these 
findings from 1 H and I3C NMR confirmed that the substructure B was a p-coumaroyl 
moiety.71 The presence of a tryptamine derived substructure and a p-coumaroyl 
moiety were further confirmed by the IH)H COSY and IH_I3C HMBC exp,eriments 
(Table 32). The IH_IH COSY revealed four different spin systems:H-7~H-6~H-4, 
H2a~H2~' H-7'~H-8' and H-2' (H-6') ~H-3' (H-5'). The IH_I3C HMBC 
correlations were observed between H-2 to C-3, C-3a, C-7a; H-4 to C-2, C-3a, C-4, 
C-7a; H-2' to C-4', C-6', and H-3' to C-I' and C-5'. The IH_I3C long-range 
correlation from H2a (0 3.52/3.47) to carbonyl carbon C-9' (3 168.0) formed an 
amide linkage between the p-coumaroyl and serotonin moieties giving the complete 
structure of SM38 as (E) N-(4-hydroxycinnamoyl)-5-hydroxytryptamine (145) and 
SM39 as (2) N-(4-hydroxycinnamoyl)-5-hydroxytryptamine (192).215 
H 
A 
H 
N"",¥ OH 
B 
Figure 56. Key IH_I3C HMBC correlations ofSM38 (145) 
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Table 32. IH NMR (chemical shift, multiplicity, coupling constant J in Hz), I3C 
NMR data and long-range HMBC for SM38 (145) and SM39 (192) 
Carbon Chemical shift 0 in ppm HMBC 
number (Ha IHa J3Ca J3Ca eH-+I3C) 
{SM38} {SM39} {SM38} {SM39} of SM38 
2 6.98, s 6.91, s 123.0 123.0 C-3, C-3a, C-7a 
3 110.5 111.0 
3a 128.0 128.0 
4 6.91, d, 2.0 6.91, d, 2.0 102.3 102.3 C-2, C-3a, C-6, 
C-7a 
5 149.0 149.0 
6 6.63, dd, 2.0, 6.63, dd, 8.0, 111.2 111.2 C-7a 
8.0 2.0 
7 7.11,d,8.0 7.11, d, 8.0 111.4 111.4 C-3a, C-5, C-7a 
7a 131.9 131.0 
a-CH2 3.52, t, 7.2 3.47, t, 7.2 40.2 39.9 C-3, C-p, C-9' 
P-CH2 2.89, t, 7.2 2.83, t, 7.2 25.2 24.9 C-2, C-3, C-3a, 
C-a 
1 ' 127.0 129.3 
2' 7.33, d, 8.4 7.35, d, 8.0 129.3 128.2 C-4', C-6' 
3' 6.75, d, 8.4 6.67, d, 8.0 115.7 114.8 C-l', C-5' 
4' 160.0 159.5 
5' 6.75, d, 8.4 6.67, d, 8.0 115.7 114.8 C-l', C-3' 
6' 7.33, d, 8.4 7.35, d, 8.0 129.3 128.2 C-2', C-4' 
7' 7.41, d, 15.6 6.57, d, 12.0 140.6 136.7 C-2', C-9' 
8' 6.35, d, 15.6 5.77, d, 12.0 117.1 120.4 C-l' 
9' 168.0 168.0 
alH NMR (400 MHz) and I3C NMR (lOO MHz) in CDJOD 
3.7.1.4 Characterisation of SM40 and SM41 as Centcyamine (146) and cis-
Centcyamine (147), respectively 
The HRESIMS data (Table 30) of SM40 and SM41 revealed the pseudomolecular 
ion mlz 337.1551 [M+Ht (calculated 337.1547 for C20H2IN203). The IH NMR and 
I3C NMR spectra (Table 33) of SM40 were similar to that of SM38 indicating the 
presence of a tryptamine derived substructure and a p-coumaroyl moiety. 
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Figure 57. Structure of indole alkaloids (SM39, SM41 and SM43) 
The signals at 8 3.81 in the 'H NMR spectrum and 855.1 in the I3C NMR suggested 
that SM40 had an additional methoxy group. The long range 'H _l3c 3 J correlation 
between the methoxy signal (8 3.81) and 8 148.7(C-5) confirmed that the methoxy 
group was linked to C-5 of the tryptamine derived substructure. The long range 'H-
13C correlation between H2Cl (8 3.57) and the carbonyl carbon C-9' (0 168.0) 
confirmed the formation of an amide linkage between the p-coumaroyl moiety and 5-
methoxy tryptamine giving the complete structure of SM40 as (E) N-( 4-
hydroxycinnamoyl)-5-methoxytryptamine or centcyamine (146). SM41 had the same 
'H NMR and I3C NMR data as SM40 except the signals and coupling constant 
associated with the two olefinic protons (8 6.62, J=12.0 and 5.74, J=12.0 Hz). A 
lower coupling constant (J=12.0 Hz) between olefinic protons revealed that SM41 
was the cis isomer of N-( 4-hydroxycinnamoyl)-5-methoxytryptamine or cis-
centcyamine (147). These compounds were previously isolated from C. cyanus.7' 
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Table 33. IH NMR (chemical shift, multiplicity, coupling constant J in Hz), I3C 
NMR data, IH_IH COSY and long-range HMBC in CD30D for SM40 (146) 
Carbon Chemical shift 0 in ppm HMBC 
number 'Ha 13Ca COSY ('H-'H) eH~I3C) 
2 7.04, s 123.0 C-3, C-3a, C-7a 
3 111.2 
3a 128.0 
4 7.2, d, 2.0 111.0 C-3a 
5 148.7 
6 6.9, dd, 8.0, 111.0 C-4, C-3, C-3a 
2.0 
7 7.2, d, 2.0 111.2 C-3a 
7a 137.5 
P-CH2 2.98, t, 7.2 27.5 C-2, C-3, C-3a 
a-CH2 3.57, t, 7.2 40.4 C-3, C-9' 
1 ' 127.0 
2' 7.38, d, 8.0 129.5 H-2' to H-3' C-3', C-4' 
3' 6.75, d, 8.0 115.0 H-3' to H-2' C-l ' 
4' 160.0 
5' 6.7S, d, 8.0 115.0 H-3' to H-2' C-l ' 
6' 7.38, d, 8.0 129.S H-2' to H-3' C-2', C-3', C-4' 
7' 7.42, d, 16.0 140.7 C-9' 
8' 6.38, d, 16.0 117.5 C-l', C-9' 
9' 168.0 
O-CH3 (S) 3.81, s 5S.1 C-S 
alH NMR (400 MHz) and 13C NMR (100 MHz) in CD30D 
3.7.1.5 Characterisation of SM42 and SM43 as Moscbamine (148) and cis-
Moscbamine (149), respectively 
The I H and I3C NMR of SM42 and SM43 (Table 34) revealed that they were 
geometrical isomers. The I H NMR data showed the presence of two olefinic protons 
at 8 7.39 (d, J=IS.6 Hz) and 6.37 (d, J=IS.6 Hz) for SM42 and 6.S7 (d, J=12.0 Hz) 
and S.77 (d, J=12.0 Hz) for SM43. The higher coupling constant between olefinic 
protons for SM42 confirmed that it had frans configuration and SM43 was its cis 
isomer?14 The ESIMS data (Table 30) of SM42 and SM43 revealed the 
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pseudomolecular ion m/z 353 [M+Ht which was calculated for the molecular 
formula C20H21N204. The IH NMR of SM42 also showed the presence of a 
tryptamine derivative by showing the signals at 0 7.12 (d, J=8.4 Hz), 6.98 (s), 6.92 
(d, J=2.0 Hz) and 6.63 (dd, J=8.4, 2.0 Hz), 3.52 (t, J=7.2 Hz) and 2.88 (t, J=7.2 Hz). 
Table 34. IH NMR (chemical shift, multiplicity, coupling constant J in Hz), \3C 
NMR data and long-range HMBC for SM42 (148) 
Carbon Chemical shift 0 in ppm 
number JHa J3Ca 
2 6.98, s 122.0 
3 111.3 
3a 128.3 
4 6.92, d, 2.0 102.4 
5 150.0 
6 6.63, dd, 8.4, 2.0 110.4 
7 7.12, d, 8.4 111.2 
7a 132.0 
a-CH2 3.53, t, 7.2 40.3 
~-CH2 2.88, t, 7.2 25.2 
1 ' 127.1 
2' 7.05, d, 2.0 111.5 
3' 148.6 
4' 148.1 
5' 6.74, d, 8.4 115.3 
6' 6.94, dd, 8.4, 2.0 123.1 
7' 7.39, d, 15.6 140.8 
8' 6.37, d, 15.6 117.7 
9' 168.0 
O-CH3 (3') 3.81, s 55.2 
• IH NMR (400 MHz) and J3C NMR (100 MHz) in CD30D 
C-3, C-7a 
C-3, C-7a 
C-7a 
C-3a, C-5 
C-2, C-~, C-9' 
C-2, C-a 
C-4' 
C-l', C-3' 
C-2' 
C-9' 
C-l', C-9' 
C-3' 
The \3C NMR signal at 0 168.0 indicated the presence of a carbonyl carbon and the 
signals at 0 7.05 (d, J=2.0 Hz), 6.94 (dd, J=8.4, 2.0 Hz) and 6.74 (d, J=8.2 Hz) in the 
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1 H NMR spectrum (Figure 125; Table 34) were due to the ABX aromatic ring 
systems. The 1 H and l3C NMR data confirmed that SM42 had a 3-methoxy-4-
hydroxycinnamoyl moiety. The presence of a tryptamine derivative and a 3-
methoxy-4-hydroxycinnamoyl moiety were also confirmed by the IH_IH COSY and 
IH_l3C HMBC correlations (Figure 128; Table 34). The IH)H COSY revealed four 
different spin systems:H-7~H-6~H-4, H2<l~H2J3, H-7' ~H-8' and H-6' ~H-5'. 
The IH_l3C long-range correlation between H2<l (8 3.52) to the carbonyl C-9' (8 
168.0) confirmed the existence of an amide linkage between the 3-methoxy-4-
hydroxycinnamoyl moiety and serotonin giving the complete structure of SM42 as 
(E) N-(3-methoxy-4-hydroxycinnamoyl)-5-hydroxytryptamine or moschamine (148). 
Thus, the structure SM43 was elucidated as (Z) N-(3-methoxy-4-hydroxcinnamoyl)-
5-hydroxytryptamine or cis-moschamine (149). Both of these compounds were 
isolated previously from C. cyanus, C. moschata and C. nigra.95 ,71,105 
3.7.1.6 Characterisation of SM44 as Montamine (193) 
The l3C NMR spectrum of SM44 (Table 35) displayed 20 carbons. The DEPT -135 
indicated the presence of two methylenes (8 41.0, 25.0), nine methine (8 141.0, 
121.0,126.0,117.5,115.0,111.5,111.2,111.1, llO.O), seven quartemary (8149.0, 
148.0, 146.0, 133.0, 129.5, 129.0, 111.0), one carbonyl carbon (8 172.0) and a 
methoxy group (8 55.5). All protonated carbons were assigned by the IH_13C HSQC 
experiment (Figure 130).150 These carbon signals and the IH NMR data (Figure 129; 
Table 35) implied that SM44 was composed of a tryptamine derived substructure 
and a p-coumaroyl moiety like moschamine (SM42). This fact was further confirmed 
by the IH-IH COSY and IH_13C HMBC experiments. The IH_IH COSY spectrum 
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(Figure 131) revealed four different spin systems:H-7~H-6~H-4, H2a~H2~, H-
7'~H-8' and H-H-6' ~ H-5' and the IH_13C HMBC spectrum (Figure 132) 
showed key correlations between H-2 to C-3, C-3a and C-7a, H-4 and C-5 and C-7a, 
H-6 and C-5 and C-7a, H-7 and C-3a and C-5, H-8' and C-I' and C-9'. All 
spectroscopic data including UV, IR, ID and 2D NMR suggested that SM44 
possessed a moschamine (148) type structure. However, the a-CH2 and P-CH2 
protons of SM44 gave rise to different resonance in the IH NMR spectrum (Table 
36). For moschamine (148) the signals for a-CH2 and P-CH2 protons were observed 
at 0 3.53 (t, J=7.2 Hz) and 2.88 (t, J=7.2 Hz) whereas they were found at 0 2.86, m 
and 2.27, m respectively for SM44. 
HO 
H 
193 
Figure 58. Structure of montamine (SM44) 
The ESIMS spectrum showed that SM44 had the molecular mass of 702 instead of 
352. The HRESIMS gave [M+Nat at 725.2590 (required 725.2587), counted for the 
molecular formula C4oH3SN40S. The HRESIMS and I H NMR confirmed that SM44 
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was a dimer ofmoschamine, named montamine (193). Montamine (193), isolated 
from C. montana, is a new natural product. 
Table 35. I H NMR (chemical shift, multiplicity, coupling constant J in Hz), I3C 
NMR data and long-range HMBC for SM44 (193) 
Carbon Chemical shift S in ppm HMBC ctH~I3C) 
number IHa I3Ca zJ 3J 
2 6.93, s 126.0 C-3 C-3a, C-7a 
3 111.0 
3a 129.5 
4 6.83, d, 2 111.2 C-5 C-7a 
5 148.0 
6 6.82, dd, 2, 8 111.1 C-5 C-7a 
7 7.26, d, 8 111.5 C-7a C-3a, C-5 
7a 133.0 
~-CH2 2.27, m 25.0 C-2, C-cx.-CH2 C-3 
2.19,m 
a-CH2 2.86, m 41.0 C- ~ -CH2 C-3, C-9' 
2.77, m 
1 ' 129.0 
2' 6.99, d, 2 110.0 C-6, C-4', C-7' 
3' 146.0 
4' 149.0 
5' 6.70, d, 8.4 115.0 C-l', C-3' 
6' 6.91, dd, 2,8.4 121.0 C-2', C-4',C-7' 
7' 7.27, d, 15.6 141.0 C-2', C-6' C-9' 
8' 6.31,d,15.6 117.5 C-9' C-l ' 
9' 172.0 
OCH3 (3') 3.78, s 55.5 C-3' 
IIH NMR (400 MHz) and I3C NMR (100 MHz) in CD30D 
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Table 36. Major differences in NMR data of SM42 (148) and SM44 (193) 
Molecule Group IH 13C HMBC HRESIMS 
eH~l3C) [M+Nat 
Moschamine a-CH2 3.53, t, 7.2 40.3 C-2, C-9' 
(SM42) 375.1321 
P-CH2 2.88, t, 7.2 25.2 C-2 
Montamine(SM44) a-CH2 2.86,m 41.0 C-3, C-9', C-J3-
2.77, m CH2 725.2590 
J3-CH2 2.27, m 25.0 C-2, C-3, 
2.19, m C-a.-CH2 
3.7.1.7 Characterisation of SM45 as Schischkiniin (194) 
The ESIMS spectrum ofSM45 revealed the [M+Nat ion peak at mlz 475 suggesting 
Mr=452 and the molecular fonnula was detennined as C26H24N602 from its 
HRESIMS spectrum where the [M+Nat ion was observed at mlz 475.1857 
(calculated 475.1858 for C26H24N602Na). In the IH NMR spectrum ofSM45 (Figure 
133; Table 37), a singlet at ~ 7.15 and the signals at ~ 7.65, 7.32, 7.08 and 7.01, were 
typical of a 3-substituted indole skeleton as described earlier in this chapter and were 
assigned to H-2, H-4, H-5, H-6 and H-7 by HSQC. 1SO Signals at ~ 137.2, 127.3, 
123.9, 121.5, 118.9, 118.1, 111.2 and 108.4 in the l3C NMR spectrum also fulfilled 
the requirement for a 3-substituted indole skeleton which was further confinned by 
the IH_l3C HMBC. The HMBC showed correlations between H-2 to C-3a, C-7a and 
C-8; H-4 to C-3, C-6 and C-7a; H-5 to C-3a and C-7; H-6 to C-4 and C-7; H-7 to C-
3a, C-5. In addition to the signals attributable to the 3-substituted indole skeleton, 
the IH and l3C NMR spectra also showed signals for a methylene (~H 3.47 and 3.10, 
~c 27.3), three methines (~H 3.80-3.86, ~c 55.5, 55.4 and 55.5) and an amide 
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carbonyl (oc 174.0). A IH)3C long-range HMBC correlation was observed between 
H-8 (OH 3.47) to amide carbonyl (oc 174.0). All these signals formed the 
substructure 194a. 
N N>--: l~~~ 
\" 0 NPN 
" H H H H 
H H H H 
ool:~ ~: 
H H H H 
o 
194a 194b 194c 
Figure 59. Tentative structures of schischkiniin (SM45) 
Taking the molecular formula and mass into account, it was clear that the I H and I3C 
NMR signals actually displayed signals for just one of the two identical parts of the 
molecule. Therefore, the molecule must be composed of two of these part structures 
194a. When combining two 194a structures, only structure 194 could satisfy the 
molecular formula and molecular mass of this compound. Further evidence to 
support the structure of 194 was obtained from a series of IH_I3C long-range 
couplings observed in its HMBC spectrum (Table 37). In the HMBC spectrum, H-12 
showed 2Jcorrelation to C-13 and C-12', and 3Jto C-I0 and C-13'. Similarly, H-13 
displayed 2J correlation to C-12 and C-13', and 3J to C-9 and C-12'. Owing to 
overlapped IH NMR signals for H-9, H-12 and H-13, the IH}H NOESY was not 
successful in establishing the relative stereochemistry at C-9 (and C-9'), C-12 (and 
C-12') and C-13 (and C-13'). Although it is difficult to completely determine the 
relative stereochemistry of this unique molecule, the use of biogenetic speculation in 
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tandem with molecular mechanics may give an insight into the stereochemistry of 
schischkiniin (194). 
6 
5 
4 
H 2 H 
~):t~ 
N 12 N 
H H 
194 
Figure 60. Structure of schischkiniin (SM4S) 
Table 37. IH NMR (chemical shift, multiplicity, coupling constant J in Hz), \3C 
NMR data and long range HMBC for SM45 (194) 
Carbon Chemical shift () in ppm HMBC correlation eH-+\3C) 
Number IH8 1JC8 zJ JJ 
2 7.15, S 123.9 C-3 C-3a, C-7a, C-8 
3 108.4 
3a 127.3 
4 7.65, d, 8.2 118.1 C-3a C-3, C-6, C-7a 
5 7.01, dd, 8.2,8.2 118.9 C-3a, C-7 
6 7.08, dd, 8.2, 8.2 121.5 C-7 C-4, C-7a 
7 7.32, d, 8.2 111.2 C-3a, C-5 
7a 137.2 
8 3.47 dd, 4.4, 15.2 27.3 C-3, C-9 C-2, C-3a, C-lO 
3.10 dd, 9.2,15.2 
9 3.82b 55.5 C-8 C-12, C-3 
10 174.0 
12 3.86b 55.4 C-13, C-12' C-I0, C-13' 
13 3.84b 55.5 C-12, C-13' C-9, C-12' 
a'H NMR (400 MHz) and DC NMR (100 MHz) in CDlOD 
b Overlapped peaks, assigned with the help of 'H-t3C HSQC correlation. 
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Simple diketopiperazines such as the Trp-Gly diketopiperazine (195) are common 
natural products (Figure 61). On this occasion we are assuming that the naturally 
occurring L-Trp has been incorporated into 195. The next steps would involve the 
reduction and dehydration of the Gly residue, resulting in the formation of 196, 
followed or preceded by the dimerisation at the Trp indole N to give the dimer 197. 
This dimer would then undergo a photochemically allowed 2+2 cycloaddition to give 
4 possible products. Schischkiniin (194) is a symmetrical structure as is evident from 
the degeneracy of the resonances in the NMR spectra. For this reason two possible 
asymmetric structures can be ruled out leaving only possibilities 194b and 194c. 
h · I I' 216217 d . h I b I .. f Molecular mec anICS ca cu atlOns ' to etermme t ego a energy mInIma 0 
these possible structures suggest that 194c has the lowest total energy function 
986.93 kcallmol (Figure 62). Although it is possible that a natural product IS 
enzymetically biosynthesised in a high-energy conformation, in this case a 
photochemically driven cycloaddition reaction will result in the lowest energy 
product. We therefore speculate that the relative stereochemistry of schischkiniin is 
as shown in 194c. If we assume that the origin of the Trp residue is L-Trp then we 
may also predict the absolute stereochemistry as shown. Thus this novel indole 
alkaloid was identified as schischkiniin (194), which is a tryptophan-derived 
alkaloid. In addition to the indole skeleton, compound 194 also possesses a distinct 
macrocyclic polyamine (n = 14) structure. 
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Figure 61. Proposed biogenetic pathway for the fonnation of schischkiniin (194) 
from a simple diketopiperazine 195. The reduction/dehydration and dimerisation 
steps may be reversed 
194b 
Figure 62. Global energy minimaa for structures 194b and 194c (Heavy atoms and 
polar hydrogens only shown) The global minimum for 194b was found 15 times (Etot 
= 1022.68 kcal/mol) and the global minimum for 194c was found 37 times (Etot = 
986.93 kcal/mol) 
-[Modelling conditions: Minimisations (2000) steps were carried out using 
MacroModel version 6.5216 using the Merck Molecular Force Field. The generalised 
Born solvent accessible area continuum solvent model217 was used to simulate H20 
solvent, due to the unavailability of parameters for MeOH. The minimisations were 
followed by 1000 steps of Monte Carlo confonnational searching to give the global 
energy minima shown in the figures]. 
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3.7.2 Properties of Indole Alkaloids (SM37-SM45) 
3.7.2.1 Properties of Tryptamine, 191 (SM37) 
Gum; UV: Table 29; LRESIMS: Table 30; 'H NMR: Table 31; l3C NMR: Table 
31. 
3.7.2.2 Properties of (E) N-(4-Hydroxycinnamoyl)-5-hydroxytryptamine, 145 
(SM38) 
Amorphous; UV: Table 29; IR Amax (thin film): 3346,2937, 1653, 1594, 1516, 1456, 
1270, 1213, 1125, 1030 cm-I; HRESIMS: Table 30; 'H NMR: Table 32, l3C NMR: 
Table 32. 
3.7.2.3 Properties of (Z) N-(4-Hydroxycinnamoyl)-5-hydroxytryptamine, 192 
(SM39) 
Amorphous. UV: Table 29; IR Amax (neat): 3346, 2937, 1653, 1594, 1516, 1456, 
1270, 1213, 1125, 1030 cm-I; HRESIMS Table 30, 'H NMR: Table 32; l3C NMR: 
Table 32. 
3.7.2.4 Properties of (E) N-(4-Hydroxycinnamoyl)-5-methoxytryptamine, 146 or 
Centcyamine (SM40) 
Amorphous. UV: Table 29; IR Amax (neat): 3433, 3388, 2360, 1651, 1592, 1515, 
1463, 1367, 1269, 1212, 1125, 1030 cm-I; HRESIMS: Table 30; 'H NMR: Table 33; 
DC NMR: Table 33. 
3.7.2.5 Properties of (E) N-(4-Hydroxycinnamoyl)-5-methoxytryptamine or cis-
Centcyamine, 147 (SM41) 
Amorphous. UV: Table 29; IR Amax (neat): 3433, 3388, 2360, 1651, 1592, 1515, 
1463, 1367, 1269, 1212, 1125, 1030 cm-I; HRESIMS: Table 30; 'H NMR: (major 
signals) 0 6.62, d, J=12.0 Hz and 5.74, d, J=12.0 Hz; l3C NMR: Table 33. 
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3.7.2.6 Properties of (E) N-(3-Methoxy-4-hydroxycinnamoyl)-5-
hydroxytyptamine or Moschamine, 148 (SM42) 
Amorphous. UV: Table 29; IR Amax (neat): 3433, 3388, 2360, 1651, 1592, 1515, 
1463, 1367, 1269, 1212, 1125, 1030 cm-I; ESIMS: Table 30; IH NMR: Table 34; 
l3C NMR: Table 34. 
3.7.2.7 Properties of (Z) N-(3-Methoxy-4-hydroxycinnamoyl)-5-
hydroxytyptamine or cis-Moschamine, 149 (SM43) 
Amorphous. UV: Table 29; IR Amax (neat): 3433, 3388, 2360, 1651, 1592, 1515, 
1463, 1367, 1269, 1212, 1125, 1030 cm-I; ESIMS: Table 30; IH NMR: (major 
signals) 0 6.57, d, J=12 Hz and 5.77, d, J=12 Hz; l3C NMR: Table 34. 
3.7.2.8 Properties of Montamine, 193 (SM44) 
Gum; UV: Table 29; HRESIMS: Table 30; IH NMR: Table 35; l3C NMR: Table 
35. 
3.7.2.9 Properties of Schischkiniin, 194 (SM45) 
Gum; UV: Table 29; ESIMS: 475 [M+Nat, 430, 413, 393, 354; HRESIMS: Table 
30; IH NMR: Table 37, l3C NMR: Table 37. 
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CHAPTER FOUR 
Biological Activities of Secondary 
Metabolites from Centaurea Species 
4. 1 Introduction 
4.1.1 Background 
The chapters 1-3 have dealt with the description and collection of Centaurea species, 
followed by the isolation and characterisation of compounds from twelve Centaurea 
species. In this chapter the biological activities of the extracts and the characterised 
compounds from all these Centaurea species are discussed. The brine-shrimp 
lethality assayl8, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide 
(MIT) cytotoxicity assay219 and 2,2-diphenyl-l-picryl hydrazyl (DPPH) antioxidant 
assay20 were carried out for evaluating, respectively, general toxicity, cytotoxicity 
and antioxidant activity of extracts and pure compounds in this study. 
4.1.2 Brine Shrimp Letbality Assay 
The brine shrimp lethality assay was performed to evaluate the general toxicity of 
extracts and pure compounds.22I Ferrigni et. al. screened the ethanol extracts from 
the seeds of 41 Euphorbiaceae species for toxicity and cytotoxicity in brine shrimp 
assay and potato disc assay, respectively, and found a positive correlation between 
them.222 It has been now established that cytotoxic compound usually shows good 
activity in brine shrimp assay.223,224 This assay is recommended as a guide for the 
detection of antitumour and pesticidal compounds?25 The brine shrimp assay is a 
simple, inexpensive and easy to perform for rapid screening of natural productS?18 
The eggs of brine shrimp, Artemia saUna Leach, are readily available at a low cost in 
pet shops. The eggs hatch within 48 hours, providing large numbers of larvae 
(nauplii) upon being placed in a brine solution under illumination, and test 
compounds or plant extracts of desired concentration can be added in vials 
containing 14 to 16 nauplii.226 After 24 hours the number ofnauplii are counted and 
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the percentage of deaths at each dose are recorded using the LDPLINE software 
program.227 A LDso, defined as the concentration of compound which causes 50% 
mortality of nauplii, is determined using Probit analysis described by Finney?28 
4.1.3 MTT Cytotoxicity Assay 
Cytotoxicity means toxicity to cells and is measured as functions of fundamental 
biochemical pathways leading to cell death. The discovery and development of 
cytotoxic agents for cancer therapy involves the systematic screening of large 
number of extracts and compounds. The screening of natural products for their 
cytotoxicity requires methods that are easy, reliable, rapid, sensitive and economic. 
The most commonly used cytotoxicity assays includes ATP measurements229, MTT 
assal 19, neutral red23o, membrane integritylLDH release assal31 , alamar blue 
assal32 and sulforhodamine B (SRB) assal33 • 
MTT (Thiozolyl Blue) 
Metabolically active 
viable cells 
n 
NADH NAD+ 
Formazan Dye 
Scheme 5. Transformation ofMTT by viable cells 
The MTI assay is a well-documented cell viability assay and has been modified by 
several investigators since it was first developed by Mosmann.219,234 This assay is 
based on the transformation of tetrazolium salt, 3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyl tetrazolium bromide (MTI) by mitochondrial succinic dehydrogenases in 
viable cells yielding purple formazan crystals that are not soluble in aqueous solution 
(Scheme 5). 
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The amount of formazan generated by dehydrogenase enzyme is directly 
proportional to the number of viable cells in culture and is measured at 560 nm. In 
cytotoxicity screening, the most commonly determined parameter is the ICso, which 
is defined as the drug concentrations required to reduce the absorbance by 50% of 
the control values. This can easily be calculated from percentage of cell viability 
against concentration curve as shown in Figure 63. In this project, the MTT assay 
was used to evaluate cytotoxicity of the extracts and compounds from Centaurea 
species on human colon cancer cell line (CaCo-2). 
-~ 120 
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~ 
- 80 ~ 60 ~ i 40 ,~ 
.s; 20 ~--.------......... 
IClO 
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o 100 200 300 
Concentration blM) 
Figure 63. Cell viability (%) against drug concentration curve for determination 
of ICso value by MTT assay 
4.1.4 DPPH Antioxidant Assay 
Antioxidants are important species, which have the ability to protect body from 
damage caused by free-radical induced oxidative stress.23S Oxygen free radicals or 
reactive species (ROS) such as superoxide anion radicals (02'), hydrogen peroxides 
(H20 2), hydroxyl radicals (OH) and singlet oxygen e02) are continuously generated 
in cells exposed to an aerobic environment.236 The role of reactive oxygen (ROS) has 
been implicated in many human degenerative diseases, including aging, cancer, and 
neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and 
Huntington's disease.237. 238 It is reported that hydrogen peroxide (H202) can cause 
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lipid peroxidation and DNA damage.239,24o Antioxidant defence systems have co-
evolved with aerobic metabolism to counteract oxidative damage from reactive 
oxygen species.241 Furthermore many antioxidant compounds have shown anticancer 
properties.242,243 For example, resveratrol (198), a phenolic natural product from 
grapes was reported to protect cells from oxidative damage and cell death.244, 245 
Resveratrol (198) was also reported to prevent carcinogenesis in a murine model.246 
One of the rapid, simple and inexpensive methods to measure antioxidant capacity of 
natural products involves the use of the free radical, 2,2-diphenyl-I-picryl hydrazyl 
(DPPH). The DPPH assay was performed to evaluate the antioxidant properties of 
the extracts and compounds from Centaurea species.22o, 247 
OH 
HO 
OH 198 
Figure 64. Structure of resveratrol (198) 
The DPPH antioxidant assay is used to test the ability of compounds to act as free 
radical scavengers or hydrogen donors, and to evaluate antioxidant activity of natural 
products and synthetic compounds. The potential antioxidant activity of plant 
extracts is based on scavenging stable 2,2-diphenyl-I-picryl hydrazyl (DPPH) free 
radicals. Antioxidants can react with the stable free radical DPPH and produce 2,2-
diphenyl-I-picryl hydrazine (Scheme 6). 
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QN~ 
I N . 
02NVNO I 2 
~ 
+ RH + R· 
N02 
DPPH 
Scheme 6. DPPH reduction 
Due to its unpaired electron, 2, 2-diphenyl-2-picryl-hydrazyl radical (DPPH) gives 
strong absorption at 517 run and is purple in colour. In the presence of a free radical 
scavenger electron becomes paired off and the absorption is quenched. The resulting 
decolourisation is stoichiometric with respect to the number of electrons being taken 
up. The change of absorbance produced in this reaction is assessed to evaluate the 
antioxidant potential of test samples. An ICso, which is defined as the concentration 
of compound that causes a 50% reduction potential in absorbance compared to 
control can be calculated as shown in Figure 65. 
~ 80 
> ;:: 
~ _ 60 
~ ~o 40 
._ 0 
D .... 
c-CD 20 
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U) 
o 0.02 0.04 0.06 
Concentration (mg/mL) 
Figure 65. Scavenging activity (%) against drug concentration curve to determine 
the ICso value by DPPH assay 
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4.2 Materials and Methods 
4.2.1 Brine Shrimp Lethality Assay 
4.2.1.1 Preparation of Brine Shrimp Medium (BSM) 
Brine shrimp mediwn (BSM) was prepared by dissolving the material in Table 38 in 
1.25 L of distilled water. Each chemical was dissolved separately in the order shown 
in Table 38 and the disodium glycerophosphate was added last to prevent the 
formations of any insoluble precipitate forming. The stock solution was stored in 
brown glass bottle in the refrigerator (-4°C). 
Table 38. Composition of brine shrimp medium 
Chemicals 
Sodium chloride 
Calcium chloride dihydrate 
Magnesium chloride 
Magnesiwn sulphate 
Potassium chloride 
Glycine 
Disodium glycerophsphate 
4.2.1.2 Bioassay of Sample with BSM 
Amount (g) 
300 
3 
15 
5 
8 
60 
30 
BSM stock solution (20 mL) was mixed with distilled water (140 mL) in a 250 mL 
conical flask to get a working solution. Brine shrimp eggs (100 mg) were added in 
the solution and incubated at 25° C for 48 hours. During this time the brine shrimp 
eggs hatched completely. Hatched larvae were separated from unhatched eggs and 
were transferred into a Petri dish. A desk lamp was positioned one side so that the 
larvae could get light as they concentrate near the light. Dried methanol extract 
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(10 mg) or pure compound (1 mg) was dissolved in 1 mL of 20% aqueous DMSO 
solution and poured into 9.0 mL of working solution in a universal bottle. The 
solution (5.0 mL) was taken from the latter and added into another universal bottle 
containing 5.0 mL of working solution. In a similar way, serial dilutions were 
performed to obtain 7 different concentrations (lOO, 50, 25, 12.5, 6.25, 3.12, 1.56 
Jlg/mL). About 14 to 16 nauplii were added to each bottle and all universal bottles 
were kept in a water bath at 25°C for 24 hours. After 24 hours the number of nauplii 
was counted with a magnifying glass and the percentage mortality was calculated 
based on 3 replicates. An LDso value (Le. the concentration of cell extract which 
causes 50% mortality) for each sample was determined as described in Section 4.1.2. 
Podophyllotoxin (10, page 200) was used as a positive control in this experiment. 
4.2.2 MTT Cytotoxicity Assay 
4.2.2.1 Materials and Chemicals 
CaCo-2, human colon cancer cell line was obtained from the European collection of 
cell cultures. Earle's minimum essential medium, Earle's balanced salt solution, 
trypsin, L-glutamine, non essential amino acids, penicillin and streptomycin were 
purchased from Sigma, UK. Foetal calf serum (FCS) was purchased from Biosera, 
UK. 96 well plates were bought from Sero-Wel, Bibbly Sterilin Ltd., Stones, Staffs, 
UK. 
4.2.2.2 Cryopreservat;on 
Cells were cryopreserved to ensure the continuous supply of a cell line during this 
study. Healthy and viable cells 4-10 x 106 per ampoule were used for this purpose. 
Freezing medium was prepared from the growth medium containing 10% (v/v) 
sterile dimethyl sulphoxide. Cell pellets dissolved in 1 mL freezing medium were 
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p ur dint 
b tw 
cr w-top cryotubes and immediately cooled at a rate of 
rmally th cryotubes were placed in the -200 e freezer for 
3-4 h ur and tran ~ IT d t th - ooe for approximately 16 hours (overnight) . After 
fre zing th amp ul tran ferr d to liquid nitrogen. 
Figure 66. Laminar Flow hood 
4.2.2.3 TirO) ill of Fro ell Cell 
The amp ul d from torage and unscrewed the cap ~ turn to release any 
re idual nitr g n. ft r \-2 minute (to let gas escape) it was placed in the water bath 
at 37° . p ial 
contaminating th 
a talc n in order to prevent water entering the ampoule and 
II . Wh n ampoul were fully thawed, they were taken to the 
Fi ure 66). Then the ampoule contents were transferred into a 
30 m Un! r at. Th gr wth medium (10 mL) were added slowly to the 
d and ntri fug d at the lowest peed to pellet the cells at 70-100 x g. 
Aft r d anting th u matant th p 11 ted cells were resuspended in fresh medium 
and tran fi IT d t a ultur fl a k. 
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4.2.2.4 Cell Counting 
Cells were counted by haemocytometer (Figure 67) and particle size distributor 
(Figure 68). Similar results were obtained in both cases and constant cell density 
was maintained for all cell culture work in this study. 
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Figure 67. Haemocytometer 
Figure 68. Particle size distributor 
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4.2.2.5 11 tabitif) ay 
) r maintained in Earle' s minimum essential medium 
( igm 
( / ) n n-
m nt d ith 10% ( / ) foetal calf serum, 2 mM L-glutamine, 1 % 
ntial amin a id 100 IU/mL penicillin and 100 flglmL streptomycin. 
gr \ ing 
and in ubat d fi r -
d d on 96-well plates at 1 x 104 cells per well 
th addition of drugs. Stock solution of the test 
m un w initi II di I d in DMSO or H20 and further diluted with serum 
c n ntrati n f t 
in ea h w II in tri 
72 h ur fin u 
reag nt I m m 
in ubat d at 7° 
" ing a 24 h ur in ubation at 37°C, 5% CO2, 100 fll of various 
m und 
li and 
ati n at 7° 
III rum fr 
fi r 4 h ur . 
(500 250, 100, 50, 25, 10,5 and 1 flM) were added 
11 w re further incubated for 72 hours?48,249 After 
th medium was removed, and 100 flL of MTT 
m diurn wa added to each well. The plates were 
t the end of the incubation period, the supernatants 
wer r m d and pur DM 0 (200 flL) wa added to each well and plates were 
Fi ure 69. Untreated CaCo-2 cell 
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shaken g ntly for 15 minutes. The metabolised MTT product dissolved in DMSO 
was quantified by r ading the absorbance at 560 nrn using a micro plate reader 
(Dynex T chnologie USA, Figure 70). 1Cso values are defined as the drug 
concentration r quired to reduce the absorbance by 50% of the control values. They 
are calculated from the equation of the logarithmic line determined by fitting the best 
line (Micro oft Excel) to the curve formed from the data. The ICso value was 
obtained from the quation y = 50 (50% value) . 
- . -
------- ~ ...... 
Figure 70. Plate reader 
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4.2.3 DPP" antioxidant assay 
4.2.3.1 Chemicals and materials 
2,2-Diphenyl-l-picrylhydrazyl (DPPH), molecular formula ClSHI2Ns06, was 
obtained from Fluka Chemie AG, Bucks. Quercetin was purchased from Avocado 
Research Chemicals Ltd, Shore road, Heysham, Lancs. 
4.2.3.2 Qualitative Assay 
Test compounds of lignans, flavonoids and alkaloids were applied on a TLC plate 
and sprayed with DPPH solution using an atomiser. It was allowed to develop for 30 
min. The colour change (purple on white) was noted. Positive colour change 
indicated the presence of antioxidants. 
4.2.3.3 Quantitative assay 
DPPH (4 mg) was dissolved in Me OH (50 mL) to obtain a concentration of 80 
~g/mL. Test compounds were also dissolved in MeOH to obtain initial concentration 
of 0.5 mglmL. Serial dilutions were made up to eight different concentrations (5 x 
10-2, 2.5x 10-2, 1.25 x 10-2,6.25 X 10-3,3.12 X 10-3 1.56 X 10-3, 7.8 X 10-4 and 3.9 x 
10-4 mg/mL) with a volume of 5.0 mL in each case. Each solution (5.0 mL) was 
mixed with DPPH solution (5.0 mL) and allowed to stand for 30 min. The UV 
absorbance was recorded at 517 nm. The experiment was performed in triplicate and 
the average absorption was determined for each concentration. The same procedure 
was repeated for the positive control, quercetin. 
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4.3 Results and Discussion 
4.3.1 Brine Shrimp Lethality Assay 
4.3.1.1 Brine Shrimp Letha/ily Assay ofCentaurea Extracts 
Brine shrimp lethality assay was performed to evaluate general toxicity of MeOH 
extracts of twelve Centaurea species, and the results are summarised in Table 39. 
The C. bornmuelleri, C. huber-morathii, C. gigantea and C. montana extracts were 
the most toxic among the extracts tested, and the LDso values for them were found to 
be 55.2 x to'2, 42.4 x to'2, 69.2 x to'2 and 62.5 x to-2 mg/mL, respectively. 
Table 39. Brine shrimp lethality assay of the extracts of Centaurea species 
Methanol extracts LDs08 (mg/mL) 
C. americana 89.3 x to-2 
C. bornmuelleri 55.2 x to-2 
C. cyanus 71.2 x to-2 
C. dealbata 110.0 x to-2 
C. gigantea 69.2 x to-2 
C. huber-morathii 42.4 x 10-2 
C. macrocephala 85.1 x to-2 
C. montana 62.5 x 10-2 
C. mucronifera 120.0 x to-2 
C. pamphylica 125.0 x to-2 
C. schischkinii 76.4 x to-2 
C. urvillei 115.5 x to-2 
Podophyllotoxin (10) 2.8 x 10-3 
Imost toxic: 1-70 xl 0'2 mg/mL; moderate toxic:70-1 00 xl 0-2 mg/mL; 
non toxic: above 100 xl 0.2 mg/mL 
While the extracts of C. americana, C. cyanus, C. macrocephala and C. schischkinii 
showed moderate toxicity by displaying their LDso values between 70-10·0 x 10.2 
mg/mL, the extracts of C. dealbata, C. mucronifera, C. pamphylica and C. urvillei 
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were the least toxic having their LDso values above 100 x 10-2 mg/mL. 
Podophyllotoxin (10, page 201), a cytotoxic lignan2SO, was used as the positive 
control in this study and the LDso value for podophyllotoxin was found to be 2.8 x 
10-3 mg/mL. 
4.3.1.2 Brine Shrimp Lethality Assay of Lignans 
The brine shrimp lethality assay of lignans is presented in Table 40. Lariciresinol 
type lignans, lariciresinol 4' -O-glucoside (171), berchemol (172) and berchemol 4'-
O-glucoside (173) showed moderate level of activity and their LDso values were 
found to be, respectively, 4.5 x 10-2, 3.1 x 10-2 and 10.3 x 10-2 mg/mL. 
Dibenzylbutyrolactone type lignans (137-140) showed significantly higher activity 
than that of lariciresinol type in this assay. For example, arctigenin (139), 
matairesinol (140) and lappaol A (143) exhibited LDso values of2.0 x 10-3,5.5 x 10-3 
and 9.2 x 10-3 mg/mL, respectively. Arctiin (137; LDso= 9.80 x 10-2 mg/mL) and 
matairesinoside (138; LDso= 1.65 x 10-2 mg/mL) were moderately active in the brine 
shrimp lethality assay. Epoxylignans of pinoresinol-type (144,176,178) were found 
to be the least toxic among the lignans tested in this study. For example, LDso values 
for pinoresinol (144), pinoresinol monoglucosde (176), pinoresinol dj-glucoside 
(177) and pinoresinol-apiose-glucoside (178) were found to be 6.5 x 10-2,6.8 x 10-2, 
7.2 x 10-2 and 8.3 x 10-2 mg/mL, respectively. 
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Figure 71. Structures of lignans tested in the bioassay 
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Table 40. Brine shrimp lethality assay of lignans 
Lignans 
Arctiin (137) 
Matairesinoside (138) 
Arctigenin (139) 
Matairesinol (140) 
Caffeoyl-arctiin (170) 
Lappaol A (143) 
Lariciresinol 4' -O-p-o-glucoside (171) 
Berchemol (172) 
Berchemol 4' -O-p-o-glucoside (173) 
Pinoresinol (144) 
Pinoresinol 4-0-p-o-glucopyranoside (176) 
Pinoresinol 4,4' -di -O-o-glucopyranoside (177) 
Pinoresinol 4-0-p-apiose-p-o-glucopyranoside (178) 
4.3.1.3 Brine Shrimp Lethality Assay of Sesquiterpene lactones 
LDso (mg/mL) 
9.8 x 10-2 
1.6 x 10-2 
2.0 x 10-3 
5.5 x 10-3 
7.6 x 10-2 
9.2 x 10-3 
4.5 x 10-2 
3.1 x 10-2 
10.3 x 10-2 
6.5 x 10-2 
6.8 x 10-2 
7.2 x 10-2 
8.3 x 10-2 
The results of the brine shrimp lethality assay of sesquiterpene lactones are 
summarised in Table 41. Both arctiopicrin (21) and 8-0-(4-hydroxy-3-
methylbutanoyl)-salonitenolide (179) showed significant toxicity (LDso values of 4.7 
x 10-3 and 5.8 x 10-3 mg/mL respectively), and were more toxic than the lignans 
tested (137-140). 
Table 41. Brine shrimp lethality assay of sesquiterpene lactones 
Sesquiterpe lactones 
Arctiopicrin (21) 
8-0-( 4_Hydroxy-3-methylbutanoyl)-salonitenolide (179) 
LDso (mg/mL) 
4.7 x 10-3 
5.8 x 10-3 
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Figure 72. Structures of sesquiterpene lactones tested in the bioassay 
4.3.1.4 Brine Shrimp LethalityAssay ofQuinic acid Derivatives 
The quinic acid derivatives, isolated from the Centaurea species exhibited moderate 
levels of activity in the brine shrimp lethality assay (Table 42). Chlorogenic acid 
(168; LDso=2.5 x 10.2 mglmL) was more toxic compound than its other derivative, 
p-coumaroyl quinic acid (181; LDso=7.8 x 10.2 mglmL). 
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Figure 73. Structures of quinic acid derivatives in the bioassay 
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Table 42. Brine shrimp lethality assay of quinic acid derivatives 
Compounds 
p-Coumaroylquinic acid (181) 
cis-p-Coumaroylquinic acid (182) 
Chlorogenic acid (168) 
4.3.1.5 Brine Shrimp Lethality Assay of Flavonoids 
LDso (mg/mL) 
7.8 x 10-2 
10.3 x 10-2 
2.5 x 10-2 
Among the Cenlaurea flavonoids, tested in this study, kaempferol derivatives, 
astragalin (123) and afzelin (187) showed no significant activity with the LDso values 
of 1.4 x 10-1 and 8.0 x 10-1 mg/mL respectively (Table 43). However, apigenin 
(108), cirsiliol (114) and flavanone apiose-glucuronic acid (190) showed significant 
toxicity with the LDso values of 9.3 x 10-3, 6.4 x 10-3 and 7.2 x 10-3 mg/mL, 
respectively. 
Table 43. Brine shrimp lethality assay of flavonoids 
Flavonoids LDso (mg/mL) 
Astragalin (123) 
Afzelin (187) 
Apigenin (108) 
Cirsiliol (114) 
Flavanone-apiose-glucuronic acid (190) 
1.4 x 10-1 
8.0 x 10-1 
9.3 x 10-3 
6.4 x 10-3 
7.2 x 10-3 
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Figure 74. Structures offlavonoids 
4.3.1.6 Brine Shrimp Lethality Assay of Alkaloids 
Four alkaloids (146, 148, 193 and 194) were tested in the brine shrimp assay and the 
results are summarised in Table 4.7. It was observed that all tested alkaloids showed 
significant toxicities in this assay with LDso values for centcyamine (146), 
moschamine (148). montamine (193) and schischkiniin (194), respectively of 15 x 
10-3, 20 x 10-3, 3.5 x 10-3 and 7.2 x 10-3 mg/mL. Montamine (193), a dimer of 
moschamine (148) was the most toxic among these alkaloids. 
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Table 44. Brine shrimp lethality assay of alkaloids 
Alkaloids 
Centcyamine (146) 
Moschamine (148) 
Montamine (193) 
Schischkiniin (194) 
o 
< o 
OH 
: H 
: = 
H 0 () 
MeO~OMe 
OMe 
10 
HO 
OH 0 
125 
LDso (mglmL) 
15 X 10-3 
20 X 10-3 
3.5 X 10-3 
7.2 x 10-3 
OH 
OH 
Figure 76. Structures of podophyllotoxin (10) and quercetin (125) 
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4.3.2. In vitro Cytotoxicity Studies against Colon Cancer Cell (CaCo-2) 
4.3.2.1 MTT Cytotoxicity Assay ofCentaurea Extracts 
The MeOH extracts of twelve Centaurea species were tested for cytotoxicity 
against a human colon cancer cell line (CaCo-2) using the MTT assay and the results 
are summarised in Table 45. The cytotoxic lignan podophyllotoxin25o (10) was used 
as positive control with an ICso value of 0.06 J..lM in this study. Among the extracts, 
C. bornmuelleri, C. huber-morathii, C. gigantea and C. montana showed significant 
cytotoxicity with the ICso values of29.8, 33.0, 43.2 and 56.4 J..lglml respectively. 
Table 45. Cytotoxicity activities of Centaurea species 
Methanol extracts ICso8 (J..lglmL) 
C. americana 77.5 
C. bornmuelleri 29.8 
C. cyanus 69.3 
C. dealbata >100 
C. gigantea 43.2 
C. huber-morathii 33.0 
C. macrocephala 86.2 
C. montana 56.4 
C. mucronifera >100 
C. pamphylica >100 
C. schischkinii 68.8 
C. urvillei >100 
Podophyllotoxins (10) 0.06 (J..lM) 
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On the other hand, C. americana, C. cyanus, C. macrocephala and C. schischkinii 
showed moderate levels of cytotoxicity with ICso values between 68-78 ~g/mL. The 
extracts from C. dealbata, C. mucronifera, C. pamphylica and C. urvillei were the 
least active with ICso values to be above 1 00 ~g1mL. 
4.3.2.2 MTT Cytotoxicity Assay of Lignans 
The cytotoxicity results of twelve lignans against a human colon cancer cell line 
(CaCo-2) by MTT assay are summarised in Table 46. Dibenzylbutyrolignans, 137-
140 were more cytotoxic than the other lignans. The 1Cso values for arctiin (137), 
matairesinoside (138), arctigenin (139), matairesinol (140) and lappaol A (143) were 
220.0, 288.0, 7.0, 124.0 and 135.0 ~M respectively (Table 46). Both arctiin (137) 
and matairesinoside (138) contain glucose moiety and the cytotoxicity of glycosides 
decreased significantly. Arctigenin (139), matairesinol (140) and lappol A (143) do 
not have any glucose moiety and they exhibited higher cytotoxicity. Arctigenin (139) 
contained a -OCH3 group in C-4' and was less polar than matairesinol (-OH group in 
C-4') and showed potent cytotoxicity in colon cancer cell line among all lignans 
tested in this study. These results suggest that the presence of appropriate 
hydrophobicity of lignan was important for cytotoxicity to CaCo-2. 
The ICso values of lariciresinol 4'-O-glucoside (171), berchemol (172) and 
berchemol 4'-O-glucoside (173) were found to be 607.0, 833.0, 1260.0 ~M, 
respectively. They were considered to be inactive towards colon cancer cell line. 
Pinoresinol (144) was the most cytotoxic compound (lCso=233.0 ~M) among all 
pinoresinol derivatives (176-178) tested in this study. The other derivatives contain 
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one or two sugar moieties and had higher ICso values than pinoresinol (Table 46). 
Pinoresinol monoglucoside (176) and pinoresinol-di-glucoside (177) had the ICso 
values of 705.0 and 843.2 j.1M, respectively. Pinoresinol-apiose-glucoside (178), 
having one glucose and one apiose moieties in the molecule, exhibited the least 
cytotoxic properties towards colon cancer cell line (lCso=l.13 mM). The above 
results concluded that the presence of a sugar molecule in all the isolated compounds 
exhibited reduced cytotoxicity. Pinoresinol type lignans (144, 176-178) were less 
cytotoxic than dibenzylbutyrolactones (137-140) and more cytotoxic than the 
lariciresinol type lignans (171-173). 
Table 46. Cytotoxicity activities of Iignans 
Lignans 
Arctiin (137) 
Matairesinoside (138) 
Arctigenin (139) 
Matairesinol (140) 
Lappaol A (143) 
Lariciresinol 4' -O-p- o-glucoside (171) 
Berchemol (172) 
Berchemol 4' -O-p-o-glucoside (173) 
Pinoresinol (144) 
Pinoresinol 4-0-p-o-glucopyranoside (176) 
Pinoresinol 4, 4' di-O-o-glucopyranoside (177) 
Pinoresinol 4-0-p-apiose-p-o-glucopyranosideside (178) 
4.3.2.3 MTT Cytotoxicity Assay of Sesquiterpene lactones 
ICso (j.1M) 
220.0 
288.0 
7.0 
124.0 
135.0 
607.0 
833.0 
1260.0 
233.0 
705.0 
843.2 
1130.0 
In vitro cytotoxicity results for two sesquiterpene lactones, arctiopicrin (21) and 8-0-
(4_hydroxy-3-methylbutanoYl)-salonitenolide (179) are summarised in Table 47. The 
respective ICso were found to be 8.5 and 26.4 j.1M. Arctiopicrin (21) was more 
cytotoxic than 8-0-( 4-hydroxy-3-methylbutanoyl)-salonitenolide (179). However, 
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both sesquiterpene lactones showed prominent cytotoxicity than most of the lignans 
except arctigenin (139). 
Table 47. Cytotoxic activities of sesquiterpene lactones 
Sesquiterpene lactones 
Arctiopicrin (21) 
8-0-( 4_Hydroxy-3-methylbutanoyl)-salonitenolide (179) 
4.3.2.4 MTT Cytotoxicity Assay of Quinic acid Derivatives 
ICso (J-lM) 
8.5 
26.4 
The ICso values of p-coumaroylquinic acid (181), eis-p-coumaroylquinic acid (182) 
and chlorogenic acid (168) were 146.4,325.0 and 79.0 J-lM, respectively (Table 48). 
The Irans compound (181) showed higher cytotoxicity than the eis-compound (182) 
towards the colon cancer cell line. These results corresponded well to the findings 
from other studies, that the Irans configuration was essential for cytotoxic activity of 
phenolic compounds.2SI Chlorogenic acid (168) showed the most cytotoxic 
properties among all quinic acid derivatives. They were significantly more toxic than 
the tested epoxy lignans (171-173 and 176-178). These could be due to the fact that 
all these compounds possess an a,~-unsaturated carbonyl moiety, which can be 
considered as Michael acceptor, an active moiety often employed in the design of 
. d IS2 
anticancer rug. 
Table 48. Cytotoxicity activities of quinic acid derivatives 
Compounds 
p_Coumaroylquinic acid (181) 
cis-p-Coumaroylquinic acid (182) 
Chlorogenic acid (168) 
ICso (J-lM) 
146.4 
325.0 
79.0 
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4.3.2.5 MTT Cytotoxicity Assay of Flavonoids 
The ICso values of the flavonoids tested are shown in Table 49. Flavonoid glycosides 
were found to be less cytotoxic than the corresponding aglycones. For example, the 
ICso value for kaempferol (122) was 201.0 J..lM while that of astragalin (123) and 
afzelin (187) were 302.0 and 316.0 J..lM respectively. However, flavanone apiose-
glucuronic acid (190) which contained a carboxylic acid (-COOH) group instead of a 
free hydroxy group (-OH) in its glucose moiety showed higher cytotoxicity 
(I Cso= 15 3.4 J..lM) than other flavonoid glycosides. The better cytotoxicity of 
flavonoid 190 may be due to the presence of a carboxylic acid group which could 
provide more binding affinity towards receptors than an OH group. The ICso value 
for two C-glycosides 188 and 189 were 290.3 and 285.7 J..lM respectively. They were 
more cytotoxic than the O-glycosides (123 and 187). Apigenin (108) (ICso=133.0 
J..lM) and cirsiliol (114) (lCso=96.0 J..lM) showed the most potent activities among the 
flavonoids evaluated in this study. 
Table 49. Cytotoxicity activities of flavonoids 
Flavonoids 
Kaempferol (122) 
Astragalin (123) 
Afzelin (187) 
Apigenin (108) 
Cirsiliol (114) 
Orientin (188) 
Hydroxybenzoyl-isoorientin (189) 
Flavanone-apiose-glucuronic acid (190) 
ICso (J..lM) 
201.0 
302.0 
316.0 
133.1 
96.0 
290.3 
285.7 
153.4 
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4.3.2.6 MTT Cytotoxicity Assay of Alkaloids 
The cytotoxicity of nine alkaloids are presented in Table 50. Among the eis-trans 
isomers (148 and 149), the trans compounds (148) (ICso=<100 IlM) showed higher 
cytotoxicity than the eis-compound (149; ICso >200 IlM). A similar phenomenon was 
also observed for quinic acid derivatives suggesting that the trans configuration is 
essential for cytotoxicity in both alkaloids (148) and quinic acid (168). Moschamine 
(148) (lCso=81.0 IlM) was found to be more cytotoxic than centcyamine (146) 
(lCso=82.2 IlM). Although both 146 and 148 were structurally similar, moschamine 
had an additional methoxy group at C-3' position. This methoxy group may be 
responsible for higher cytotoxicity. However, montamine (193; ICso=43.9 IlM», a 
dimer of moschamine (148) showed the most cytotoxic properties among all 
alkaloids. This result suggested that dimerisation could lead to an increase in 
cytotoxicity. Another dimer, schischkiniin (194) which was a trpytophan-derived 
indole alkaloid exhibited ICso=76.0 IlM . It can thus be suggested that indole 
alkaloids having a p-coumaroyl moiety linked to them might be candidate for further 
study as potential anticancer agents. 
Table 50. Cytotoxicity activities of alkaloids 
Alkaloids 
N-( 4_hydroxycinnamoyl)-5-hydroxytryptamine (145) 
eis-N-( 4_hydroxycinnamoyl)-5-hydroxytryptamine (192) 
Centcyamine (146) 
cis-Centcyamine (147) 
Moschamine (148) 
cis-moschamine (149) 
Tryptamine (191) 
Montamine (193) 
Schischkiniin (194) 
ICso (IlM ) 
125.0 
411.0 
82.2 
213.0 
81.0 
213.0 
198.0 
43.9 
76.0 
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4.3.3 DPPH Antioxidant Assay 
4.3.3.1 DPPH Assay ofCentaurea Extracts 
The DPPH assay of the MeOH extracts of Centaurea species are summarised in 
Table 51. The extracts of C. huber-morathii, C. macrocephala, C. dealbata, C. 
americana. C. gigantea and C. schischkinii showed significant antioxidant properties 
having the ICso values of 3.1 x 10-2,3.5 x 10-2,4.7 x 10-2,5.2 x 10-2, 7.2 x 10-2 and 
15 x 10-2 mg/mL respectively. Quercetin (125) with ICso value of2.8 x 10-3 mg/mL 
was used as a positive control for antioxidant activity in this study. 
Table 51. DPPH assay of Centaurea species 
Methanol extracts 
C. americana 
C. bornmuelleri 
C. cyanus 
C. dealbala 
C. giganlea 
C. huber-moralhii 
C. macrocephala 
C. monlana 
C. mucronifera 
C. pamphylica 
C. schischkinii 
C. urvillei 
Quercetin (125) 
4.3.3.2 DPPH Assay of Lignans 
ICso (mg/mL) 
5.2 x 10-2 
63.0 x 10-2 
42.0 X 10-2 
4.7 X 10-2 
7.2 X 10-2 
3.1 x 10-2 
3.5 x 10-2 
32.7 x 10-2 
53.6 X 10-2 
47.3 X 10-2 
15.0 x 10-2 
51.6 x 10-2 
2.8 x 10-3 
Antioxidant activity of lignans (137-140) are shown in Table 52. Matairesinoside 
(138) and matairesinol (140) showed the most prominent free radical scavenging 
activities (lC50 values of 2.2 x 10-3 and 2.0 x 10-3 mg/mL, respectively) among all 
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the lignans tested in this study. Both matairesinoside (138) and matairesinol (140) 
had hydroxy groups in C-3/C-3' of benzene ring and showed higher antioxidant 
activities. These results suggested that the presence of C-3' hydroxy group in 
benzene rings increased free radical scavenging activity significantly. For arctiin 
(137) and arctigenin (139) methoxy groups were present instead of the hydroxy 
groups at C-3/C-3', and their ICso values were 16.0 x 10-2 and 1.9 x 10-2 mg/mL, 
respectively. Lappol A (143) and caffeoyl arctiin (170) showed better scavenging 
activities with the ICso values of 3.6 x 10-2 and 3.2 x 10-2 mg/mL, respectively, than 
the corresponding arctiin (137) and arctigenin (138). Lariciresinol and pinoresinol 
type lignans (171 and 144) showed moderate levels of antioxidant activities with the 
ICso values between 1.4-3.8 x 10-2 mg/mL. 
Table 52. DPPH assay of lignans 
Lignans 
Arctiin (137) 
Matairesinoside (138) 
Arctigenin (139) 
Matairesinol (140) 
Lappaol A (143) 
Caffeoyl-arctiin (170) 
LariciresinoI4-0-p-o-glucoside (171) 
Berchemol (172) 
Berchemol 4' -O-p-o-gl ucoside (173) 
Pinoresinol (144) 
Pinoresinol 4-0-p-o-glucopyranoside (176) 
Pinoresinol 4, 4' di-O-o-glucopyranoside (177) 
Pinoresinol 4-0-p-apiose-p-o-glucopyranoside (178) 
4.3.3.3 DPPH Assay of Sesquiterpene lactones 
ICso (mg/mL) 
16.0 X 10-2 
2.2 X 10-3 
1.9 x 10-2 
2.0 x 10-3 
3.6 x 10-2 
3.2 x 10-2 
3.8 X to-2 
3.2 X to-2 
2.1 X to-2 
1.4 X to-2 
3.6 X to-2 
>5 X 10-2 
3.0 X to-2 
The sesquiterpene lactones are not common to be used as antioxidants. However, the 
antioxidant activity of two sesquiterpene lactones (21 and 179) were evaluated and 
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the results (Table 53) indicated that they did not have any free radical scavenging 
properties at the test concentrations. 
Table 53. DPPH assay of sesquiterpene lactones 
Sesquiterpe lactones 
Arctiopicrin (21) 
8-0-( 4-Hydroxy-3-methylbutanoyl)-salonitenolide (179) 
4.3.3.4 DPPH Assay of Quinic acid derivatives 
ICso (mglmL) 
>5 x 10-2 
>5 x 10-2 
Of the three quinic acid derivatives (Table 54), chlorogenic acid (168) with the ICso 
value of 2.3 x t 0-2 mglmL showed the highest antioxidant activity. p-Coumaroyl 
quinic acid (181; ICso=7.6 x 10-2 mglmL) exhibited better activity than its eis-isomer 
(ICso=lO.O x t 0-2 mglmL). 
Table 54. DPPH assay of quinic acid derivatives 
Compounds 
p-CoumaroyJquinic acid (181) 
cis-p-Coumaroylquinic acid (182) 
Chlorogenic acid (168) 
4.3.3.5 DPPH Assay of Flavonoids 
ICso (mglmL) 
7.6 X 10-2 
10.0 X 10-2 
2.3 x 10-2 
Flavonoids are widely used as antioxidant. The results from the DPPH assay of 
flavonoids are summarised in 55. Kaempferol (122) had an ICso value of 3.5 x 10-3 
mg/mL. The ICso values for astragalin (123) and afzelin (187) were 8.0 x 10-2 and 
11.6 X 10-2 respectively. These results showed that glycosidation did not effect 
significantly the scavenging activities ofthese flavonoids (108 and 123). 
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Table 55. DPPH assay of flavonoids 
Flavonoids 
Kaempferol (122) 
Astragalin (123) 
Afzelin (187) 
Apigenin (108) 
Orientin (188) 
Hydroxybenzoyl-isoorientin (189) 
Flavanone-apiose-glucuronic acid (190) 
4.3.3.6 DPPH Assay of Alkaloids 
ICso (m~mL) 
3.5 x 10-
8.0 x 10-2 
11.6 x 10-2 
1.4 X 10-2 
3.5 X 10-2 
4.6 X 10-2 
>5.0 x 10-2 
The antioxidant activities of alkaloids are summarised in Table 56. Moschamine 
(148), centcyamine (146) and schischkiniin (194) showed the highest antioxidant 
properties with the ICso values of 2.2 x 10-3, 2.8 x 10-3 and 3.8 x 10-3 mg/mL, 
respectively. Although alkaloids were not well reported as antioxidant like 
flavonoids, the higher antioxidant properties for moschamine, centcyamine and 
schischkiniin were due to the presence of indole moiety in these alkaloids. 
Table 56. DPPH assay of alkaloids 
Alkaloids 
N-( 4_Hydroxycinnamoyl)-5-hydroxytryptamine (145) 
cis_N-(4-Hydroxycinnamoyl)-5-hydroxytryptamine (192) 
Centcyamine (146) 
cis-Centcyamine (147) 
Moschamine (148) 
cis-Moschamine (149) 
Tryptamine (192) 
Montamine (193) 
Schischkiniin (194) 
1Cso (m~mL) 
1.6 x 10-
4.8 x 10-2 
2.8 x 10-3 
3.2 x 10-3 
2.2 x 10-3 
4.5 x 10-3 
6.4 x 10-2 
3.6 x 10-2 
3.8 x 10-3 
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In benzene rings played a crucial part for their antioxidant properties. Further 
investigation is necessary to use these compounds for antioxidant agents. Two 
sesquiterene lactones, arctiopicrin (21) and 8-0-(4-hydroxy-3-methylbutanoyl)-
salonitenolide (179) showed prominent cytotoxicity but they did not show 
scavenging activities at the test concentrations. These two compounds can be studied 
further for potential cytotoxic agents. 
Flavonoids showed better antioxidant properties than cytotoxicity. Kaempferol (122) 
was the most active against DPPH assay among the tested flavonoids. Among the 
cis-Irans isomers (148-149, and 181-182), the Irans compounds (148 and 181) 
showed higher cytotoxicity than the eis-compound (149 and 182). These results 
suggest that the Irans configuration is essential for cytotoxicity in both alkaloids 
(148) and quinic acid (168). Among the alkaloids, two novel dimers montamine 
(193) and schischkiniin (194) showed potent cytotoxic properties which implied that 
dimerisation can lead to an increase in cytotoxicity. It can be suggested that this type 
of indole alkaloids might be the candidate for further study as potential anticancer 
agents. 
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Appendix A 
NMR Spectra of Isolated Compounds (Figure 78-134) 
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DATA PROCESSING 
line broadening 9.0 Hz 
Sine bell 0.157 sec 
Fl DATA PROCESSING 
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OATA PROCESSING 
line broadening &.3 Hz 
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Fl DATA PROCESSING 
line broadening 53&.3 Hz 
Sine bell 0.005 s ec 
FT size 4096 x 512 
Total tl.e 5 hr , 42 .In, 8 sec 
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Figure 90. HMBC ,spectrUm (CD30D, 400 MHz) of SMS (3"-O-caffeoyl-
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file: MS1_41_3 
INOVA-400 "ca l1fornlulI.che •• abdn.ac.ulC" 
Rela~ . delay 1.000 sec 
pulse 84.9 degrees 
Acq. tllle 2 . 924 sec 
WIdth 2871.0 Hz 
16 repetitions 
OBSERVE H1, 3".8S81~94 MHz 
DATA PROCESSING 
Line broadening 0.2 Hz 
FT size 32768 
Total tl.e 1 .In, 2 sec 
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FigUre 93. IHNMR spectrum (CD30D, 400 MHz) ofSM8 (berchemol, 172) 
Pulse ~equ.ne., ~.cy_l. 
Solv4nt: CD300 
Temp. 26.0 C / 2".1 K 
fIle : "51 41 3 CD30D noISY 
INOVA-400- "callfornTu ... che •. abdn.ac.uk" 
Relax. delay 1.000 sec 
MIxIng 0 . 800 sec 
Acq. tIme 0.346 sec 
WIdth 2871.0 Hz 
20 WIdth 2871.0 Hz 
16 repetItIons 
2 x 256 Incre.ents 
OeSERVE H1, 399.81813'4 "Hz 
DATA PROCESSING 
Sq. sIne bell 0.346 sec 
ShIfted by -0.340 sec 
F1 DATA PROCESSING 
Sq. sIne bell 0 . 081 sec 
FT sIze 4096 x 1024 
Total tl.e 5 hr, 1 .In, 22 SIC 
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Figure 94. NOESY spectrum (CD30D, 400 MHz) of SM8 (berchemol, 172) 
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Pulse $equenee. g~.4e_J. 
Solvent : C0300 
Tellp. 26.0 C / 2".1 K 
INDVA-400 "ca I Ifornl UII. ch ••. abdn.ac.uk" 
Relax. delay 1.odo sec 
Acq . tl.e 0.431 sec 
WIdth 2302.2 Hz 
20 WIdth 13317.8 "z 
64 r.petltlons 
256 I ncr •• ents 
D8SERVE "1, 311.8181394 M"z 
DATA PROCESSING 
LIne broadenIng 3.0 Hz 
SIne bell 0.215 sec 
F1 DATA PROCESSING 
LIne broadenIng 83.6 Hz 
SIn. bell 0.010 sec 
FT slz. 4016 x 512 
Total tl •• 6 hr, 53 .In, 26 SIC 
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Figure 96. HMBC spectrum (CD30D, 400 MHz) of SM9 (berchemol 4' -O-p-o-
glucopyranoside, 173) . 
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Figure 98. DEPT-135 spectrum (CD30D, 100 MHz) ofSMI0 (pinoresinol, 144) 
40 ppm 
Pulse Sequene.1 §h.4~_6A 
Solvent: CD3DD 
Temp. 26.0 C / 29'.1 K 
INOVA-400 "callfornluM.ch ••• abdn.ac.Uk" 
Rela~. delay 1.0~ sec 
Acq . time 0.307 sec 
Width 3227 . 0 Hz 
20 Width 12596.4 Kz 
64 repet It Ions 
256 Increments 
OBSERVE HI, 399.8981394 "Hz 
DATA PROCESSING 
Line broadening 3.6 Hz 
Sine bell 0 . 154 sec 
Fl DATA PROCESSING 
Line broadening 52.4 HZ 
Sine bell 0.010 sec 
FT size 4096 ~ 512 
Total time 6 hr, 19 .In, SO sec 
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Figure 99. HMBC spectrum (CD30D, 400 MHz) ofSMI0 (pinoresinol, 144) 
Puis. §equ."t!'1 r"~'tJ,-tl6 
solvent: cd30d 
TeMp. 26.0 C I 2" . 1 K 
File: Shoeb_MS13_10_1H_TROESY_800MS_CD30D 
INOVA-400 "call fornl u •• che • • abdn .ac. uk" -
Rela~. delay 1.000 sec 
"1~lng 0.800 sec 
Acq. tl.e 0. 177 sec 
Width 5602.2 Hz 
20 Width 5602.2 Hz 
16 repet I t Ions 
2 ~ 256 Incre •• nts 
O&SERVE Hl, 311.8181314 "Hz 
DECOUPLt Hl, 31'.10013'2 "Hz 
Power 46 d& 
off during acquIsItIon 
on durIng delay 
sIngle frequency 
DATA PROCESSING 
Sq. sIne bell 0.177 seC 
Shifted by -0.117 lec 
Fl DATA PROCESSING 
Sq . sIn. bell 0.046 sec 
ShIfted by -0 . 046 sec 
FT size 4016 ~ 1024 
Tota] tl.e 4 hr, 35 .In, 0 lee 
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Figure 100. ROESY spectrum (CD30D, 400 MHz) of SMI0 (pinoresinol, 144) 
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Figure 101. l3C NMR spectrum (CD30D, 100 MHz) ofSM13 (pinoresinoI4-0-~-D-
glucopyranoside, 176) , . . 
Solvent : CD300 
Ts.p . 2~ . O C / 2".J K 
IHOVA-400 "callfornluIII.che •. abdn.aC.u,," 
RelaK. delay 1.000 sec 
Acq . tl.e 0.506 sac 
Width 1959 . S Hz 
20 width 11467.9 Hz 
54 repetitions 
256 Incre.ents 
OBSERVE H1, 399.8981394 MHz 
DATA PROCESSING 
LIne broadening 2.8 Hz 
Sine bell 0.253 sec 
F1 DATA PROCESSING 
Line broadening 41.3 Hz 
Sine bell 0.011 sec 
FT size 4096 K 512 
Total tl.e 7 hr, 14 .In, 25 sec 
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Figure 102. HMBC spectrum of SM15 (Pinoresinol 4-0-p-D-apiose furanosyl-
(1 ~2)-P-D-glucopyranoside, 178) 
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Figure 103.0 DEPT-135 spectrum (CD30D, 100 MHz) ofSM16 (arctiopicrin, 21) 
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Solvent: cdSod 
Te.p. 26.0 C / 2".1 K 
INOVA-400 .. c.llfornlu •. Ch •••• bdn •• C.Uk .. 
2 
Rela •. delay 1.010 ,ec 
Acq. ti •• 0.177 sec 
Width 5602.2 Hz 
20 WIdth 2503'.1 Hz 
96 r.petltlons 
128 Incre.ents 
OBSERVE HI, 311.8981314 "Hz 
DATA PROCESSING 
lIne broadenIng 0.2 Hz 
SIne bell 0 . 08' sec 
Fl DATA PROCESSING 
lIne broadenIng 536 .3 Hz 
SIne bell 0.005 sec 
FT sIze 4096 • 512 
Total tl •• 4 hr, 16 .In, 41 sec 
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Figure 104.HMBC spe~trum (CD30D, 100 MHz) ofSM16 (arctiopicrin, 21) 
So 1vent: cd30d 
Temp. 26.0 C / 211.1 K 
INOVA-400 .. calffornfu •• ch ••.• bdn .• c.uIC N 
Rela~ . delay 1.010 sec 
Pulse 65 . 3 degre., 
Acq . tl •• 2.925 ,ec 
Width 5602.2 Hz 
16 repet !'lIons 
08SERVE H1, 3 ••• 8.84633 MHz 
DATA PROCESSING 
Line broadening 0.2 Hz 
FT size 32768 
Total tl.e 1 .In, 37 ,ec 
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Figure 105. IH NMR spectrum (CD30D, 400 MHz) of SM17 (8-0-4-hydroxy-3-
methylbutanoy.l-salonitenolide, 179) 
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Figure 106. 13C NMR spectrum (CD30b, 100 MHz) of SM17 (8-0-4-hydroxy-3-
methylbutanoyl-salonitenolide, 179) 
~-VJ 
So1v.nt: Cd30d 
T •• p. 26 . 0 C / 2".1 K 
INOVA-400 .. callfornlu •• ch ••.• bdn •• C.Uk" 
Rela~. delay 1.080 sec 
Acq. ti.e 0 . 177 sec 
Width 5602.2 Hz 
20 Width 2503'.1 Hz 
128 repet i t ions 
128 lncre.ents 
OBSERVE Hi, 3!8 . 8184633 "Hz 
DATA PROCESSING 
Line broadening 0.2 Hz 
Sine bell 0.08' sec 
Fl DATA PROCESSING 
Line broadening 0.3 Hz 
Sine bell 0.005 sec 
FT size 4086 ~ 512 
Tot., ti.e 5 hr, 42 .In, 8 $ec 
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Figure 107. HMBC spectrum (CD30D, 400 MHz) of SM17 (8-0-4-hydroxy-3-
methylbutanoyl-saloniten6lide, 179) 
Pulse Sequence : s 2puJ 
Solvent: cd30d 
Temp . 26.0 C I 299 . 1 K 
INOVA-400 "caltforntulI.chelll.abdn.ac.uk" 
Relax. delay 1.000 sec 
Pulse 65.3 degrees 
Acq. tt.e 2.925 sec 
Width 5602.2 Hz 
Single scan 
OBSERVE HI, 311.8181394 MHz 
DATA PROCESSING 
line broadentng 0.2 Hz 
FT size 32768 
Tota l tt.e 0 .In , 3 sec 
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Figure 108. IH NMR spectrum (CD30D, · 400 MHz) of SM19 (trans 3-0-p-
coumaroyl quinic acid, 181) 
ppm 
PuJse Sequence: gh.qc_da 
Solvent: cd30d 
re.p . 26.0 C / 2" . 1 K 
INOVA-400 "callfornlu • . che •. abdn.ac.UIC" 
Relax. dela~ 1.boo sec 
Acq . tl.e 0.177 ,ec 
Width 5602 . 2 Hz 
20 Width 25031.1 Hz 
96 repet I t Ions 
128 Incre.enU 
OBSERVE Hl, 311.8'81394 "Hz 
DATA PROCESSING 
Line broadening 0.2 Hz 
Sine bell 0.08' ,ec 
Ft DATA PROCESSING 
Line broadening 0. 3 Hz 
Sine bell 0.005 sec 
FT size 40.6 x 512 
Total tl.e 4 hr, 16 .In, 41 ,ec 
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Figure 109. HMBC spectrum (CD30D, 400 MHz) of SM19 (trans 3-0-p-coumaroyl 
quinic acid, 181) 
PU1S6 S.qu.nc.: gh.qc_da 
Solvent: cd30d 
Te_p . 26 . 0 C I 2" . 1 K 
INOYA-400 "cellfornlu •• che •. abdn.ac.ulC" 
Relax. delay 1.000 sec 
Acq . tIme 0.177 sec 
WIdth 5602.2 Hz 
20 WIdth 2503' . 1 Hz 
96 repetItIons 
128 I ncre. ents 
06SERYE Hl , 3".8181394 MHz 
DATA PROCESSING 
line broadening 0.2 Hz 
SIne bell 0.08' sec 
F1 DATA PROCESSING 
lIne broadenIng 0.3 Hz 
SIne bell 0.005 sec 
FT sIze 4096 x 512 
Total tIme 4 hr , 16 mln, 41 sec 
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. Figure 110. HMBC spectrum (CD30D, 400 MHz) ofSM21 (chlorogenic acid, 168) 
Puls e S e quence : c~~d' 
'<o1vent : C0300 
Temp . 26 . 0 C / 299.1.K 
INOVA-400 "callfornlum.chem.abdn.ac.uk" 
Relax . delay 1 . 000 sec 
Pulse 46 . 2 degrees 
Acq . time 2 . 925 sec 
Wi dth 4000 . 0 HZ 
16 repetitions 
OBSERVE Hl, 399.8981394 KHz 
DATA PROCESSING 
Line broadening 0.2 HZ 
FT size 32768 
Total time 1 ml n, 2 sec 
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Figure 111. IH NMR spectrum (CD30D, 400 MHz) ofSM29 (afzelin, 187) 
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Figure 112. l3C NMR spectrum (CD30D, 100 MHz) ofSM29 (afzelin, 187) 
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Pulse s e quence: g",q/eopc_J .. 
so~vent: CD300 
Temp . 26 . 0 C I 299 . 1 K 
INOVA-400 ·callfornlpm.chem.abdn.aC.Uk" 
Relax. delay 1.0aO sec 
Acq. time 0.248 sec 
Width 4000.0 Hz 
20 width 4000 . 0 Hz 
8 repetitions 
2 x 256 Increments 
OBSERVE Hi, 399 .8981394 "Hz 
DATA PROCESSING 
Sq . sine bell 0.248 sec 
Shifted by -0.248 sec 
F1 DATA PROCESSING 
Sq . sine bell 0.064 sec 
Shifted by -0 . 064 sec 
FT size 4096 x 1024 
Total time 1 hr, 2B mln, 46 sec 
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Figure 113~ lH_1H COSY spectrum (CDJOD, 400 MHz) of SM29 (afzelin, 187) 
Pulse Sequence: ghmqc_d4 
Solvent : CD300 . 
Temp . 26 . 0 C / 299.1 K 
INOVA-400 "callfornlum.chem.abdn.ac . uk" 
Relax. delay 1.00~ sec 
Acq. time 0 . 248 sec 
Width 4000.0 Hz 
20 Width 25039 . 1 Hz 
96 repetitions 
256 Increments 
OBSERVE HI, 399.8981394 MHz 
DATA PROCESSING 
Sine bell 0 . 124 sec 
F1 DATA PROCESSING 
line broadening 0.3 Hz 
Sine bell O. OOS sec 
FT s i ze 4096 x 512 
Total time! hr, 3 mln, 9 sec 
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Figure 114. HMBCspectrum (CD30D, 400 MHz) of SM29 (afzelin, 187) 
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Pulse sequence: s2pul 
solvent: OIlSO 
Temp. 26.0 C I 2!!.1 K 
INOVA-400 "callfornlum.che •. abdn.ac.ulC-
Relax. delay 1.00~ sec 
Pulse 65 . 3 degre., 
Acq. tl.e 2.'25 ,ec 
Width 10000 . 0 Hz 
16 repetition, 
oaSERVE HI. 3 ••. 1.14633 "Hz 
DATA PROCESSING 
Line broadening 0.2 Hz 
FT & 1 ze 65536 
Total tl •• 1 .In. 2 ,ec 
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Figure 115. IH NMR spectruni (DMSO-<4, 400 MHz) ofSM30 (apigenin, 108) 
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Pulse Sequence: s2pul 
Solv.nt: DMSD 
Te.p. 26.0 C I 1".1 K 
IMOVA-400 Mca'1fornlu • . th •••• bdn •• t.ukM 
R.'aK. d.'ay 1.'00 ,.t 
Pulse 15.3 degree' 
Acq . tl.e 2 . '25 'ec 
WIdth 8000.0 Hz 
32 r.p.tltlon, 
Oa5ERVE H1, 3" . 8'84633 "Hz 
. DATA PROCESSING 
lln. broad.nlng 0.2 Hz 
FT ,lz. 65531 
Total tt •• 2 .In, 5 'eC 
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Figure 117. H NMR spectrum (DMSO-<4, 400 MHz) of SM33 (orientin, 188) 
Pu'~~ ~4~U4NC'! ~~pul 
(!..L\ 
., 
... 
to 
N 
to 
... 
e-l~E 
~~ 
N 
N 
..... 
., 
.. 
" 
N'" ON 
NO 
." ... 
...... 
...... ~-L\ 
~~~ 
'" It> 
.. ... 
." 
.. 
.. 
It> 
" 
It> 
.,. 
.,. 
.. 
.,. 
... 
~~' 
c:i-~ 
o 
... 
... 
. . 
If) 
C> , (';'c, , 
c-5 
. ~c:.-\O . 
... 
~\~ 
..... 
... (1')" 
It> 00 ..... 
CD N· 
. . ., 
~ po.. CD = 
... 0'" . 
o ... 
o 
N 
" 
c::l ' 
'" ..,. 
" 
<t> 
It> 
..... 
N 
... 
00 · 
... . 
o 
o.,N 
'" . '" 0"'''' ('I") .,..... 
~ ~ I ~ 
..... 
" 
... 
... 
N 
N 
11 <t> 
." I 
'JI<::'-~ ~~ 11 
c.-L C-G 0 c,-l.\ 
c_G,J 
...... '" I"" '" OD g,r--r-. U")~('I') f'V')('t') cnr-.U') 
. .. . . . 
000 en en en 
~~~ (")('1')('1') 
H 
,. 
Fi~~e 118. l3C NMR spectrum~MSO-<4, 100 MHz) ofSM33 (orientin, 188) 
OH 
OH 
R=C-Glucoside 
Pulse Sequence: gh.qc_da 
Soll/ent: D"SO 
Te_p . 26.0 C I 2".1 K 
INOVA-400 "californlu • . che •. abdn.aC.UIC" 
Relax. delay 1.&00 .ec 
Acq. tl.e 0.180 .ec 
Width 5525.2 Hz 
20 Width 18885.0 Hz 
16 repetitions 
256 Incre.ents 
08SERVE . H1, 3".8'84633 MHz 
DATA PROCESSING 
line broadening 7.6 Hz 
Sine bell 0.010 sec 
F1 DATA PROCESSING 
line broadening 35.2 Hz 
Sine bell 0.006 sec 
FT 51ze 40'6 x 512 
Total tl.e 1 hr, 26 .In, 12 sec 
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Figure 119. HMBGsPectium (DMSO-~, 400 MHz) ofSM33 (orientin, 188) 
Z 
l5 
PuJ s . Sequence : gh.qc_da 
Solvent: CD3DD 
Te.p . 26 . 0 C I 2".1 K 
INOVA-400 -e.llfornlu •. eh •••• bdn •• e.Uk" 
Relax. del.y 1.'000 see 
Acq . tl.e 0. 288 ,ec 
Width 3445.0 Hz 
2D Width 14144 . 1 Hz 
32 repetitions 
. 256 I ncre •• ntl 
OBSERVE HI, 311 .SIS131. "Hz 
DATA PROCESSING 
Line broadening 3 . 1 Hz 
Sine bell 0.144 ,ee 
Fl DATA PROCESSING 
Line broadening 102 . 0 Hz 
Sine bell 0.001 .ee 
FT ,Ize 40.1 x 512 
Tot.l tl.e 3 hr, 7 .In, 13 ,ec 
-
, 
... ~ "'~ r. 
- ",'" b ~ 
... . 
... -? :::::::!I 
a AD " 
~ 
J ---
:r 
~ 
(/l 
j 
eJ 
i;~ ==I 
-
= ;;---1 
.., . 
,-t) . 
---._-
1 
ppm 
80 
90 
100 
110 
120 
130 
140 
150 
160 
170 
180 
\-\-t'" \\-G' ~-i 
c . 
o 
\\-~ 
• 0 oe ~-~_ <:.-\0 
e 
\-\ 
0 , 
o -~'_t-e:, @l .' ; • . ' 
\4-J. ~':' c- C:" \\-i " c. - \ >' , 
"e I 0 ,-' \"\-~Lc.-':; . \i ~ ~ - c.- !~/ 
\\ ", ",., . 
(& \1-" - ,-- '1 ' ,-
co 
e ' H-~- ~-~ 
00° 
\-\~~-,--", 
\-\-\" 
se @ 
cC> 
00 ~, t 
\-\ - \ - ,,- \c::> 
00 \--\_ ,)) _ Co-\;) 
I" \-\ -\ ~ '- <:.- i 
~<.TI...,r-..-..,...-r-r ..... ~-r-,....,....,-;,....,. ..... :..;.-r-,......,.......,-,-,-r-r--.,.---..,...-r-.-.... -r---,r--T-..,.....,.- .-,....,1 ""~-r - 1 •.• r- T ' ·" - r-, ,......,.1-.-.... -,-' 
8.0 . 7.5 7.0 6. S· 6.0 5.5 5.0 4.5 4.0 3.5 
F2 (ppm) 
Figure 120. HMBCspectrum (CD30D, 400 MHz) of SM35 (4"'-hydroxybenzoyl-
isoorientin, 189) · . 
Pul s e Sequ.nce: s2pul 
Solvent : cd30d 
Ta_p. 26.0 C I 299.1 K 
INOVA-400 "cllllfornlu •. che •. llbdn.llc.ulC" 
Relax. delay 1 . 000 sec 
Pulse 65.3 degrees 
Acq. tl.e 2.925 ,ec 
Width 5602.2 Hz 
16 repetitions 
OBSERVE H1, 319.8181314 "Hz 
DATA PROCESSING e 
line broadening 0.2 H~­
FT size 32768 ~~ 
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Figure 121. IH NMR spectrum (CD30D, 400 MHz) of SM36 (7-0-apiofuranosyl 
(1~4)-glucuronic acid, 190)" ' 
Pulse Sequence: gh.qc_de 
Solvent: cd30d 
Te_p. 26.0 C I 29'.1 K 
INOVA-400 "callfornlu ... ch ••• abdn.ac.ulC" 
R.'ax. delay 1.0db sec 
Acq. tl •• 0.177 sec 
WIdth 5602 . 2 Hz 
20 WIdth 2503'.1 Hz 
96 repetItIons 
128 Incre.ents 
08SERVE H1, 311.8181314 "Hz 
DATA PROCESSING 
LIne broadenIng 0.2 Hz . 
SIne bell 0.089 sec 
F1 DATA PROCESSING 
LIne broadenIng 0.3 Hz 
SIne bell 0.005 sec 
FT size 4096 x 512 
Total tl •• 4 hr, 16 .In, 41 sec 
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Figure 123. HMBC spectrum (CD30D, 400 MHz) of 
(l ~4)-glucuronic acid, 190) 
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Pulse Sequence: gh_qc_da 
Solvent: cd30d 
Te_p. 26.0 C I 299.1 K 
File: Shoeb "S_87 3_gH"BC CD300 
INDVA-400 "callfornlu_.che •• abdn.aC.Uk" 
Relax . delay 1.000 sec 
Acq. tl.e 0 . 177 sec 
width 5602.2 Hz 
20 Width 2503'.1 Hz 
112 repetitions 
128 I ncre.ents 
D8SERVE HI, 3.8.81813.4 MHz 
DATA PROCESSING 
Line broadening 0.2 Hz 
Sine bell 0.081 sec 
Fl DATA PROCESSING 
Line broadening 0.3 Hz 
Sine bell 0.005 sec 
FT size 401. x 512 
Total tl.e 4 hr, SI .In, 24 sec 
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Figure 124. HMBC spectrum (CD30D, 400 MHz) ofSM37 (tryptamine, 191) 
Pulse Sequence: s2pul 
Solvent: CD30D 
--------------------------------------------~>~----------~ .. 
Teep . 26.0 C I 219.1 ~ 
INOVA- 400 "callfornlu •. che •. abdn.ac.uk" 
Rela~. delay 1 . 0GO sec 
Pulse 65 . 3 degrees 
Acq. tl.e 2 . 125 sec 
wIdth 5602 . 2 Hz 
32 repetItIons 
08SERVE H1, 3" . 8181314 MHz 
DATA PROCESSING 
line broadenIng 0.2 Hz 
FT sIZe 32768 
Total tl.e 2 Mln, 5 sec 
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Figure 125. IH NMR spectrum (CD30D,400 MHz) ofSM42 (moschamine, 148) 
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Figure 126. l3C NMR spectrum (CD30D, 100 MHz) of SM42 (moschamine, 148) 
... ~ IO~"'N'" .... ~ .... 0 00&0 ID V) If) C') C') 
"": ~ . ..; . ~ ~ ~ I ~ ~fJ . ~ 
<:.-c, 
N 
.... 
... 
'11 1 1 ~ 1 ~ 
<:re, 
<:.-,' 11 1 1 I1 1 O-~\\~~') ~ ; ~-~ I 
~- ~-e\-\.t.1 (j- ~-C\\~ 
OH 
7' 6' 
Figure 127. DEPT-135 spectrum (CD30D, 100 MHz) ofSM42 (moschamine, 148) 
- ------_ . ... - -- .. 
Solvt1nt: C0300 
Temp . 26 . 0 C / 2".1 ~ 
INOVA-400 "ca llforn j um. ch .... abdn .ae. u"" 
Relax . delay 1.000 sec 
Acq. time 0 . 351 sec 
Width 2827.3 Hz 
20 Width 17028.5 Hz 
16 repetitions 
256 Increments 
OBSERVE HI, 399.8981394 "Hz 
DATA PROCESSING 
Line broadening 6.4 Hz 
Sine bell 0 . 17S sec 
Fl DATA PROCESSING 
Line broadening 118.4 Hz 
Sine bell 0.008 sec 
FT size 4096 x 512 
Total time 1 hr, 38 mln, 2 sec 
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Figure 128. HMBCspectrurit (CD30D, 400 MHz) of SM42 (moschamine, 148) 
Pulse Sequence: s2pul 
Solvent: cd30d 
Temp . 26 . 0 C / 2".1 K 
INOVA-400 "call fornl um. chem.abdn.ac .UfC" 
Relax. delay 1.000 sec 
Pulse 65 . 3 degree, 
Acq. time 2.925 sec 
Width 5602.2 Hz 
Single scan 
OBSERVE H1, 399.8981394 MHz 
DATA PROCESSING · 
Line broadening 0.2 Hz 
FT size 32768 
Total time 0 .In, 3 sec 
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Figure 129. IH NMR spectrum (CD30D~ 400 MHz) of SM44 (montamine, 193) 
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Pulse Sequence: ghsqc_da 
Solvent: cd30d 
Temp. 26 . 0 C I 299.1 K 
INOVA-400 "callfornlum.chem.abdn .ac.uk" 
Relax . delay 1 . 000 sec 
Acq. time 0.177 sec 
Width 5602 . 2 Hz 
20 Width 25047.0 Hz 
32 repetitions 
2 x 128 Increments 
OBSERVE H1, 399 . 8981394 "Hz 
DECOUPLE C13, 100.5639584 "Hz 
Power 45 dB 
on during acquisition 
off during delay 
GARP-1 modulated 
DATA PROCESSING 
Sq. sine bell 0 . 177 sec 
Shifted by -0 . 177 sec 
Fl DATA PROCESSING 
Sq. Sine bell 0.010 sec 
Shifted by -0 . 010 sec 
FT size 4096 x 1024 
Total time 2 hr, 44 mln, 43 sec 
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:Figure 130. HSQCspectrum (CD)OD, 400 MHz) ofSM44 (montamine, 193) 
I 
Pulse Se~uenct~ g.~tco~~_d, 
Solvent: cd30d 
Temp . 26 . 0 C I 21'.J ~ 
INOVA-400 "callfornlu •. che •. abdn.ac.ulC" 
Relax. delay 1.000 sec 
Acq. tl.e 0 . 177 sec 
Width 5602.2 Hz 
20 Width 5602 . 2 Hz 
8 repetltlon~ 
2 x 256 Incre.ents 
08SERVE HI, 3".8'81394 "Hz 
DATA PROCESSING 
Sq. sine bell 0.177 sec 
Shifted by -0.177 sec 
Fl DATA PROCESSING 
Sine bell 0.046 sec 
Shifted by -0.046 sec 
FT size 4096 x 1024 
Total tl.e 1 hr, 23 .In, 18 sec 
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Figure 131. Ifl)H COSY spectrum (CD30D, 400 MHz) ofSM44 (montamine, 193) 
Pulse Sequence: ghmqc_da 
Solvent: cd30d 
Temp. 26 . 0 C / 2'9 . 1 K 
INOVA-400 "callfornlum.cheM.abdn.ac . uk" 
Rela~. delay ,1.000 sec 
Acq. tiMe 0.177 sec 
Width 5602.2 Hz 
20 Width 25039.1 Hz 
96 repetitions 
128 I ncre.ents 
08SERVE H1, 3'9.8981394 MHz 
OATA PROCESSING 
Line broadening 0.2 Hz 
Sine bell 0.089 sec 
F1 DATA PROCESSING 
Line broadening 0.3 Hz 
Sine bell 0 . 005 sec 
FT size 40.6 ~ 512 
Total tiMe 4 hr, 16 Mln, 41 sec 
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Figure 132. HMBC spectrum (CD30D,400 MHz) ofSM44 (montamine, 193) 
, , , 
Pulse SeQuence~ $~pu\ 
Solvent: C0300 
Temp . 26 . 0 C I 299.1 K 
INOYA-400 "callfornlum . chem . abdn .ac . uk" 
Rela~ . delay 1 . 00e sec 
Pulse 65.3 degrees 
Acq . time 2.925 sec 
Width 5602 . 2 Hz 
128 repet It Ions 
OBSERVE H1, 399.8981394 "Hz 
DATA PROCESSING 
line broadening 0.2 Hz 
FT size 32768 
Total time 8 mln, 23 sec 
\\-~ 
-8 
7 
5 
" 
2 H 
H 13' N ~~2' ~N' .... 0 N 12 H 
H 
I If I 
.... . _ . .. A-- . ___ _ 
I I I I I I - , I I --'-_·'--'--r--.--r--r---'- -r--' "' ·-T-U ,--'---'-
1 0 9 8 7 6 5 4 3 2 1 0 P pm 
L..-,..--' ',',',',' ~~ L.. ..,._I 
1.00 1.UI.25 1.38 2.31 2.34 0 . 62 
1.051.111.30 -5 . 52 1.96 0 . 67 
t..-r _ J 
0 . 68 
~~-...L.-r J 
0 . 96 0.50 
0 . 93 
Figure 133. IH NMR spectrum(CD30D, 400 MHz) of SM45 (schischkiniin, 194) 
-'-'-----_ ._- -- - .-_ . 
Pu'~e ~e~u~nc~! Qm~(cap~_~ 
Solvent: C0300 
Temp . 26 . 0 C / 299 . 1 K 
INOVA-400 "callfornlum . chelll.abdn.IlC . u/c" 
Relax. delay 1.060 sec 
Acq. time 0.300 sec 
Width 3304.4 Hz 
2D Width 3304.4 Hz 
16 repetitions 
2 x 256 .lncrelllents 
OBSERVE HI, 3'9.89813'4 "Hz 
DATA PROCESSING 
Sq. sine bell 0 . 300 sec 
Shifted by -0.300 sec 
Fl DATA PROCESSING 
Sq. sine bell 0.078 sec 
Shifted by -0 . 077 sec 
FT size 40'6 x 1024 
Total tl . e 3 hr, 5 IIlln, 30 sec 
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Figure 134. IH_IH COSY spectrum (CD30D, 400 MHz) of SM45 (schischkiniin, 
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Figure 91. DEPT-135 spectrum (CD30D, 100 MHz) ofSM7 (lariciresino14'-O-P-D-
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